Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nCPM"	"RNA single nuclei brain specificity"	"RNA single nuclei brain distribution"	"RNA single nuclei brain specificity score"	"RNA single nuclei brain specific nCPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific pTPM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Secretome function"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Brain expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	Interactions	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Cancer prognostics - Bladder Urothelial Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (TCGA)"	"Cancer prognostics - Breast Invasive Carcinoma (validation)"	"Cancer prognostics - Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (TCGA)"	"Cancer prognostics - Colon Adenocarcinoma (validation)"	"Cancer prognostics - Glioblastoma Multiforme (TCGA)"	"Cancer prognostics - Glioblastoma Multiforme (validation)"	"Cancer prognostics - Head and Neck Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Chromophobe (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (TCGA)"	"Cancer prognostics - Kidney Renal Clear Cell Carcinoma (validation)"	"Cancer prognostics - Kidney Renal Papillary Cell Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (TCGA)"	"Cancer prognostics - Liver Hepatocellular Carcinoma (validation)"	"Cancer prognostics - Lung Adenocarcinoma (TCGA)"	"Cancer prognostics - Lung Adenocarcinoma (validation)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (TCGA)"	"Cancer prognostics - Lung Squamous Cell Carcinoma (validation)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (TCGA)"	"Cancer prognostics - Ovary Serous Cystadenocarcinoma (validation)"	"Cancer prognostics - Pancreatic Adenocarcinoma (TCGA)"	"Cancer prognostics - Pancreatic Adenocarcinoma (validation)"	"Cancer prognostics - Prostate Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (TCGA)"	"Cancer prognostics - Rectum Adenocarcinoma (validation)"	"Cancer prognostics - Skin Cutaneous Melanoma (TCGA)"	"Cancer prognostics - Stomach Adenocarcinoma (TCGA)"	"Cancer prognostics - Testicular Germ Cell Tumor (TCGA)"	"Cancer prognostics - Thyroid Carcinoma (TCGA)"	"Cancer prognostics - Uterine Corpus Endometrial Carcinoma (TCGA)"
C3	"ARMD9, C3a, C3b, CPAMD1"	ENSG00000125730	"Complement C3"	P01024	19	6677704-6730562	"Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Fatty acid metabolism, Immunity, Inflammatory response, Innate immunity, Lipid metabolism"		"Age-related macular degeneration, Disease variant, FDA approved drug targets, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	9	"liver: 5062.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 600.4;Cholangiocytes: 820.3;Conjunctival goblet cells: 549.5;Decidual stromal cells: 714.5;Endometrial secretory cells: 578.5;Epicardial cells: 755.0;Fibroblasts: 641.5;Hepatocytes: 4896.9;Lacrimal acinar cells: 537.2;Mesothelial cells: 1368.4;Microglia: 649.7;Pancreatic duct cells: 642.3"	"Cell type enriched"	"Detected in many"	49	"central nervous system macrophage: 753.0"	"Cancer enriched"	"Detected in all"	4	"Liver Hepatocellular Carcinoma (TCGA): 2548.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"non-classical monocyte: 14.5"	"Lineage enriched"	"Detected in many"	5	"monocytes: 14.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 255.0"	"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Fibroblasts_2, Stomach - Fibroblasts, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA003563, CAB004209, HPA020432"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	NA	1260000000000	370000000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	42			"CAB004209: , HPA003563: , HPA020432: "	"potential prognostic favorable (1.46e-4)"	"unprognostic (3.99e-3)"	"unprognostic (2.04e-2)"	"unprognostic (6.44e-2)"	"unprognostic (6.78e-2)"	"unprognostic (8.30e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.64e-3)"	"potential prognostic favorable (2.99e-6)"	"unprognostic (1.82e-1)"	"unprognostic (3.09e-3)"	"unprognostic (7.40e-3)"	"unprognostic (6.78e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.47e-3)"	"unprognostic (3.71e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.99e-2)"
CR1	"CD35, KN"	ENSG00000203710	"Complement C3b/C4b receptor 1 (Knops blood group)"	P17927	1	207496147-207641765	"Blood group antigen proteins, CD markers, Plasma proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 12.4;lymphoid tissue: 25.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 176.8;Kupffer cells: 411.0;Neutrophil progenitors: 136.8;Neutrophils: 1929.7;Podocytes: 706.7"	"Cell type enhanced"	"Detected in some"		"fibroblast: 7.1;leukocyte: 12.1;oligodendrocyte: 8.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 53.8;eosinophil: 17.2;neutrophil: 15.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 53.8"	"Group enriched"	"Detected in some"	9	"Leukemia: 3.6;lymphoma: 1.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Kidney - Podocytes, Lung - Neutrophils_2, Minor Salivary Gland - Macrophages, Pituitary gland - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002491, CAB016271, HPA042455, HPA043579, HPA049348"	Enhanced		Supported	"Plasma membrane"			NA	NA		19000000	"Cluster 20: Non-specific - DNA binding"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 11: White matter - Signal transduction"	"Cluster 55: Lymphoma - Immune response"	"Cluster 24: Neutrophils - Innate immunity signal integration"	1	"Plasma membrane"		"CAB002491: , CAB016271: , HPA042455: , HPA043579: , HPA049348: "	"unprognostic (3.19e-1)"		"unprognostic (6.73e-3)"			"unprognostic (2.40e-1)"		"potential prognostic unfavorable (3.09e-4)"				"unprognostic (6.59e-2)"				"unprognostic (1.20e-3)"	"unprognostic (6.21e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.00e-1)"			"unprognostic (4.72e-2)"	"unprognostic (3.66e-2)"			"unprognostic (1.23e-1)"		"unprognostic (5.13e-2)"	"unprognostic (2.49e-2)"		
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952086	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"liver: 2370.8"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 3.3;Endometrial secretory cells: 9.1;Epicardial cells: 34.1;Mesothelial cells: 9.3;Prostatic club cells: 5.2;Renal collecting duct principal cells: 3.5"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 5.7;vascular associated smooth muscle cell: 1.7"	"Cancer enriched"	"Detected in all"	7	"Liver Hepatocellular Carcinoma (TCGA): 1490.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"head and neck cancer: 34.6"	"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Mesothelial cells, Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Spleen - Fibroblasts_1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	Immunity	NA	NA	879000000	89000000000		"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 12: Non-specific - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 83: Epicardial mesothelial cells - Basic cellular functions"	5	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: , HPA000951: , HPA001817: , HPA001832: "	"unprognostic (4.10e-2)"	"unprognostic (4.75e-3)"	"unprognostic (3.23e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.92e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.40e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.24e-1)"	"potential prognostic unfavorable (2.40e-5)"	"unprognostic (8.00e-2)"	"unprognostic (4.95e-3)"	"unprognostic (9.65e-3)"	"potential prognostic favorable (1.37e-7)"	"unprognostic (2.35e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.76e-2)"
CFI	"C3b-INA, FI, IF, KAF"	ENSG00000205403	"Complement factor I"	P05156	4	109731008-109802150	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 917.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 15.7;Endometrial secretory cells: 20.7;Endometrial stromal cells: 15.7;Epididymal efferent duct absorptive cells: 12.7;Fallopian secretory cells: 12.7;Granulosa cells: 13.8;Hepatocytes: 50.1;Lymphatic endothelial cells: 12.7;Mesothelial cells: 20.5;Salivary duct cells: 13.3;Vascular endothelial cells: 11.4"	"Cell type enriched"	"Detected in some"	6	"endothelial cell: 68.4"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 220.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Endothelial cells, Colon - Endothelial cells, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Spleen - Endothelial cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA001143, CAB016777, HPA024061"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	30300000000	19000000000		"Cluster 16: Liver & Kidney - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 104: Brain endothelial cells - Blood brain barrier"	6			"CAB016777: , HPA001143: , HPA024061: "	"unprognostic (1.80e-1)"	"unprognostic (7.81e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.60e-3)"	"potential prognostic favorable (1.43e-4)"	"unprognostic (3.38e-1)"	"unprognostic (1.31e-1)"	"potential prognostic favorable (4.43e-5)"	"unprognostic (4.34e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.92e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.35e-3)"	"unprognostic (4.84e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.07e-2)"
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945673	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 454.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 11.6;Brain excitatory neurons: 9.4;Brain inhibitory neurons: 11.5;Choroid plexus epithelial cells: 9.6;Decidual stromal cells: 8.9;Distal convoluted tubule cells: 10.1;Hepatocytes: 8.1;Hofbauer cells: 16.3;Loop of henle epithelial cells: 8.5;Other brain neurons: 8.5;Podocytes: 11.6;Proximal tubule cells: 11.3;Renal collecting duct intercalated cells: 6.8;Renal collecting duct principal cells: 8.3;Renal connecting tubule cells: 10.0"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 250.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 20.7;non-classical monocyte: 26.1"	"Lineage enriched"	"Detected in single"	33	"monocytes: 26.1"	"Group enriched"	"Detected in many"	4	"liver cancer: 11.4;Myeloma: 14.9;thyroid cancer: 5.1"	"Adipose subcutaneous - Macrophages, Adrenal gland - Macrophages, Kidney - Proximal tubular cells, Liver - Hepatocytes, Skin - Fibroblasts_2, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	37800000000	14000000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 102: Non-specific - Mixed function"	7			"CAB016775: "	"unprognostic (8.96e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.42e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.36e-3)"	"unprognostic (2.02e-3)"	"unprognostic (7.84e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.99e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.71e-2)"	"unprognostic (5.88e-2)"	"unprognostic (5.09e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.33e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.18e-2)"
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adrenal gland: 174.9;liver: 262.1"	"Cell type enhanced"	"Detected in single"		"Epicardial cells: 2.3"	"Cell type enhanced"	"Detected in some"		"astrocyte: 1.4;vascular associated smooth muscle cell: 1.0"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 238.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 6.7;Myeloma: 3.9"	"Adipose visceral - Mesothelial cells, Heart muscle - Macrophages, Liver - Hepatocytes"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	"Complement pathway"	NA	NA	447000000000	230000000000		"Cluster 76: Non-specific - Metabolism"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 83: Epicardial mesothelial cells - Basic cellular functions"	2			"HPA046356: , HPA048287: , HPA050103: "	"unprognostic (7.64e-2)"	"unprognostic (2.28e-1)"		"unprognostic (4.09e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-3)"	"unprognostic (8.48e-2)"	"unprognostic (1.16e-3)"	"unprognostic (1.30e-1)"	"potential prognostic unfavorable (7.93e-4)"	"unprognostic (2.86e-1)"	"unprognostic (2.41e-3)"	"unprognostic (2.31e-2)"	"unprognostic (3.75e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.92e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"
C1S		ENSG00000182326	"Complement C1s"	P09871	12	6988259-7071032	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant, Ehlers-Danlos syndrome, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"liver: 2663.1"	"Cell type enhanced"	"Detected in many"		"Decidual stromal cells: 1563.7;Fibroblasts: 960.8;Hepatic stellate cells: 580.9;Hepatocytes: 3326.7;Leydig cells: 1065.9;Ovarian stromal cells: 427.5;Peritubular myoid cells: 642.6"	"Cell type enriched"	"Detected in all"	5	"fibroblast: 348.0"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 745.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells, Liver - Hepatocytes, Lung - Fibroblasts_2, Prostate - Fibroblasts, Spleen - Fibroblasts_2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016722, HPA018852"	Supported		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	"Complement pathway"	NA	NA	93000000000	27000000000		"Cluster 53: Liver - Plasma proteins"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 108: Fibroblasts - ECM organization"	4	Nucleoplasm	Cytosol	"CAB016722: , HPA018852: "	"unprognostic (7.81e-3)"	"unprognostic (6.27e-3)"	"unprognostic (1.58e-1)"	"unprognostic (6.27e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.55e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.25e-2)"	"potential prognostic unfavorable (1.67e-5)"	"unprognostic (1.49e-3)"	"potential prognostic unfavorable (7.14e-5)"	"validated prognostic favorable (5.46e-4)"	"validated prognostic favorable (2.13e-5)"	"unprognostic (1.20e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.31e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.79e-2)"	"unprognostic (7.09e-3)"	"unprognostic (2.72e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.65e-3)"
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 117.5;liver: 341.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Breast Invasive Carcinoma (TCGA): 55.1;Kidney Renal Clear Cell Carcinoma (TCGA): 49.6;Kidney Renal Papillary Cell Carcinoma (TCGA): 32.8;Liver Hepatocellular Carcinoma (TCGA): 90.9;Thyroid Carcinoma (TCGA): 27.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 8.8;Myeloma: 6.7"	"Kidney - Proximal tubular cells, Liver - Hepatocytes"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	342000000	230000000000		"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 70: DU4475 - Unknown function"	"Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc"	13			"CAB009811: , CAB032603: , HPA046356: , HPA048287: , HPA050103: "	"unprognostic (3.29e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.58e-1)"	"unprognostic (9.96e-2)"		"unprognostic (8.69e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.64e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.66e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.94e-1)"		"unprognostic (9.91e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.46e-2)"
C5	"C5a, C5b, CPAMD4"	ENSG00000106804	"Complement C5"	P01031	9	120932987-121075195	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Inflammatory response, Innate immunity"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	30	"liver: 418.8"	"Cell type enriched"	"Detected in many"	13	"Hepatocytes: 861.1"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	9	"Liver Hepatocellular Carcinoma (TCGA): 102.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"liver cancer: 21.1"	"Liver - Hepatocytes"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA029339	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	113000000000	43000000000		"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 46: Brainstem - Mixed function"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	22			"HPA029339: "		"unprognostic (3.43e-1)"	"unprognostic (1.10e-1)"	"potential prognostic favorable (8.56e-4)"	"unprognostic (9.85e-3)"	"potential prognostic unfavorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.40e-1)"	"unprognostic (9.54e-3)"		"unprognostic (1.75e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.49e-3)"	"unprognostic (1.16e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.72e-1)"		"unprognostic (1.08e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.09e-2)"	"unprognostic (8.39e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.09e-1)"	
CFH	"ARMD4, ARMS1, FHL1, HF, HF1, HF2, HUS"	ENSG00000000971	"Complement factor H"	P08603	1	196651754-196752476	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Host-virus interaction, Immunity, Innate immunity"		"Age-related macular degeneration, Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 1585.8"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 82.4;Hepatic stellate cells: 51.6;Hepatocytes: 124.0;Leydig cells: 57.2;Ovarian stromal cells: 74.8;Papillary tip epithelial cells: 99.0;Pericytes: 36.5;Peritubular myoid cells: 42.9;Podocytes: 64.8"	"Group enriched"	"Detected in many"	7	"endothelial cell: 317.6;fibroblast: 269.5;pericyte: 401.5;vascular associated smooth muscle cell: 148.7"	"Cancer enriched"	"Detected in all"	8	"Liver Hepatocellular Carcinoma (TCGA): 549.3"	"Region enhanced"	"Detected in all"		"choroid plexus: 43.6"	"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 17.6"	"Lineage enriched"	"Detected in single"	56	"T-cells: 17.6"	"Cancer enhanced"	"Detected in many"		"Gallbladder cancer: 59.2"	"Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblasts_2"									"CAB016385, CAB016769, HPA038922, HPA049176, HPA053326"	Supported		Approved	Vesicles	"Secreted to blood"	Immunity	NA	NA	396000000000	130000000000	"Cluster 1: T-cells - Unknown function"	"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 104: Brain endothelial cells - Blood brain barrier"	9	Vesicles		"CAB016385: , CAB016769: , HPA038922: , HPA049176: , HPA053326: "	"unprognostic (2.82e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.50e-3)"	"potential prognostic unfavorable (4.94e-4)"	"unprognostic (2.72e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.37e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.77e-1)"	"unprognostic (9.04e-3)"	"unprognostic (2.71e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.36e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.35e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.50e-2)"	"unprognostic (8.50e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.29e-2)"
MASP1	"CRARF, MAP-1, Map44, MASP, MASP-3, PRSS5"	ENSG00000127241	"MBL associated serine protease 1"	P48740	3	187217282-187291980	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 100.9;heart muscle: 108.6;liver: 171.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 61.5;Bergmann glia: 25.8;Cardiomyocytes: 60.7;Cholangiocytes: 40.1;Decidual stromal cells: 82.8;Endometrial stromal cells: 43.6;Ependymal cells: 42.5;Epididymal efferent duct absorptive cells: 28.1;Epididymal efferent duct ciliated cells: 25.6;Fibro-adipogenic progenitors: 53.1;Hepatic stellate cells: 90.4;Hepatocytes: 108.9;Oligodendrocyte progenitor cells: 37.3"	"Cell type enhanced"	"Detected in many"		"astrocyte: 114.5;ependymal cell: 51.3;oligodendrocyte precursor cell: 42.0"	"Group enriched"	"Detected in many"	4	"Glioblastoma Multiforme (TCGA): 40.6;Kidney Renal Clear Cell Carcinoma (TCGA): 20.1;Kidney Renal Papillary Cell Carcinoma (TCGA): 22.8;Liver Hepatocellular Carcinoma (TCGA): 28.4;Prostate Adenocarcinoma (TCGA): 14.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"liver cancer: 11.8;Rhabdoid: 14.6"	"Adipose visceral - Mast cells, Breast - Fibroblasts, Heart muscle - Cardiomyocytes, Pancreas - Fibroblasts, Prostate - Smooth muscle cells, Skin - Fibroblasts_1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001617, HPA009641"	Supported		Enhanced	Nucleoplasm,Cytosol	"Secreted to blood"	Immunity	No	NA	8670000000	2200000000		"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 28: Astrocytes - Homeostasis & neuron support"	3	"Nucleoplasm, Cytosol"		"HPA001617: , HPA009641: "			"unprognostic (6.70e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.39e-2)"	"unprognostic (4.86e-2)"	"potential prognostic favorable (8.75e-6)"	"unprognostic (1.49e-2)"	"validated prognostic favorable (2.10e-6)"	"validated prognostic favorable (2.18e-4)"	"unprognostic (2.97e-1)"	"unprognostic (1.08e-3)"	"potential prognostic favorable (2.16e-4)"		"unprognostic (5.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.27e-1)"			"unprognostic (2.15e-1)"	"unprognostic (4.35e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.33e-1)"	"unprognostic (9.69e-2)"		"unprognostic (6.74e-2)"		"unprognostic (5.01e-2)"
C1QA		ENSG00000173372	"Complement C1q A chain"	P02745	1	22635077-22639678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 604.1;lymphoid tissue: 1056.2"	"Group enriched"	"Detected in some"	8	"Kupffer cells: 45.1;Macrophages: 34.6;Microglia: 131.3"	"Cell type enriched"	"Detected in some"	24	"central nervous system macrophage: 167.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"intermediate monocyte: 227.9;non-classical monocyte: 184.6"	"Lineage enriched"	"Detected in many"	59	"monocytes: 227.9"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002350, CAB009823"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA		4400000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 1: Neuronal - Visual perception"	"Cluster 74: Microglia - Neuroimmunity & neuroinflammation"	7			"CAB009823: , HPA002350: "	"unprognostic (1.90e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.95e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.16e-2)"	"unprognostic (8.79e-2)"	"unprognostic (8.23e-2)"	"unprognostic (7.50e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.51e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-3)"	"unprognostic (7.68e-2)"	"unprognostic (2.46e-1)"
CD55	"CR, CROM, DAF, TC"	ENSG00000196352	"CD55 molecule (Cromer blood group)"	P08174	1	207321519-207386804	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Blood group antigen, Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 2487.6;Epicardial cells: 1903.5;Esophageal apical cells: 1430.3;Neutrophils: 7705.1;Ocular epithelial cells: 1980.0"	"Cell type enhanced"	"Detected in all"		"leukocyte: 199.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 653.3"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 1, Spleen - Neutrophils_2, Testis - Early spermatids, Testis - Late spermatids"					"Low region specificity"	"Detected in many"			"HPA002190, CAB010454, HPA024386"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	No	32300000	16000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 31: Neutrophils - Chemotaxis & Apoptosis"	1			"CAB010454: , HPA002190: , HPA024386: "	"unprognostic (4.12e-1)"	"unprognostic (7.61e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-2)"	"potential prognostic unfavorable (3.47e-6)"	"unprognostic (3.46e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (5.31e-3)"	"unprognostic (4.16e-1)"	"unprognostic (3.13e-2)"	"potential prognostic unfavorable (6.72e-5)"	"unprognostic (4.58e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.43e-2)"	"unprognostic (6.70e-2)"
C1QC	C1QG	ENSG00000159189	"Complement C1q C chain"	P02747	1	22643014-22648110	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 893.4"	"Group enriched"	"Detected in many"	7	"Hofbauer cells: 2312.4;Kupffer cells: 3477.5;Macrophages: 1290.5"	"Cell type enriched"	"Detected in some"	63	"central nervous system macrophage: 409.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"intermediate monocyte: 56.5"	"Lineage enriched"	"Detected in single"	559	"monocytes: 56.5"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001471, CAB009828"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	513000000	5900000000	"Cluster 40: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 72: Macrophages - Phagocytosis & lysosomal degradation"	7			"CAB009828: , HPA001471: "	"unprognostic (3.82e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.68e-2)"	"unprognostic (3.74e-1)"	"unprognostic (1.44e-2)"	"unprognostic (5.15e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-2)"	"unprognostic (4.43e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.86e-3)"	"unprognostic (4.85e-2)"	"unprognostic (1.59e-1)"
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854768-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	277	"liver: 464.3"	"Cell type enriched"	"Detected in some"	33	"Hepatocytes: 385.0"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	123	"Liver Hepatocellular Carcinoma (TCGA): 105.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA077621			Supported	"Plasma membrane"	"Secreted to blood"	"Complement pathway"	NA	NA		15000000000		"Cluster 53: Liver - Plasma proteins"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	7	"Plasma membrane"		"HPA077621: "														"unprognostic (9.39e-3)"	"potential prognostic favorable (1.71e-6)"																
C9		ENSG00000113600	"Complement C9"	P02748	5	39284140-39371324	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	263	"liver: 1222.6"	"Cell type enriched"	"Detected in some"	55	"Hepatocytes: 2516.7"	"Cell type enhanced"	"Detected in many"		"central nervous system macrophage: 7.2;fibroblast: 8.7"	"Cancer enriched"	"Detected in some"	72	"Liver Hepatocellular Carcinoma (TCGA): 113.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB002151, HPA029577"	Uncertain				"Secreted to blood"	"Complement pathway"	NA	NA	69600000000	28000000000		"Cluster 45: Liver - Metabolism & Coagulation"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	6			"CAB002151: , HPA029577: "										"unprognostic (1.09e-1)"				"unprognostic (1.52e-1)"	"unprognostic (2.45e-3)"																
CFHR3	"CFHL3, DOWN16, FHR-3, FHR3, HLF4"	ENSG00000116785	"Complement factor H related 3"	Q02985	1	196774813-196795407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	743	"liver: 366.8"	"Cell type enhanced"	"Detected in single"		"Hepatocytes: 1.1"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 1.3;pericyte: 2.5"	"Cancer enriched"	"Detected in some"	52	"Liver Hepatocellular Carcinoma (TCGA): 74.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Myeloma: 2.6;thyroid cancer: 2.8"										HPA077529			Approved	Vesicles	"Secreted to blood"	"Complement pathway"	NA	NA	582000000	2600000000		"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	2	Vesicles		"HPA077529: "	"unprognostic (1.63e-2)"		"unprognostic (2.96e-1)"	"unprognostic (2.90e-1)"										"validated prognostic favorable (1.54e-5)"	"validated prognostic favorable (1.25e-8)"		"unprognostic (2.54e-1)"		"unprognostic (8.16e-2)"							"unprognostic (6.19e-2)"					"unprognostic (1.93e-2)"
CFHR5	"CFHL5, FHR-5, FHR5"	ENSG00000134389	"Complement factor H related 5"	Q9BXR6	1	196975010-197009678	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	1562	"liver: 156.2"	"Cell type enriched"	"Detected in some"	30	"Hepatocytes: 125.4"	"Cell type enriched"	"Detected in single"	4	"deep-layer near-projecting: 1.2"	"Cancer enriched"	"Detected in single"	283	"Liver Hepatocellular Carcinoma (TCGA): 71.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									"HPA038915, HPA040726"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	2550000000	1100000000		"Cluster 45: Liver - Metabolism & Coagulation"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	15			"HPA038915: , HPA040726: "														"unprognostic (9.73e-3)"	"potential prognostic favorable (2.33e-5)"																
CR2	"C3DR, CD21"	ENSG00000117322	"Complement C3d receptor 2"	P20023	1	207453024-207489895	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 163.6"	"Cell type enriched"	"Detected in some"	4	"B-cells: 56.7"	"Low cell type specificity"	"Detected in some"			"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 11.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"memory B-cell: 17.6;naive B-cell: 20.5"	"Lineage enriched"	"Detected in many"	8	"B-cells: 20.5"	"Group enriched"	"Detected in some"	7	"Leukemia: 8.6;lymphoma: 17.5;Myeloma: 8.1"	"Minor Salivary Gland - Plasma cells, Spleen - B-cells (Spleen)"	"Not detected"	"Not detected"							"CAB002659, HPA052942, HPA060715"	Enhanced						NA	NA		39000000	"Cluster 18: Non-specific - Translation"	"Cluster 18: Lymphoid tissue - Immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 87: B-cells - Adaptive immunity: Humoral response"	2			"CAB002659: , HPA052942: , HPA060715: "	"unprognostic (4.15e-1)"	"potential prognostic favorable (6.18e-4)"	"unprognostic (4.34e-2)"		"unprognostic (1.62e-1)"	"unprognostic (1.96e-1)"						"potential prognostic unfavorable (1.38e-4)"				"potential prognostic favorable (5.82e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.48e-1)"			"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.34e-1)"	"unprognostic (1.42e-2)"		"unprognostic (1.35e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.93e-2)"
C8G		ENSG00000176919	"Complement C8 gamma chain"	P07360	9	136945185-136946975	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"liver: 522.4"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 1125.9"	"Low cell type specificity"	"Detected in some"			"Cancer enriched"	"Detected in some"	61	"Liver Hepatocellular Carcinoma (TCGA): 321.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Gastric cancer: 6.2;liver cancer: 2.1"	"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046269	Approved				"Secreted to blood"	"Complement pathway"	NA	NA		5500000000		"Cluster 31: Liver - Metabolism & Coagulation"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	3			"HPA046269: "			"unprognostic (2.28e-1)"		"unprognostic (9.72e-2)"	"unprognostic (1.36e-2)"				"unprognostic (3.98e-3)"		"unprognostic (2.23e-2)"		"potential prognostic favorable (3.25e-4)"	"unprognostic (1.30e-2)"							"unprognostic (1.19e-1)"	"unprognostic (2.46e-1)"		"unprognostic (2.24e-1)"			"unprognostic (2.28e-1)"			
CFHR2	"CFHL2, FHR2, HFL3"	ENSG00000080910	"Complement factor H related 2"	P36980	1	196943738-196959622	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2834	"liver: 1262.2"	"Cell type enriched"	"Detected in some"	144	"Hepatocytes: 1476.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	660	"Liver Hepatocellular Carcinoma (TCGA): 612.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"									"HPA038915, HPA040726, HPA049813"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	40000000000	4300000000		"Cluster 45: Liver - Metabolism & Coagulation"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	1			"HPA038915: , HPA040726: , HPA049813: "														"unprognostic (1.01e-3)"	"potential prognostic favorable (1.46e-4)"																
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, DNA damage, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Esophageal basal cells: 790.0;Esophageal suprabasal cells: 627.3;Extravillous trophoblasts: 453.8;Gastric progenitor cells: 552.4;Migrating cytotrophoblasts: 544.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026483	Supported		Supported	"Plasma membrane,Mitochondria"	"Secreted to blood"	"Complement pathway"	NA	NA		1500000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 63: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Metabolism"	"Cluster 42: Non-specific - Unknown function"	"Cluster 97: Non-specific - Cellular respiration"	179	"Plasma membrane"	Mitochondria	"HPA026483: "	"unprognostic (1.74e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.67e-2)"	"unprognostic (3.18e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.13e-1)"	"unprognostic (4.46e-2)"	"potential prognostic unfavorable (1.15e-4)"	"unprognostic (5.19e-3)"	"unprognostic (2.39e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.88e-3)"	"potential prognostic unfavorable (7.40e-4)"	"unprognostic (7.88e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (6.68e-2)"	"unprognostic (3.27e-1)"	"unprognostic (1.24e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.25e-1)"	"potential prognostic unfavorable (9.85e-4)"	"unprognostic (9.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	"potential prognostic favorable (2.66e-4)"
C1R		ENSG00000159403	"Complement C1r"		12	7080214-7092540	"Human disease related genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"liver: 1733.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.6;Decidual stromal cells: 8.9;Endometrial stromal cells: 13.5;Epicardial cells: 45.5;Fibroblasts: 37.5;Mesothelial cells: 22.5;Pericytes: 12.9;Podocytes: 35.1"	"Cell type enriched"	"Detected in many"	5	"fibroblast: 154.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Brain cancer: 73.9"	"Adipose visceral - Adipose progenitor cells, Liver - Hepatocytes, Lung - Fibroblasts_2, Spleen - Fibroblasts_1, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA001251, HPA001551"	Uncertain		Uncertain	Nucleoplasm,Cytosol			NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 108: Fibroblasts - ECM organization"	1	"Nucleoplasm, Cytosol"		"HPA001251: , HPA001551: "	"unprognostic (1.09e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.09e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.48e-2)"	"potential prognostic unfavorable (3.06e-7)"	"unprognostic (8.13e-3)"	"unprognostic (1.10e-2)"	"unprognostic (8.07e-2)"	"potential prognostic favorable (5.25e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (6.40e-2)"	"unprognostic (5.89e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.88e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.56e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.07e-1)"
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 118.4;lymphoid tissue: 80.0"	"Group enriched"	"Detected in many"	4	"monocytes: 1285.2;Neutrophils: 2460.4"	"Group enriched"	"Detected in many"	5	"choroid plexus epithelial cell: 147.9;ependymal cell: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 393.7"	"Group enriched"	"Detected in many"	42	"granulocytes: 393.7;monocytes: 116.2"	"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Neutrophils, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Neutrophils, Minor Salivary Gland - Macrophages"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"			NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 31: Neutrophils - Chemotaxis & Apoptosis"	41	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: , HPA048012: "	"unprognostic (2.00e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.13e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.45e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.75e-3)"	"unprognostic (5.35e-2)"	"unprognostic (7.23e-2)"	"unprognostic (4.86e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.30e-1)"	"potential prognostic unfavorable (3.62e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.80e-1)"	"unprognostic (3.72e-2)"	"unprognostic (9.68e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.83e-3)"	"unprognostic (6.92e-3)"	"unprognostic (5.28e-2)"	"unprognostic (5.03e-2)"	"unprognostic (4.42e-2)"
C7		ENSG00000112936	"Complement C7"	P10643	5	40909492-41020216	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 861.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 276.1;Fibro-adipogenic progenitors: 413.7;Fibroblasts: 761.2;Hepatic stellate cells: 761.7;Leydig cells: 981.3;Lymphatic endothelial cells: 153.9;Ovarian stromal cells: 355.1;Pericytes: 163.0;Vascular endothelial cells: 175.9"	"Cell type enriched"	"Detected in some"	27	"fibroblast: 381.7"	"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 85.4"	"Region enhanced"	"Detected in many"		"choroid plexus: 33.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	12	"Neuroblastoma: 50.9"	"Adrenal gland - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblasts_2, Pancreas - Fibroblasts, Prostate - Fibroblasts, Spleen - Fibroblasts_2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"spinal cord: 18.6"	HPA001465	Approved				"Secreted to blood"	"Complement pathway"	NA	NA		18000000000		"Cluster 4: Adrenal gland - Steroid metabolism"	"Cluster 8: Immune cells - Immune response"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 108: Fibroblasts - ECM organization"	1			"HPA001465: "	"unprognostic (9.33e-3)"	"unprognostic (5.01e-2)"	"unprognostic (5.94e-2)"		"unprognostic (3.49e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.16e-2)"		"unprognostic (2.79e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.00e-2)"	"unprognostic (9.53e-3)"	"unprognostic (1.58e-3)"	"potential prognostic favorable (2.61e-6)"	"potential prognostic favorable (5.59e-5)"	"unprognostic (1.16e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.96e-1)"	"unprognostic (4.29e-2)"	"unprognostic (7.59e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.02e-3)"	"potential prognostic favorable (4.64e-4)"	"unprognostic (4.71e-2)"		"unprognostic (2.43e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	
ENSG00000244255		ENSG00000244255	"Novel complement component 2 (C2) and complement factor B (CFB) protein"		6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"liver: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"			NA	NA				"Cluster 45: Liver - Metabolism & Coagulation"					"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: , HPA001817: , HPA001832: "																					"unprognostic (1.72e-1)"		"unprognostic (9.20e-2)"								
C5AR2	"C5L2, GPR77"	ENSG00000134830	"Complement C5a receptor 2"	Q9P296	19	47332175-47347329	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 13.2"	"Cell type enhanced"	"Detected in some"		"cDC: 35.4;Kupffer cells: 149.6;Macrophages: 84.4;monocytes: 139.2;Neutrophil progenitors: 56.3;Neutrophils: 240.8"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 20.0;deep-layer corticothalamic and 6b: 13.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 17.8;eosinophil: 11.9;neutrophil: 33.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 33.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 5.6;Leukemia: 3.4"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA016629	Uncertain						NA	NA			"Cluster 35: Neutrophils - Protein binding"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 40: Monocytes & Neutrophils - Inflammatory signaling"	1			"HPA016629: "	"unprognostic (2.85e-1)"	"unprognostic (1.47e-1)"		"unprognostic (1.72e-1)"		"unprognostic (1.47e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.79e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.18e-1)"	"potential prognostic favorable (2.48e-4)"	"unprognostic (2.57e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.38e-3)"		"unprognostic (1.49e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.31e-1)"			"unprognostic (1.55e-2)"	"potential prognostic unfavorable (3.24e-4)"			"unprognostic (2.68e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-3)"
C6		ENSG00000039537	"Complement C6"	P13671	5	41142116-41261438	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"liver: 588.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.5;Cardiomyocytes: 76.3;Cholangiocytes: 334.6;Endometrial ciliated cells: 75.1;Epididymal efferent duct ciliated cells: 128.0;Fallopian tube ciliated cells: 335.2;Hepatocytes: 581.8;Late spermatids: 96.3;Leydig cells: 186.4;Pancreatic duct cells: 232.1;Respiratory ciliated cells: 205.7"	"Cell type enhanced"	"Detected in many"		"ependymal cell: 19.6"	"Cancer enhanced"	"Detected in many"		"Liver Hepatocellular Carcinoma (TCGA): 78.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Bone cancer: 1.1"	"Adrenal gland - Fibroblasts, Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Lung - Respiratory ciliated cells, Minor Salivary Gland - Adipocytes (Minor salivary gland), Pancreas - Macrophages, Spleen - Fibroblasts_2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	NA	45000000000	17000000000		"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 3: Choroid plexus - Cilium"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	3			"CAB069427: , HPA043823: "			"unprognostic (1.62e-2)"							"unprognostic (1.18e-1)"	"unprognostic (1.61e-3)"	"unprognostic (3.95e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.82e-3)"	"potential prognostic favorable (8.77e-6)"	"unprognostic (5.59e-3)"	"unprognostic (1.18e-2)"					"unprognostic (1.68e-1)"	"unprognostic (4.27e-3)"					"potential prognostic unfavorable (6.61e-4)"			"unprognostic (4.96e-1)"
C8B		ENSG00000021852	"Complement C8 beta chain"	P07358	1	56929207-56974383	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	126	"liver: 607.6"	"Cell type enriched"	"Detected in some"	17	"Hepatocytes: 350.5"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	93	"Liver Hepatocellular Carcinoma (TCGA): 177.2"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	23	"basophil: 2.3"	"Lineage enriched"	"Detected in single"	23	"granulocytes: 2.3"	"Cancer enriched"	"Detected in single"	11	"liver cancer: 1.1"	"Liver - Hepatocytes, Minor Salivary Gland - Minor salivary glandular cells, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA023694	Supported				"Secreted to blood"	"Complement pathway"	NA	NA		15000000000		"Cluster 45: Liver - Metabolism & Coagulation"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	1			"HPA023694: "														"validated prognostic favorable (2.99e-4)"	"validated prognostic favorable (9.22e-8)"	"unprognostic (2.41e-3)"	"unprognostic (6.11e-2)"														
CFD	"ADN, DF, PFD"	ENSG00000197766	"Complement factor D"	P00746	19	859453-867884	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 1421.6"	"Group enriched"	"Detected in many"	7	"Decidual stromal cells: 2523.6;Fibroblasts: 2406.7;Leydig cells: 1762.2"	"Group enriched"	"Detected in many"	4	"central nervous system macrophage: 24.1;leukocyte: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1712.8"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 1712.8"	"Cancer enhanced"	"Detected in all"		"Leukemia: 84.8"	"Adipose subcutaneous - Mast cells, Colon - Fibroblasts, Kidney - Fibroblasts, Minor Salivary Gland - Fibroblasts, Pancreas - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Skin - Fibroblasts_2, Stomach - Fibroblasts"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	Immunity	NA	NA	732000000	1500000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 48: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 108: Fibroblasts - ECM organization"					"unprognostic (5.02e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.88e-2)"	"unprognostic (9.80e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.47e-2)"	"unprognostic (2.77e-1)"	"unprognostic (5.79e-2)"	"unprognostic (9.28e-3)"	"unprognostic (6.55e-2)"	"unprognostic (7.42e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.75e-3)"	"unprognostic (1.02e-2)"	"unprognostic (2.71e-1)"
CFHR1	"CFHL, CFHL1, CFHL1P, CFHR1P, FHR1, H36-1, H36-2, HFL1, HFL2"	ENSG00000244414	"Complement factor H related 1"	Q03591	1	196819731-196837159	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	225	"liver: 1937.3"	"Group enriched"	"Detected in some"	5	"Granulosa cells: 50.3;Hepatocytes: 131.2"	"Cell type enhanced"	"Detected in single"		"MGE interneuron: 1.2"	"Cancer enriched"	"Detected in some"	601	"Liver Hepatocellular Carcinoma (TCGA): 918.7"	"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Sarcoma: 3.3;thyroid cancer: 7.0"	"Liver - Hepatocytes"	"Not detected"	"Not detected"							"HPA038915, HPA038922, HPA040726"	Supported		Approved	Vesicles	"Secreted to blood"	"Complement pathway"	NA	NA	75000000000	16000000000		"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	7	Vesicles		"HPA038915: , HPA038922: , HPA040726: "			"unprognostic (8.31e-2)"								"validated prognostic unfavorable (5.54e-4)"	"validated prognostic unfavorable (9.07e-4)"		"validated prognostic favorable (2.26e-5)"	"validated prognostic favorable (1.68e-7)"								"unprognostic (9.22e-2)"								
CFHR4	"CFHL4, FHR-4, FHR4"	ENSG00000134365	"Complement factor H related 4"	Q92496	1	196888014-196918795	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	536	"liver: 95.0"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 62.8"	"Cell type enhanced"	"Detected in some"		"deep-layer near-projecting: 2.4;MGE interneuron: 1.9"	"Cancer enriched"	"Detected in single"	157	"Liver Hepatocellular Carcinoma (TCGA): 30.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Hepatocytes"														"Secreted to blood"	"Complement pathway"	NA	NA	28000000000	320000000		"Cluster 45: Liver - Metabolism & Coagulation"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"																		"validated prognostic favorable (3.05e-7)"	"validated prognostic favorable (1.26e-5)"																
CFP	PFC	ENSG00000126759	"Complement factor properdin"	P27918	X	47623172-47630305	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 79.3;lymphoid tissue: 50.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.5;Bergmann glia: 1.7;Brain excitatory neurons: 2.1;Brain inhibitory neurons: 2.3;cDC: 2.6;Kupffer cells: 1.0;Macrophages: 1.0;monocytes: 8.5;Neutrophils: 1.9;Oligodendrocyte progenitor cells: 1.1;Other brain neurons: 1.6;Podocytes: 1.0"	"Cell type enriched"	"Detected in many"	4	"leukocyte: 16.4"	"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 6.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"classical monocyte: 1169.0;intermediate monocyte: 1275.0;myeloid DC: 995.2;neutrophil: 733.0;non-classical monocyte: 872.6"	"Group enriched"	"Detected in all"	46	"dendritic cells: 995.2;granulocytes: 733.0;monocytes: 1275.0"	"Cancer enriched"	"Detected in some"	9	"Leukemia: 12.2"	"Adipose subcutaneous - Macrophages, Breast - Macrophages, Colon - Macrophages, Kidney - Macrophages, Lung - Neutrophils_2, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Macrophages"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA072644			Approved	Vesicles	"Secreted to blood"	Immunity	NA	NA	18400000000	2400000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 15: Non-specific - Transcription"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 102: Non-specific - Mixed function"	23	Vesicles		"HPA072644: "	"unprognostic (3.34e-1)"		"unprognostic (1.84e-3)"			"unprognostic (3.61e-2)"		"unprognostic (8.29e-2)"	"unprognostic (1.36e-3)"		"potential prognostic favorable (1.40e-6)"	"unprognostic (7.87e-2)"	"unprognostic (2.21e-1)"	"unprognostic (8.88e-3)"	"unprognostic (1.16e-3)"	"potential prognostic favorable (7.15e-4)"		"unprognostic (1.02e-1)"	"unprognostic (2.71e-1)"		"unprognostic (1.53e-3)"	"unprognostic (3.44e-2)"	"unprognostic (1.41e-3)"			"unprognostic (1.50e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.94e-2)"	"unprognostic (3.15e-1)"
CR1L		ENSG00000197721	"Complement C3b/C4b receptor 1 like"	Q2VPA4	1	207645113-207738416	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	9	"bone marrow: 1.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 25.4;Epididymal clear cells: 18.4;Erythrocyte progenitors: 126.2;Erythrocytes: 33.8;Fallopian tube ciliated cells: 16.3;Megakaryocyte progenitors: 17.3;Podocytes: 27.1;Renal collecting duct intercalated cells: 60.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	7	"Kidney Chromophobe (TCGA): 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												HPA049348	Approved				"Secreted in other tissues"	"No annotated function"	NA	NA				"Cluster 15: Bone marrow - Innate immune response"		"Cluster 47: Leukemia - Hemostasis"	"Cluster 66: Erythroid cells - Erythroid differentiation and maturation"				"HPA049348: "										"unprognostic (1.92e-1)"																					
C1QB		ENSG00000173369	"Complement C1q B chain"		1	22652762-22661637	"Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 1405.0"	"Group enriched"	"Detected in many"	9	"Hofbauer cells: 2336.0;Kupffer cells: 7919.5;Macrophages: 2524.3"	"Cell type enriched"	"Detected in many"	32	"central nervous system macrophage: 378.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	71	"intermediate monocyte: 142.5;non-classical monocyte: 103.0"	"Lineage enriched"	"Detected in many"	83	"monocytes: 142.5"	"Not detected"	"Not detected"			"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Spleen - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052116	Approved				"Secreted to blood"	"Complement pathway"	NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 72: Macrophages - Phagocytosis & lysosomal degradation"	1			"HPA052116: "	"unprognostic (1.90e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.59e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.31e-2)"	"unprognostic (3.58e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.27e-1)"	"unprognostic (3.30e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.56e-1)"	"unprognostic (8.72e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.42e-1)"	"unprognostic (5.17e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.45e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.68e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.53e-2)"	"unprognostic (3.80e-1)"
C3AR1	"AZ3B, C3AR"	ENSG00000171860	"Complement C3a receptor 1"	Q16581	12	8056844-8066359	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 37.8"	"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 283.3;Kupffer cells: 222.4;Macrophages: 206.2;Mast cells: 71.2;Microglia: 79.2;monocytes: 217.9;Neutrophil progenitors: 196.5;Neutrophils: 371.4"	"Cell type enriched"	"Detected in some"	9	"central nervous system macrophage: 99.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basophil: 902.8;eosinophil: 452.5;intermediate monocyte: 274.2;non-classical monocyte: 373.1"	"Group enriched"	"Detected in many"	20	"granulocytes: 902.8;monocytes: 373.1"	"Cancer enhanced"	"Detected in some"		"Leukemia: 5.8"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in many"							CAB009405	Enhanced						NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 31: Neutrophils - Chemotaxis & Apoptosis"				"CAB009405: "	"unprognostic (1.10e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.66e-2)"	"unprognostic (4.59e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.20e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.90e-2)"	"potential prognostic favorable (3.17e-4)"	"unprognostic (2.35e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.26e-2)"	"unprognostic (8.67e-3)"	"unprognostic (8.30e-2)"	"unprognostic (6.55e-3)"	"potential prognostic unfavorable (4.15e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.73e-2)"	"unprognostic (3.16e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.53e-2)"	"unprognostic (6.40e-3)"	"unprognostic (5.94e-2)"	"unprognostic (1.21e-1)"
C4BPA	C4BP	ENSG00000123838	"Complement component 4 binding protein alpha"	P04003	1	207104233-207144972	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 1793.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 195.9;Alveolar cells type 2: 396.9;Endometrial glandular cells: 94.7;Hepatocytes: 1056.8;Transitional alveolar cells: 240.3"	"Low cell type specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"Liver Hepatocellular Carcinoma (TCGA): 630.3;Lung Adenocarcinoma (TCGA): 177.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	137	"neutrophil: 29.6"	"Lineage enriched"	"Detected in single"	137	"granulocytes: 29.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.4;lung cancer: 3.9"	"Liver - Hepatocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"midbrain: 1.6"	"HPA000926, HPA001578"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	NA	30800000000	40000000000	"Cluster 4: Neutrophils - Degranulation"	"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	5			"HPA000926: , HPA001578: "		"unprognostic (2.11e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.92e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.98e-1)"					"potential prognostic unfavorable (3.90e-6)"		"unprognostic (7.08e-2)"	"potential prognostic favorable (3.54e-4)"	"unprognostic (1.95e-2)"	"potential prognostic favorable (2.16e-5)"	"unprognostic (2.87e-1)"	"potential prognostic unfavorable (9.90e-4)"	"unprognostic (2.68e-1)"		"unprognostic (2.27e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.91e-2)"		"unprognostic (1.17e-1)"	"unprognostic (2.86e-1)"		"unprognostic (1.41e-1)"			"unprognostic (1.10e-2)"
C4BPB	C4BP	ENSG00000123843	"Complement component 4 binding protein beta"	P20851	1	207088860-207099993	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 440.2"	"Cell type enriched"	"Detected in many"	9	"Hepatocytes: 685.8"	"Low cell type specificity"	"Detected in single"			"Cancer enriched"	"Detected in many"	21	"Liver Hepatocellular Carcinoma (TCGA): 320.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.1"	"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in many"		"Bile duct cancer: 39.5"	"Adipose subcutaneous - Macrophages, Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids, Testis - Late spermatids"					"Not detected"	"Not detected"			"HPA000925, HPA051620"	Approved		Uncertain	"Golgi apparatus"	"Secreted to blood"	"Complement pathway"	NA	NA	265000000000	1900000000	"Cluster 30: Non-specific - DNA binding"	"Cluster 53: Liver - Plasma proteins"		"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	1	"Golgi apparatus"		"HPA000925: , HPA051620: "	"unprognostic (1.08e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.48e-1)"				"unprognostic (2.67e-3)"				"unprognostic (1.32e-2)"	"unprognostic (4.88e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.46e-2)"					"unprognostic (2.60e-2)"	"unprognostic (3.84e-2)"		"unprognostic (2.96e-1)"	"unprognostic (2.29e-2)"		"unprognostic (2.92e-1)"			"unprognostic (3.22e-1)"
MASP2	"MAP-2, Map19, MASP1P1, sMAP"	ENSG00000009724	"MBL associated serine protease 2"	O00187	1	11022009-11047239	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	57	"liver: 452.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 70.6;Cardiomyocytes: 256.9;Epicardial cells: 170.6;Hepatocytes: 758.6;Myonuclei: 72.1"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	144	"Liver Hepatocellular Carcinoma (TCGA): 239.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA029313, HPA029314"	Uncertain		Supported	"Golgi apparatus"	"Secreted to blood"	"Complement pathway"	NA	NA	340000000	600000000		"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 2: Neurons - Nucleosome"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	6	"Golgi apparatus"		"HPA029313: , HPA029314: "			"unprognostic (2.33e-1)"			"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"					"unprognostic (2.69e-3)"		"validated prognostic favorable (8.18e-4)"	"validated prognostic favorable (5.30e-4)"		"unprognostic (6.75e-2)"		"unprognostic (5.55e-3)"							"unprognostic (4.09e-1)"					
SERPING1	"C1-INH, C1IN, C1INH, C1NH, HAE1, HAE2"	ENSG00000149131	"Serpin family G member 1"	P05155	11	57597387-57619171	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis"	"Protease inhibitor, Serine protease inhibitor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 2454.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 594.4;Decidual stromal cells: 2144.7;Fibroblasts: 889.5;Hepatocytes: 2775.5;Leydig cells: 712.3;Mesothelial cells: 692.1;Ovarian stromal cells: 466.2;Pancreatic duct cells: 639.3;Pericytes: 450.8"	"Group enriched"	"Detected in many"	4	"ependymal cell: 68.6;fibroblast: 154.2;pericyte: 114.2;vascular associated smooth muscle cell: 96.8"	"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 1194.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 65.5;plasmacytoid DC: 60.7"	"Group enriched"	"Detected in many"	231	"dendritic cells: 60.7;granulocytes: 65.5;monocytes: 25.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 37.5;testis cancer: 38.7"	"Adrenal gland - Fibroblasts, Heart muscle - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblasts_1, Prostate - Fibroblasts, Spleen - Fibroblasts_2"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 255.7"	"CAB026161, HPA048738"	Supported				"Secreted to blood"	"Blood coagulation"	NA	NA		48000000000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 8: Immune cells - Immune response"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 108: Fibroblasts - ECM organization"	9			"CAB026161: , HPA048738: "	"unprognostic (1.05e-2)"	"unprognostic (2.83e-2)"	"unprognostic (4.30e-3)"	"unprognostic (8.28e-3)"	"unprognostic (7.33e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.37e-2)"	"potential prognostic unfavorable (1.84e-4)"	"unprognostic (2.17e-1)"	"unprognostic (4.37e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"validated prognostic favorable (1.17e-4)"	"validated prognostic favorable (1.07e-6)"	"unprognostic (1.41e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.06e-2)"	"unprognostic (8.18e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.25e-1)"	"unprognostic (9.61e-2)"	"unprognostic (4.55e-2)"	"unprognostic (5.47e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.16e-1)"
SUSD4	FLJ10052	ENSG00000143502	"Sushi domain containing 4"	Q5VX71	1	223220819-223364233	"Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.5;esophagus: 46.6"	"Cell type enhanced"	"Detected in many"		"Brain excitatory neurons: 179.1;Brain inhibitory neurons: 177.9;Distal convoluted tubule cells: 144.1;Esophageal apical cells: 230.1;Esophageal suprabasal cells: 272.1;Loop of henle epithelial cells: 145.9;Oligodendrocyte progenitor cells: 155.1;Retinal amacrine cells: 240.9;Somatotrophs: 282.4"	"Cell type enhanced"	"Detected in many"		"hippocampal CA4: 722.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 6.8;naive CD4 T-cell: 10.2"	"Lineage enriched"	"Detected in single"	40	"T-cells: 10.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 16.1"	"Heart muscle - Cardiomyocytes, Lung - Respiratory ciliated cells, Minor Salivary Gland - Minor salivary gland basal cells, Pituitary gland - Somatotropes, Prostate - Urothelial cells, Skin - Outer root sheath cells, Spleen - T-cells, Stomach - Parietal cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058296	Uncertain		Approved	Vesicles	"Intracellular and membrane"	"Complement pathway"	NA	NA			"Cluster 11: T-cells - Unknown function"	"Cluster 81: Squamous epithelium - Keratinization"	"Cluster 29: Forebrain - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 35: Neurons - Synaptic function & neurogenesis"		Vesicles		"HPA058296: "	"unprognostic (7.43e-3)"	"unprognostic (9.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (7.38e-3)"		"unprognostic (4.76e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.36e-1)"	"unprognostic (3.77e-1)"	"potential prognostic unfavorable (3.69e-8)"	"unprognostic (2.99e-3)"	"unprognostic (1.11e-3)"	"unprognostic (2.36e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.22e-3)"	"unprognostic (2.11e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"		"unprognostic (3.02e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.34e-2)"
CD59	"16.3A5, EJ16, EJ30, EL32, G344, MIC11, MIN1, MIN2, MIN3, MSK21, p18-20"	ENSG00000085063	"CD59 molecule (CD59 blood group)"	P13987	11	33703010-33736479	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"			"Cancer-related genes, Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bergmann glia: 83.2;Choroid plexus epithelial cells: 92.4;Other brain neurons: 82.9"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 276.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Colon - Endothelial cells, Minor Salivary Gland - Minor salivary glandular cells"					"Low region specificity"	"Detected in all"			"CAB001448, HPA026494"	Supported		Uncertain	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	"No annotated function"	NA	NA		33000000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 1: Choroid plexus - Transmembrane transport"	"Cluster 44: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 104: Brain endothelial cells - Blood brain barrier"	10	"Golgi apparatus, Vesicles"		"CAB001448: , HPA026494: "	"unprognostic (1.58e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-3)"	"unprognostic (6.20e-2)"	"unprognostic (8.60e-3)"	"unprognostic (5.49e-3)"	"unprognostic (2.50e-2)"	"potential prognostic unfavorable (9.32e-4)"	"unprognostic (1.11e-2)"	"potential prognostic favorable (1.47e-8)"	"unprognostic (1.86e-3)"	"unprognostic (3.68e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.74e-3)"	"unprognostic (5.73e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.70e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.11e-2)"	"unprognostic (3.60e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.49e-1)"	"potential prognostic unfavorable (6.25e-5)"	"unprognostic (1.71e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.18e-1)"
CRP	PTX1	ENSG00000132693	"C-reactive protein"	P02741	1	159712289-159714589	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Acute phase"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	81	"liver: 8524.7"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 2370.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	11	"Liver Hepatocellular Carcinoma (TCGA): 1039.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Gastric cancer: 1.1"	"Liver - Neutrophils"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB005036, HPA027367, HPA027396"	Supported		Approved	"Nucleoplasm,Vesicles,Intermediate filaments"	"Secreted to blood"	"Acute phase"	NA	NA	2920000000	3400000000		"Cluster 31: Liver - Metabolism & Coagulation"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	7	"Nucleoplasm, Vesicles"	"Intermediate filaments"	"CAB005036: , HPA027367: , HPA027396: "	"unprognostic (4.41e-2)"			"unprognostic (4.64e-1)"							"unprognostic (1.57e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.30e-1)"							"unprognostic (1.61e-2)"	"unprognostic (1.16e-3)"				"unprognostic (8.16e-3)"	"unprognostic (6.04e-2)"			
CD46	"MCP, MGC26544, MIC10, TLX, TRA2.10"	ENSG00000117335	"CD46 molecule"	P15529	1	207752037-207795513	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Esophageal apical cells: 974.8;Salivary acinar cells: 736.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 301.2;eosinophil: 387.4;neutrophil: 404.1"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 404.1"	"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary glandular cells"	"Low region specificity"	"Detected in single"							"CAB010401, HPA016903"	Enhanced		Approved	"Plasma membrane"			NA	NA		1900000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 69: Parathyroid gland - Mixed function"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 38: Secretory epithelial cells - Exocrine secretion"	4	"Plasma membrane"		"CAB010401: , HPA016903: "	"unprognostic (8.50e-2)"	"unprognostic (3.35e-3)"	"unprognostic (5.19e-2)"	"potential prognostic unfavorable (1.33e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.26e-1)"	"potential prognostic favorable (1.32e-6)"	"unprognostic (9.93e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.19e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.51e-1)"
FANCG	"FAG, XRCC9"	ENSG00000221829	"FA complementation group G"	O15287	9	35073835-35080004	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Differentiating spermatogonia: 13.2;Early primary spermatocytes: 12.4;Megakaryocyte progenitors: 8.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006695, CAB008105"	Approved		Supported	"Nuclear speckles"			NA	Yes			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 49: Non-specific - Transcription"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 38: Non-specific - Transcription"	"Cluster 27: Non-specific - Cell proliferation"	82	"Nuclear speckles"		"CAB008105: , HPA006695: "	"unprognostic (9.74e-3)"	"unprognostic (4.29e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.03e-2)"	"unprognostic (2.63e-1)"	"potential prognostic favorable (2.28e-4)"	"unprognostic (1.24e-2)"	"unprognostic (8.72e-3)"	"potential prognostic favorable (1.17e-5)"	"unprognostic (2.71e-1)"	"unprognostic (2.13e-1)"	"potential prognostic unfavorable (2.30e-4)"	"unprognostic (4.40e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.61e-2)"	"unprognostic (5.90e-2)"	"unprognostic (6.74e-3)"	"unprognostic (3.49e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.32e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.03e-1)"
A1CF	"ACF, ACF64, ACF65, APOBEC1CF, ASP"	ENSG00000148584	"APOBEC1 complementation factor"	Q9NQ94	10	50799409-50885675	"Predicted intracellular proteins"	"mRNA processing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 143.1"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 254.2;Colonocytes: 141.7;Enteric transient amplifying cells: 73.3;Enterocytes: 259.2;Goblet cells: 135.0;Hepatocytes: 814.9;Neuroendocrine cells: 262.4;Pancreatic acinar cells: 88.3;Pancreatic islet cells: 160.3;Proximal tubule cells: 74.9"	"Cell type enriched"	"Detected in some"	6	"cerebellar inhibitory: 7.4"	"Cancer enriched"	"Detected in many"	5	"Liver Hepatocellular Carcinoma (TCGA): 35.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	4	"liver cancer: 21.2"	"Colon - Colon enterocytes, Kidney - Proximal tubular cells, Liver - Hepatocytes, Stomach - Gastric enteroendocrine cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA037779, HPA044079"	Enhanced		Supported	Nucleoplasm			NA	NA				"Cluster 45: Liver - Metabolism & Coagulation"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 96: Enteroendocrine cells - Neuropeptide signaling"	19	Nucleoplasm		"HPA037779: , HPA044079: "					"unprognostic (1.77e-1)"	"unprognostic (2.54e-2)"					"potential prognostic favorable (2.84e-8)"	"unprognostic (7.85e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.26e-2)"							"unprognostic (2.71e-2)"	"unprognostic (1.81e-1)"		"unprognostic (2.99e-1)"	"unprognostic (3.29e-2)"		"unprognostic (4.72e-2)"			
C1QL2	"C1QTNF10, CTRP10"	ENSG00000144119	"Complement C1q like 2"	Q7Z5L3	2	119156243-119158751	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 26.2"	"Group enriched"	"Detected in some"	15	"Oligodendrocyte progenitor cells: 51.9;Retinal amacrine cells: 151.0"	"Cell type enhanced"	"Detected in many"		"hippocampal dentate gyrus: 21.9;LAMP5-LHX6 and Chandelier: 18.6;oligodendrocyte precursor cell: 49.9"	"Cancer enhanced"	"Detected in some"		"Lung Adenocarcinoma (TCGA): 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"Bone cancer: 1.5"	"Breast - T-cells"	"Region enhanced"	"Detected in many"		"hippocampal formation: 22.7"	"Low region specificity"	"Detected in many"			"HPA057934, HPA071349"	Uncertain		Approved	Vesicles,Cytosol	"Secreted in brain"	"Complement pathway"	NA	NA				"Cluster 78: Brain - Neuronal signaling"	"Cluster 29: Forebrain - Mixed function"	"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 109: Neurons - Neuronal signaling"		Vesicles	Cytosol	"HPA057934: , HPA071349: "			"unprognostic (3.87e-1)"				"unprognostic (1.03e-1)"									"potential prognostic favorable (9.44e-4)"														"unprognostic (1.29e-1)"	
C1QL3	"C1ql, C1QTNF13, CTRP13, K100"	ENSG00000165985	"Complement C1q like 3"	Q5VWW1	10	16513734-16521879	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 26.1;retina: 6.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 6.5;Brain excitatory neurons: 13.3;Cardiomyocytes: 16.0;Epicardial cells: 9.1;Myonuclei: 7.5;Retinal ganglion cells: 7.7;Rod photoreceptor cells: 17.3"	"Cell type enhanced"	"Detected in many"		"hippocampal dentate gyrus: 82.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Uterine cancer: 5.3"		"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 95.8;cerebral cortex: 76.5;hippocampal formation: 68.7"	HPA071349			Approved	Vesicles,Cytosol	"Secreted in brain"	"Complement pathway"	NA	NA				"Cluster 10: Brain - Synaptic signal transduction"	"Cluster 51: Neurons - Mixed function"	"Cluster 1: Neuronal - Visual perception"	"Cluster 35: Neurons - Synaptic function & neurogenesis"	1	Vesicles	Cytosol	"HPA071349: "			"unprognostic (2.10e-2)"			"unprognostic (3.96e-1)"		"unprognostic (2.14e-1)"			"potential prognostic favorable (5.26e-5)"	"unprognostic (3.97e-2)"	"unprognostic (1.83e-1)"				"unprognostic (1.22e-1)"									"unprognostic (3.72e-1)"					
C1QL4	"C1QTNF11, CTRP11"	ENSG00000186897	"Complement C1q like 4"	Q86Z23	12	49332409-49337188	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 3.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 176.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"pons: 16.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Rhabdoid: 19.0"	"Adipose visceral - Mesothelial cells, Testis - Late spermatids"	"Region enhanced"	"Detected in some"		"midbrain: 6.2"	"Region enhanced"	"Detected in many"		"pons: 11.2"	HPA071349			Approved	Vesicles,Cytosol	"Secreted in brain"	"Complement pathway"	NA	NA				"Cluster 67: Testis - Mixed function"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 3: Rhabdoid - Membrane components"	"Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization"	33	Vesicles	Cytosol	"HPA071349: "			"unprognostic (1.33e-1)"				"unprognostic (3.33e-1)"	"unprognostic (1.21e-3)"			"unprognostic (3.87e-3)"	"unprognostic (3.99e-1)"	"unprognostic (6.25e-3)"							"unprognostic (6.30e-2)"	"unprognostic (9.27e-3)"						"unprognostic (1.27e-1)"		"unprognostic (3.88e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.49e-2)"
C1RL	"C1r-LP, C1RL1"	ENSG00000139178	"Complement C1r subcomponent like"	Q9NZP8	12	7089587-7109238	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Choroid plexus epithelial cells: 29.8;Distal convoluted tubule cells: 33.9;Loop of henle epithelial cells: 39.5;Microglia: 29.0;Papillary tip epithelial cells: 45.4;Podocytes: 34.6;Proximal tubule cells: 47.4;Renal collecting duct intercalated cells: 23.0;Renal collecting duct principal cells: 41.7;Renal connecting tubule cells: 32.8"	"Cell type enhanced"	"Detected in many"		"fibroblast: 82.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.4"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011338, CAB026172"	Supported				"Secreted to blood"	"Complement pathway"	NA	NA	5500000000	3600000000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 105: Non-specific - Mixed function"	2			"CAB026172: , HPA011338: "	"unprognostic (7.56e-3)"	"unprognostic (4.11e-2)"	"unprognostic (2.54e-3)"	"potential prognostic unfavorable (1.90e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.13e-1)"	"validated prognostic unfavorable (7.48e-4)"	"validated prognostic unfavorable (7.27e-5)"	"unprognostic (5.73e-2)"	"unprognostic (7.21e-2)"	"potential prognostic unfavorable (1.00e-5)"	"unprognostic (7.01e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.22e-2)"	"potential prognostic favorable (9.60e-4)"	"unprognostic (2.20e-2)"	"potential prognostic unfavorable (1.37e-4)"	"unprognostic (2.02e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.38e-2)"	"potential prognostic unfavorable (3.53e-4)"	"unprognostic (9.27e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.33e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.67e-2)"
FPR3	"FMLPY, FPRH1, FPRL2, RMLP-R-I"	ENSG00000187474	"Formyl peptide receptor 3"	P25089	19	51795157-51826190	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 26.6"	"Cell type enhanced"	"Detected in some"		"cDC: 304.3;Kupffer cells: 196.8;Macrophages: 236.0;monocytes: 74.5"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 17.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	20	"classical monocyte: 2.3;intermediate monocyte: 6.7;myeloid DC: 2.4"	"Group enriched"	"Detected in many"	46	"dendritic cells: 2.4;monocytes: 6.7"	"Cancer enriched"	"Detected in some"	5	"Gastric cancer: 6.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"									HPA059452			Approved	"Plasma membrane,Primary cilium"			NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 32: Non-specific - Cell proliferation"	"Cluster 82: Dendritic cells - Antigen presentation"		"Plasma membrane, Primary cilium"		"HPA059452: "	"unprognostic (1.33e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.46e-1)"	"unprognostic (7.03e-3)"	"unprognostic (3.65e-1)"	"unprognostic (2.22e-1)"	"unprognostic (6.54e-2)"	"unprognostic (9.26e-3)"	"unprognostic (4.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.69e-2)"	"potential prognostic unfavorable (2.57e-4)"	"unprognostic (7.49e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.80e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-2)"	"unprognostic (8.25e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.49e-3)"	"unprognostic (2.81e-1)"	"unprognostic (8.47e-2)"
VSIG4	"CRIg, Z39IG"	ENSG00000155659	"V-set and immunoglobulin domain containing 4"	Q9Y279	X	66021738-66040125	"Plasma proteins, Predicted membrane proteins"	"Complement alternate pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 156.3"	"Cell type enhanced"	"Detected in some"		"cDC: 172.6;Hofbauer cells: 2052.5;Kupffer cells: 708.2;Macrophages: 452.7;monocytes: 314.5"	"Cell type enriched"	"Detected in some"	12	"central nervous system macrophage: 52.9"	"Cancer enriched"	"Detected in all"	4	"Glioblastoma Multiforme (TCGA): 177.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	26	"classical monocyte: 18.7;intermediate monocyte: 11.1;myeloid DC: 17.8"	"Group enriched"	"Detected in many"	30	"dendritic cells: 17.8;monocytes: 18.7"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 2.7"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Liver - Kupffer cells, Lung - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Skin - Macrophages, Stomach - Macrophages, Thyroid gland - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA003903, CAB026000, HPA072756"	Enhanced		Uncertain	"Nucleoli,Plasma membrane,Cytosol"			NA	NA		21000000	"Cluster 26: Monocytes - Plasma membrane proteins"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 72: Macrophages - Phagocytosis & lysosomal degradation"	86	"Plasma membrane, Cytosol"	Nucleoli	"CAB026000: , HPA003903: , HPA072756: "	"unprognostic (2.26e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-2)"	"unprognostic (7.28e-3)"	"unprognostic (8.25e-3)"	"unprognostic (2.07e-1)"	"unprognostic (9.73e-3)"	"unprognostic (2.67e-1)"	"potential prognostic unfavorable (6.15e-4)"	"unprognostic (6.63e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.31e-2)"	"unprognostic (7.19e-3)"	"unprognostic (1.35e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.48e-1)"	"unprognostic (8.10e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.81e-2)"	"unprognostic (1.50e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.18e-1)"
CD5L	"API6, Spalpha"	ENSG00000073754	"CD5 molecule like"	O43866	1	157830911-157898256	"Plasma proteins, Predicted secreted proteins"	"Apoptosis, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"lymphoid tissue: 540.1"	"Group enriched"	"Detected in some"	7	"Hofbauer cells: 633.8;Kupffer cells: 1539.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Liver Hepatocellular Carcinoma (TCGA): 6.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Kupffer cells, Spleen - Macrophages"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA065686, HPA068384"	Enhanced				"Secreted to blood"	Immunity	NA	NA	4030000000	3800000000		"Cluster 66: Lymphoid tissue - Immune response"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 72: Macrophages - Phagocytosis & lysosomal degradation"				"HPA065686: , HPA068384: "											"unprognostic (3.38e-3)"	"unprognostic (3.12e-2)"		"potential prognostic favorable (3.92e-5)"	"unprognostic (2.69e-2)"														"unprognostic (1.53e-1)"		
FANCF	FAF	ENSG00000183161	"FA complementation group F"	Q9NPI8	11	22622533-22625823	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 173.2;Late primary spermatocytes: 113.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Prostate - Prostate basal glandular cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008899			Supported	Nucleoplasm			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 61: Non-specific - Transcription"	"Cluster 21: Non-specific - Metabolism"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase"	19	Nucleoplasm		"HPA008899: "	"unprognostic (2.10e-3)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.08e-2)"	"unprognostic (9.51e-2)"	"unprognostic (6.63e-3)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.63e-3)"	"unprognostic (1.07e-2)"	"unprognostic (3.61e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.07e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.61e-1)"	"potential prognostic favorable (1.00e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.22e-2)"
FCN3	"FCNH, HAKA1"	ENSG00000142748	"Ficolin 3"	O75636	1	27369110-27374824	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"liver: 260.7;lung: 688.3"	"Cell type enriched"	"Detected in some"	4	"Vascular endothelial cells: 388.8"	"Cell type enhanced"	"Detected in single"		"endothelial cell: 2.4"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 41.0"	"Region enriched"	"Detected in all"	8	"choroid plexus: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Liver - Sinusoid Endothelial cells"									CAB025945	Approved				"Secreted to blood"	Immunity	NA	NA	22800000000	4600000000		"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 32: Endothelial cells - Angiogenesis & vascular immunity"	2			"CAB025945: "	"unprognostic (2.73e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.39e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.28e-2)"	"potential prognostic unfavorable (2.64e-4)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.66e-3)"	"validated prognostic favorable (7.23e-6)"	"validated prognostic favorable (1.33e-5)"	"unprognostic (3.09e-2)"	"unprognostic (1.19e-3)"	"unprognostic (5.18e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.65e-3)"	"unprognostic (1.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.36e-1)"	"potential prognostic favorable (9.24e-4)"	"unprognostic (2.94e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.10e-2)"
MBL2	"COLEC1, MBL, MBP, MBP-C, MBP1"	ENSG00000165471	"Mannose binding lectin 2"	P11226	10	52765380-52772784	"Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Complement pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2628	"liver: 262.8"	"Cell type enriched"	"Detected in some"	290	"Hepatocytes: 297.6"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	240	"Liver Hepatocellular Carcinoma (TCGA): 27.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"liver cancer: 1.0"		"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"basal ganglia: 1.3"	"HPA002027, CAB016782"	Enhanced				"Secreted to blood"	"Complement pathway"	NA	NA	1220000000	780000000		"Cluster 45: Liver - Metabolism & Coagulation"		"Cluster 18: Liver cancer - Metabolism"	"Cluster 93: Hepatocytes - Bile production & excretion"	27			"CAB016782: , HPA002027: "														"unprognostic (1.50e-2)"	"potential prognostic favorable (2.52e-7)"																
PHB1	PHB	ENSG00000167085	"Prohibitin 1"	P35232	17	49404049-49414905	"Essential proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"DNA synthesis, Host-virus interaction"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Esophageal basal cells: 372.7;Salivary acinar cells: 356.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Stomach - Mitotic cells (Stomach), Thyroid gland - Thyroid glandular cells"					"Low region specificity"	"Detected in all"			HPA003280	Supported		Supported	Mitochondria	"Intracellular and membrane"	Other	NA	NA		910000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 76: Non-specific - Metabolism"	"Cluster 21: Non-specific - Metabolism"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 97: Non-specific - Cellular respiration"	140	Mitochondria		"HPA003280: "	"unprognostic (8.65e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.21e-1)"	"unprognostic (8.77e-3)"	"unprognostic (1.63e-2)"	"potential prognostic favorable (1.77e-6)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-3)"	"unprognostic (2.02e-2)"	"potential prognostic unfavorable (1.18e-8)"	"unprognostic (1.16e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.41e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.13e-3)"	"unprognostic (1.39e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.03e-2)"	"unprognostic (1.62e-1)"
RGCC	"bA157L14.2, C13orf15, RGC-32, RGC32"	ENSG00000102760	"Regulator of cell cycle"	Q9H4X1	13	41457550-41470871	"Predicted intracellular proteins"	"Cell cycle"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 391.7;lung: 668.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 384.3;Bergmann glia: 482.7;Breast lactating cells: 544.0;Breast secretory cells: 542.6;cDC: 375.2;Fallopian tube ciliated cells: 330.4;Hofbauer cells: 374.1;Innate lymphoid cells: 333.5;Late primary spermatocytes: 342.1;Neutrophil progenitors: 439.7;Schwann cells: 509.0;T-cells: 437.0;Vascular endothelial cells: 439.0"	"Cell type enhanced"	"Detected in many"		"Bergmann glia: 596.0;endothelial cell: 312.4;oligodendrocyte: 207.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 160.9;T-reg: 91.1"	"Lineage enriched"	"Detected in many"	15	"T-cells: 160.9"	"Cancer enhanced"	"Detected in many"		"lymphoma: 34.0"	"Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035638, HPA063701"	Enhanced		Supported	Nucleoplasm,Nucleoli			No	No		870000	"Cluster 31: T-cells - T-cell receptor"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 32: Endothelial cells - Angiogenesis & vascular immunity"	3	Nucleoplasm	Nucleoli	"HPA035638: , HPA063701: "	"unprognostic (1.08e-1)"	"unprognostic (5.66e-3)"		"unprognostic (1.65e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.05e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.75e-1)"	"unprognostic (2.41e-1)"	"validated prognostic favorable (3.81e-11)"	"validated prognostic favorable (3.68e-4)"	"unprognostic (2.50e-1)"	"potential prognostic favorable (5.37e-4)"		"unprognostic (2.73e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.89e-1)"	"potential prognostic unfavorable (4.69e-4)"	"unprognostic (3.08e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.35e-2)"	"unprognostic (3.73e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.80e-2)"
FANCA	"FA-H, FAA, FACA, FAH, FANCH"	ENSG00000187741	"FA complementation group A"	O15360	16	89726683-89816977	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 21.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 85.8;Differentiating spermatogonia: 85.2;Early primary spermatocytes: 143.1;Epicardial cells: 95.5;Erythrocyte progenitors: 121.5;Megakaryocyte progenitors: 69.2;Monocyte progenitors: 83.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Lung - Mitotic cells (Lung), Minor Salivary Gland - Mitotic cells (Minor salivary gland), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Spermatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA063236			Supported	Nucleoplasm			NA	Yes			"Cluster 25: Non-specific - Unknown function"	"Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 53: Neurons - Mixed function"	"Cluster 68: Non-specific - Cell cycle regulation"	"Cluster 27: Non-specific - Cell proliferation"	73	Nucleoplasm		"HPA063236: "	"unprognostic (8.70e-2)"	"unprognostic (7.67e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (8.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.26e-2)"	"unprognostic (3.67e-1)"	"unprognostic (7.29e-3)"	"potential prognostic unfavorable (2.49e-5)"	"unprognostic (5.59e-3)"	"unprognostic (2.14e-1)"	"unprognostic (1.94e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.22e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.67e-2)"	"unprognostic (4.90e-3)"	"unprognostic (7.02e-3)"	"unprognostic (2.69e-2)"	"potential prognostic unfavorable (5.39e-4)"	"unprognostic (2.43e-2)"	"unprognostic (2.87e-1)"	"unprognostic (8.15e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.24e-1)"	"unprognostic (8.44e-2)"	"unprognostic (2.94e-1)"
FANCC	"FA3, FAC, FACC"	ENSG00000158169	"FA complementation group C"	Q00597	9	95099054-95426796	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 23.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 495.0;Myonuclei: 298.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"basophil: 10.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 10.6"	"Low cancer specificity"	"Detected in all"			"Stomach - Mitotic cells (Stomach), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017793, HPA030771"	Approved		Supported	Nucleoplasm			NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 25: Non-specific - Transcription"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure"	48	Nucleoplasm		"CAB017793: , HPA030771: "	"unprognostic (5.57e-2)"	"unprognostic (9.37e-3)"	"unprognostic (3.00e-1)"	"unprognostic (3.23e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.34e-2)"	"validated prognostic favorable (7.08e-7)"	"validated prognostic favorable (2.70e-4)"	"unprognostic (8.54e-3)"	"unprognostic (1.72e-2)"	"unprognostic (7.60e-2)"	"unprognostic (4.19e-3)"	"unprognostic (4.08e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.44e-2)"	"unprognostic (1.75e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.13e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.32e-2)"
FANCD2	"FA-D2, FACD, FAD, FANCD"	ENSG00000144554	"FA complementation group D2"	Q9BXW9	3	10026370-10101932	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.8;lymphoid tissue: 10.0"	"Cell type enhanced"	"Detected in many"		"Differentiating spermatogonia: 59.3;Early primary spermatocytes: 103.7;Erythrocyte progenitors: 90.2;Megakaryocyte progenitors: 69.7;Monocyte progenitors: 72.8;Neutrophil progenitors: 52.6"	"Cell type enhanced"	"Detected in many"		"leukocyte: 15.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Lung - Mitotic cells (Lung), Spleen - B-cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Spermatocytes"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016117, HPA063742"	Approved		Supported	"Nucleoplasm,Nucleoli,Nuclear bodies,Cytosol"			No	No			"Cluster 32: Basophils - Transcription"	"Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 6: Non-specific - Immune response"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 27: Non-specific - Cell proliferation"	88	"Nucleoplasm, Nuclear bodies"	"Nucleoli, Cytosol"	"CAB016117: , HPA063742: "	"unprognostic (1.27e-1)"	"unprognostic (3.27e-3)"	"unprognostic (5.45e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.99e-3)"	"unprognostic (3.31e-2)"	"potential prognostic unfavorable (1.89e-4)"	"unprognostic (5.41e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.34e-3)"	"potential prognostic unfavorable (1.50e-4)"	"unprognostic (8.86e-2)"	"potential prognostic unfavorable (6.14e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.69e-2)"	"unprognostic (7.62e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.69e-2)"	"unprognostic (6.85e-2)"	"unprognostic (3.68e-3)"	"unprognostic (3.55e-1)"	"unprognostic (1.52e-3)"	"unprognostic (2.51e-2)"
FANCE	"FACE, FAE"	ENSG00000112039	"FA complementation group E"	Q9HB96	6	35452338-35467104	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 25.8;Extravillous trophoblasts: 152.7;Migrating cytotrophoblasts: 28.8;Syncytiotrophoblasts: 61.6"	"Cell type enhanced"	"Detected in many"		"pericyte: 14.5;vascular associated smooth muscle cell: 10.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Skin - Keratinocyte (other), Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013343, CAB014893"	Enhanced		Supported	"Nucleoplasm,Mitotic chromosome,Centrosome"			Yes	NA				"Cluster 24: Non-specific - Transcription"		"Cluster 28: Non-specific - Nuclear processes"	"Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio"	16	Nucleoplasm	"Mitotic chromosome, Centrosome"	"CAB014893: , HPA013343: "	"unprognostic (2.69e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.92e-2)"	"unprognostic (2.00e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.66e-1)"	"validated prognostic unfavorable (1.36e-8)"	"validated prognostic unfavorable (1.44e-4)"	"unprognostic (5.16e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.94e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.34e-2)"	"unprognostic (4.70e-2)"	"unprognostic (7.44e-3)"	"unprognostic (2.06e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.78e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.73e-1)"
FANCI	"FLJ10719, KIAA1794"	ENSG00000140525	"FA complementation group I"	Q9NVI1	15	89243945-89317261	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, DNA damage, DNA repair"	DNA-binding	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.0;lymphoid tissue: 41.4;testis: 29.9"	"Cell type enhanced"	"Detected in many"		"Differentiating spermatogonia: 102.5;Early primary spermatocytes: 179.0;Erythrocyte progenitors: 193.8;Megakaryocyte progenitors: 137.4;Monocyte progenitors: 136.5;Neutrophil progenitors: 109.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 22.3"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Lung - Mitotic cells (Lung), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Spermatocytes, Thyroid gland - Mitotic cells (Thyroid)"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA039972, HPA040379"	Approved		Enhanced	Nucleoplasm			NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 37: Neurons - Mixed function"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 27: Non-specific - Cell proliferation"	26	Nucleoplasm		"HPA039972: , HPA040379: "	"unprognostic (9.23e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.98e-1)"	"potential prognostic favorable (2.36e-4)"	"unprognostic (2.27e-1)"	"potential prognostic unfavorable (1.46e-6)"	"unprognostic (1.64e-1)"	"unprognostic (4.80e-2)"	"unprognostic (6.36e-3)"	"validated prognostic unfavorable (2.59e-5)"	"validated prognostic unfavorable (2.62e-4)"	"unprognostic (1.38e-3)"	"potential prognostic unfavorable (2.11e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.87e-3)"	"unprognostic (9.77e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (4.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.53e-1)"
FANCL	"FAAP43, FLJ10335, PHF9, Pog"	ENSG00000115392	"FA complementation group L"	Q9NW38	2	58159243-58241410	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Lactotrophs: 236.5;Oligodendrocytes: 180.3;Somatotrophs: 226.9;Thyrotrophs: 205.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033842, HPA036685, HPA036686"	Supported		Approved	"Nuclear bodies,Vesicles"			NA	Yes			"Cluster 14: Non-specific - Unknown function"	"Cluster 68: Non-specific - Basic cellular processes"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 2: Mucus-secreting cells - Unknown function"	"Cluster 59: Pituitary endocrine cells - Neuroendocrine signaling"	60	"Nuclear bodies"	Vesicles	"CAB033842: , HPA036685: , HPA036686: "	"unprognostic (4.57e-2)"	"unprognostic (2.67e-1)"	"unprognostic (3.24e-1)"	"unprognostic (8.80e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.17e-2)"	"unprognostic (8.52e-3)"	"unprognostic (6.59e-3)"	"unprognostic (6.56e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.13e-2)"	"potential prognostic unfavorable (1.10e-7)"	"unprognostic (1.19e-2)"	"potential prognostic unfavorable (2.09e-5)"	"unprognostic (7.39e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.52e-2)"	"unprognostic (4.04e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.44e-3)"	"unprognostic (2.64e-2)"
FANCM	"FAAP250, KIAA1596"	ENSG00000187790	"FA complementation group M"	Q8IYD8	14	45135930-45200890	"Disease related genes, Enzymes, Essential proteins, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 6.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 101.8;Late spermatids: 345.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Stomach - Mitotic cells (Stomach), Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055144			Supported	Nucleoplasm			NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 39: Testis - Nuclear processes"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization"	31	Nucleoplasm		"HPA055144: "	"unprognostic (1.12e-1)"	"unprognostic (1.86e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-3)"	"unprognostic (6.66e-3)"	"unprognostic (3.39e-2)"	"potential prognostic favorable (8.72e-4)"	"unprognostic (1.41e-2)"	"unprognostic (5.83e-2)"		"unprognostic (1.21e-3)"	"unprognostic (2.33e-3)"	"unprognostic (4.52e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.11e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.61e-1)"	"potential prognostic unfavorable (2.92e-4)"	"unprognostic (7.89e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.95e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"
ITGAM	"CD11B, CR3A, MAC-1"	ENSG00000169896	"Integrin subunit alpha M"	P11215	16	31259967-31332892	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Immunity, Innate immunity"	"Integrin, Receptor"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 172.8"	"Cell type enhanced"	"Detected in many"		"cDC: 94.6;Hofbauer cells: 96.0;Kupffer cells: 97.4;Macrophages: 116.8;Mast cells: 82.2;Microglia: 200.5;Monocyte progenitors: 119.9;monocytes: 229.9;Neutrophil progenitors: 685.8;Neutrophils: 730.8;NK-cells: 98.7;pDCs: 86.5"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 246.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	8	"Leukemia: 11.3"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Lung - Neutrophils_2, Minor Salivary Gland - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils_2, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002274, CAB025091, CAB072870"	Enhanced						NA	NA		730000	"Cluster 41: Basophils - Unknown function"	"Cluster 15: Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 48: Neutrophils - Phagocytosis & degranulation"	37			"CAB025091: , CAB072870: , HPA002274: "	"unprognostic (3.46e-2)"	"unprognostic (7.29e-3)"	"unprognostic (4.18e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.46e-1)"	"potential prognostic unfavorable (1.80e-4)"	"unprognostic (2.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.91e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.80e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (7.95e-3)"	"unprognostic (1.69e-3)"	"unprognostic (2.41e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.27e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.14e-1)"
XRCC3		ENSG00000126215	"X-ray repair cross complementing 3"	O43542	14	103697609-103715504	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 122.9;Epicardial cells: 166.0;Erythrocyte progenitors: 38.1;Megakaryocyte progenitors: 39.0"	"Cell type enhanced"	"Detected in many"		"Bergmann glia: 15.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Colon - Enteric glia cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062422, HPA068953"			Enhanced	Nucleoplasm			NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 58: Skin - Keratinization"	"Cluster 6: Non-specific - Immune response"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc"	17	Nucleoplasm		"HPA062422: , HPA068953: "	"unprognostic (3.19e-2)"	"unprognostic (6.99e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.26e-2)"	"potential prognostic unfavorable (3.79e-4)"	"unprognostic (5.33e-2)"	"unprognostic (7.28e-2)"	"potential prognostic unfavorable (6.54e-5)"	"unprognostic (1.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.65e-2)"	"unprognostic (6.31e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.36e-1)"	"unprognostic (8.00e-3)"
C1QL1	"C1QRF, C1QTNF14, CRF, CTRP14"	ENSG00000131094	"Complement C1q like 1"	O75973	17	44959693-44968303	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.9;kidney: 17.1"	"Cell type enhanced"	"Detected in some"		"Mesothelial cells: 38.4;Oligodendrocyte progenitor cells: 185.6;Pancreatic islet cells: 81.7;Podocytes: 74.3;Retinal amacrine cells: 110.5;Retinal horizontal cells: 434.7;Schwann cells: 34.3"	"Group enriched"	"Detected in many"	4	"committed oligodendrocyte precursor: 67.9;LAMP5-LHX6 and Chandelier: 156.3;oligodendrocyte precursor cell: 199.8"	"Cancer enriched"	"Detected in many"	5	"Glioblastoma Multiforme (TCGA): 167.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 91.1"	"Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal medulla cells, Kidney - Podocytes, Liver - Cholangiocytes, Pancreas - Alpha cells, Pancreas - Beta cells, Prostate - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071349			Approved	Vesicles,Cytosol	"Secreted in brain"	"Complement pathway"	NA	NA				"Cluster 3: Oligodendrocytes - Myelination"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 109: Neurons - Neuronal signaling"		Vesicles	Cytosol	"HPA071349: "	"unprognostic (6.34e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.38e-1)"	"unprognostic (6.82e-3)"		"unprognostic (2.45e-1)"	"unprognostic (1.56e-2)"	"potential prognostic favorable (1.17e-5)"	"unprognostic (1.24e-1)"	"unprognostic (8.44e-2)"	"validated prognostic unfavorable (5.75e-4)"	"validated prognostic unfavorable (8.66e-4)"	"unprognostic (5.21e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.32e-2)"			"unprognostic (8.28e-2)"		"unprognostic (1.63e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.64e-3)"	"unprognostic (1.17e-1)"			"unprognostic (1.40e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.15e-2)"	"unprognostic (5.59e-2)"	"unprognostic (2.40e-2)"	"unprognostic (3.85e-2)"
C1QTNF2	CTRP2	ENSG00000145861	"C1q and TNF related 2"	Q9BXJ5	5	160347754-160370641	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood vessel: 13.2"	"Cell type enhanced"	"Detected in some"		"Fibro-adipogenic progenitors: 15.5;Fibroblasts: 17.7;Hepatic stellate cells: 12.9;Leydig cells: 15.7;Myosatellite cells: 8.5;Pericytes: 14.0;Peritubular myoid cells: 28.5;Sertoli cells: 7.1;Smooth muscle cells: 16.0;Vascular smooth muscle cells: 38.6"	"Cell type enhanced"	"Detected in many"		"pericyte: 19.3;vascular associated smooth muscle cell: 27.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.2"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.2"	"Cancer enhanced"	"Detected in some"		"Sarcoma: 7.0"	"Kidney - Fibroblasts, Liver - Hepatic stellate cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Spleen - Fibroblasts_1, Stomach - Fibroblasts, Testis - Sertoli cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061290	Uncertain		Approved	"Golgi apparatus,Centrosome"	"Secreted to blood"	"Complement pathway"	NA	NA	1080000			"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 108: Fibroblasts - ECM organization"	28	"Golgi apparatus, Centrosome"		"HPA061290: "	"unprognostic (4.66e-3)"	"unprognostic (4.38e-2)"	"unprognostic (3.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (2.54e-1)"	"unprognostic (9.14e-3)"	"unprognostic (1.19e-2)"	"unprognostic (7.99e-2)"		"unprognostic (3.49e-2)"					"unprognostic (1.42e-1)"						"unprognostic (8.53e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.10e-1)"		"unprognostic (1.31e-2)"		"potential prognostic unfavorable (9.85e-5)"	"unprognostic (1.17e-1)"		
CD93	"C1qR(P), C1QR1, C1qRP, CDw93, dJ737E23.1, ECSM3, MXRA4"	ENSG00000125810	"CD93 molecule"	Q9NPY3	20	23079360-23086324	"CD markers, Plasma proteins, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 129.3"	"Cell type enhanced"	"Detected in some"		"cDC: 53.2;Kupffer cells: 153.7;Macrophages: 99.3;Monocyte progenitors: 44.1;monocytes: 260.9;Neutrophil progenitors: 132.5;Neutrophils: 207.5;Vascular endothelial cells: 307.0"	"Group enriched"	"Detected in some"	21	"central nervous system macrophage: 10.9;endothelial cell: 34.4;leukocyte: 9.8;vascular associated smooth muscle cell: 15.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 65.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	15	"classical monocyte: 25.8;intermediate monocyte: 16.8;myeloid DC: 9.1;neutrophil: 27.8;non-classical monocyte: 7.5"	"Group enriched"	"Detected in many"	41	"dendritic cells: 9.1;granulocytes: 27.8;monocytes: 25.8"	"Cancer enhanced"	"Detected in some"		"Leukemia: 17.2;lymphoma: 6.8"	"Adipose subcutaneous - Endothelial cells, Breast - Endothelial cells, Colon - Endothelial cells, Heart muscle - Endothelial cells, Kidney - Endothelial cells, Liver - Vascular endothelial cells, Lung - Endothelial cells, Minor Salivary Gland - Endothelial cells, Pituitary gland - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Endothelial cells, Stomach - Endothelial cells, Testis - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009300, HPA012368"	Enhanced		Approved	"Vesicles,Plasma membrane"			NA	NA		100000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 12: Non-specific - Vasculature"	"Cluster 48: Adipocytes & Endothelial cells - Angiogenesis"	"Cluster 32: Endothelial cells - Angiogenesis & vascular immunity"	9	"Vesicles, Plasma membrane"		"HPA009300: , HPA012368: "	"unprognostic (7.45e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.81e-2)"	"potential prognostic favorable (3.00e-6)"	"unprognostic (1.42e-3)"	"unprognostic (5.89e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.62e-2)"	"unprognostic (6.68e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.62e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.21e-1)"
CLU	"APOJ, CLI, CLU1, CLU2, KUB1, SGP-2, SP-40, TRPM-2"	ENSG00000120885	Clusterin	P10909	8	27596917-27614700	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Apoptosis, Complement pathway, Immunity, Innate immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 9103.3"	"Cell type enhanced"	"Detected in all"		"Endometrial secretory cells: 6414.6;Epididymal basal cells: 3407.6;Epididymal efferent duct absorptive cells: 6925.0;Epididymal principal cells: 6408.2;Fallopian secretory cells: 6163.8;Hepatocytes: 4532.6;Müller glia: 7063.0;Ocular epithelial cells: 11976.2;Pancreatic duct cells: 3168.6;Platelets: 3677.9;Submucosal glandular cells: 4613.4"	"Cell type enhanced"	"Detected in all"		"astrocyte: 1942.6;ependymal cell: 2071.7"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 20296.0;Thyroid Carcinoma (TCGA): 13243.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 773.3"	"Lineage enriched"	"Detected in all"	33	"granulocytes: 773.3"	"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Fibroblasts_2, Prostate - Smooth muscle cells, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000572, CAB016253, HPA075983, CAB080180"	Enhanced		Supported	Cytosol	"Secreted to blood"	"Complement pathway"	NA	NA	169000000000	48000000000	"Cluster 41: Basophils - Unknown function"	"Cluster 22: Epididymis - Mixed function"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 100: Stratified epithelial cells - Barrier functions"	50	Cytosol		"CAB016253: , CAB080180: , HPA000572: , HPA075983: "	"unprognostic (3.04e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.82e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.27e-2)"	"potential prognostic unfavorable (3.61e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.17e-3)"	"unprognostic (8.77e-2)"	"unprognostic (1.15e-3)"	"potential prognostic favorable (5.56e-5)"	"unprognostic (1.08e-1)"	"unprognostic (1.47e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.38e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.37e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.13e-1)"
CMKLR1	RVER1	ENSG00000174600	"Chemerin chemokine-like receptor 1"	Q99788	12	108288044-108339317	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 32.3"	"Cell type enhanced"	"Detected in some"		"Fibro-adipogenic progenitors: 24.5;Hofbauer cells: 77.3;Kupffer cells: 233.7;Macrophages: 104.8;Microglia: 98.4;monocytes: 33.9;pDCs: 59.0"	"Group enriched"	"Detected in some"	5	"central nervous system macrophage: 144.7;fibroblast: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 14.6;plasmacytoid DC: 18.2"	"Group enriched"	"Detected in many"	22	"dendritic cells: 18.2;monocytes: 14.6;T-cells: 7.1"	"Low cancer specificity"	"Detected in some"			"Adrenal gland - Macrophages, Liver - Kupffer cells, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Spleen - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047865	Uncertain						NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 70: DU4475 - Unknown function"	"Cluster 72: Macrophages - Phagocytosis & lysosomal degradation"				"HPA047865: "	"unprognostic (2.08e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.71e-2)"	"unprognostic (3.28e-1)"	"unprognostic (5.52e-2)"	"unprognostic (8.19e-3)"	"unprognostic (2.87e-1)"	"unprognostic (4.27e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-1)"
COLEC11	"CL-11, CL-K1, MGC3279"	ENSG00000118004	"Collectin subfamily member 11"	Q9BWP8	2	3594832-3644644	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 50.7;liver: 108.9;ovary: 50.7"	"Cell type enriched"	"Detected in many"	5	"Hepatic stellate cells: 813.3"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"Liver Hepatocellular Carcinoma (TCGA): 31.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	4	"Neuroblastoma: 27.6"	"Adrenal gland - Fibroblasts, Colon - Enteric glia cells, Kidney - Proximal tubular cells, Liver - Hepatic stellate cells, Pituitary gland - Fibroblasts, Prostate - Fibroblasts"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA035241	Uncertain				"Secreted to blood"	"Developmental protein"	NA	NA	299000000	250000000		"Cluster 76: Non-specific - Metabolism"	"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 94: Gonadal somatic cells - Mixed function"	2			"HPA035241: "	"unprognostic (1.15e-1)"	"unprognostic (4.79e-2)"	"unprognostic (4.49e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.61e-3)"	"unprognostic (1.44e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (7.97e-2)"	"unprognostic (5.05e-3)"	"unprognostic (3.16e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.71e-3)"	"unprognostic (5.34e-3)"	"potential prognostic favorable (1.51e-4)"	"unprognostic (2.96e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.47e-1)"	"unprognostic (9.03e-2)"
ERCC8	"CKN1, CSA"	ENSG00000049167	"ERCC excision repair 8, CSA ubiquitin ligase complex subunit"	Q13216	5	60866454-60945073	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cockayne syndrome, Deafness, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Myonuclei: 144.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029328			Approved	"Nuclear speckles"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 61: Non-specific - Transcription"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 7: Non-specific - Transcription"	35	"Nuclear speckles"		"HPA029328: "	"unprognostic (1.21e-1)"	"unprognostic (3.96e-2)"	"unprognostic (8.54e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.88e-2)"	"unprognostic (4.39e-2)"	"unprognostic (8.01e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.73e-2)"	"unprognostic (4.09e-3)"	"potential prognostic favorable (7.29e-4)"	"unprognostic (4.43e-1)"	"unprognostic (1.33e-1)"		"unprognostic (3.29e-2)"	"unprognostic (1.15e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.21e-1)"	"unprognostic (5.82e-3)"	"unprognostic (6.23e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.99e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.95e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-1)"
FANCB	"FAAP95, FAB, FLJ34064"	ENSG00000181544	"FA complementation group B"	Q8NB91	X	14690388-14873255	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.3;lymphoid tissue: 1.7"	"Cell type enhanced"	"Detected in many"		"Early primary spermatocytes: 31.4;Erythrocyte progenitors: 97.1;Extravillous trophoblasts: 29.8;Megakaryocyte progenitors: 44.4;Megakaryocyte-Erythroid progenitors: 27.8;Monocyte progenitors: 59.5;Neutrophil progenitors: 46.4;Oligodendrocytes: 34.7;Undifferentiated spermatogonia: 27.4"	"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 44.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA003124	Uncertain						NA	NA			"Cluster 32: Basophils - Transcription"	"Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 27: Non-specific - Cell proliferation"	17			"HPA003124: "			"unprognostic (2.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (3.15e-1)"		"unprognostic (1.33e-1)"										"unprognostic (1.45e-1)"	"unprognostic (7.35e-3)"		"unprognostic (2.18e-1)"		"potential prognostic unfavorable (2.66e-4)"			"unprognostic (1.02e-2)"			"unprognostic (1.79e-1)"		
FCN1	FCNM	ENSG00000085265	"Ficolin 1"	O00602	9	134903232-134917912	"Plasma proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"bone marrow: 150.0;lymphoid tissue: 45.0"	"Cell type enhanced"	"Detected in some"		"cDC: 203.9;Macrophages: 82.6;Monocyte progenitors: 322.6;monocytes: 1136.9;Neutrophil progenitors: 713.6;Neutrophils: 345.7"	"Cell type enriched"	"Detected in single"	606	"leukocyte: 101.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 1694.0;intermediate monocyte: 1189.2"	"Lineage enhanced"	"Detected in all"		"monocytes: 1694.0"	"Cancer enriched"	"Detected in single"	7	"Leukemia: 1.1"	"Adipose visceral - Neutrophils, Lung - Neutrophils_2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA000685, HPA001295, CAB016760"	Enhanced				"Secreted to blood"	Immunity	NA	NA	1060000000	29000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 15: Bone marrow - Innate immune response"	"Cluster 48: Non-specific - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 40: Monocytes & Neutrophils - Inflammatory signaling"	13			"CAB016760: , HPA000685: , HPA001295: "	"unprognostic (5.76e-2)"		"unprognostic (1.62e-2)"			"unprognostic (2.27e-1)"		"unprognostic (9.34e-2)"			"unprognostic (1.42e-1)"	"unprognostic (7.87e-2)"	"unprognostic (6.55e-2)"		"unprognostic (9.51e-2)"	"potential prognostic favorable (8.48e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.54e-3)"	"unprognostic (1.38e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.82e-1)"			"unprognostic (2.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.72e-2)"		"unprognostic (2.46e-2)"
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804115	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 179.3;lymphoid tissue: 175.1"	"Cell type enriched"	"Detected in some"	7	"Neutrophils: 3550.8"	"Cell type enriched"	"Detected in some"	4	"central nervous system macrophage: 26.0"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 76.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 4198.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 4198.3"	"Low cancer specificity"	"Detected in some"			"Adrenal gland - Macrophages, Breast - Macrophages, Colon - Neutrophils, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophils_2, Prostate - Macrophages, Skeletal muscle - Neutrophils, Skin - Macrophages, Spleen - Neutrophils_2"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 31: Neutrophils - Chemotaxis & Apoptosis"	51	"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: , HPA061744: "	"unprognostic (1.05e-1)"	"unprognostic (9.55e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.81e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.80e-2)"	"unprognostic (5.94e-2)"	"unprognostic (6.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.92e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.18e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (2.96e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.55e-2)"	"unprognostic (7.47e-2)"	"unprognostic (6.93e-2)"	"unprognostic (5.41e-3)"	"unprognostic (5.14e-3)"	"unprognostic (2.83e-1)"
FPR2	"ALX, ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770531	"G-protein coupled receptors, Predicted membrane proteins"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 52.9"	"Cell type enriched"	"Detected in some"	8	"Neutrophils: 786.9"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 1.9;miscellaneous: 2.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"neutrophil: 1191.9"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 1191.9"	"Group enriched"	"Detected in some"	4	"Bladder cancer: 2.8;Leukemia: 2.6;liver cancer: 2.1"	"Adrenal gland - Macrophages, Colon - Neutrophils, Heart muscle - Neutrophils, Kidney - Macrophages, Liver - Neutrophils, Lung - Neutrophils_2, Prostate - Macrophages, Skeletal muscle - Neutrophils, Spleen - Neutrophils_2, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Neutrophils"	"Not detected"	"Not detected"							HPA029154	Approved						NA	NA			"Cluster 28: Neutrophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 31: Neutrophils - Chemotaxis & Apoptosis"	58			"HPA029154: "	"unprognostic (9.37e-2)"		"unprognostic (2.27e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.91e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.23e-2)"	"unprognostic (4.30e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.47e-1)"			"unprognostic (4.79e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.33e-3)"	"unprognostic (1.70e-1)"			"unprognostic (8.54e-2)"	"unprognostic (5.97e-2)"		"unprognostic (1.27e-1)"	"unprognostic (1.08e-1)"		"unprognostic (2.85e-2)"	"unprognostic (1.12e-1)"		"unprognostic (3.02e-1)"
GPR32	RVDR1	ENSG00000142511	"G protein-coupled receptor 32"	O75388	19	50770464-50771732	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	32	"parathyroid gland: 54.6"	"Group enriched"	"Detected in some"	5	"Extravillous trophoblasts: 8.0;Syncytiotrophoblasts: 2.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	30	"testis cancer: 2.9"						"Not detected"	"Not detected"										NA	NA				"Cluster 69: Parathyroid gland - Mixed function"		"Cluster 34: Testis cancer - Unknown function"	"Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio"																																			
GPR33		ENSG00000214943	"G protein-coupled receptor 33"	Q49SQ1	14	31482875-31488039	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"cDC: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.6"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.6"	"Not detected"	"Not detected"				"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"										NA	NA			"Cluster 2: Dendritic cells - Unknown function"			"Cluster 55: Lymphoma - Immune response"	"Cluster 82: Dendritic cells - Antigen presentation"																																			
PTX3	"TNFAIP5, TSG-14"	ENSG00000163661	"Pentraxin 3"	P26022	3	157436850-157443633	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 230.2;urinary bladder: 177.9"	"Cell type enhanced"	"Detected in many"		"Endometrial luminal cells: 37.7;Fallopian secretory cells: 90.2;Fibroblasts: 91.7;Lymphatic endothelial cells: 74.7;monocytes: 134.3;Neutrophil progenitors: 185.4;Neutrophils: 79.3;Pancreatic duct cells: 37.1;Schwann cells: 64.4"	"Cell type enhanced"	"Detected in some"		"hippocampal CA4: 5.2;lower rhombic lip: 5.8"	"Cancer enhanced"	"Detected in many"		"Glioblastoma Multiforme (TCGA): 39.1"	"Region enhanced"	"Detected in many"		"thalamus: 9.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Sarcoma: 203.9"	"Colon - Neutrophils, Skin - Macrophages"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069320	Approved		Uncertain	"Plasma membrane"	"Secreted to blood"	"No annotated function"	NA	NA	1090000	6900000	"Cluster 19: Eosinophils - Unknown function"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 12: Non-specific - Vasculature"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 37: Neutrophil progenitors - Granulopoiesis"	10	"Plasma membrane"		"HPA069320: "	"unprognostic (2.63e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.61e-2)"		"unprognostic (2.48e-1)"	"unprognostic (4.71e-3)"	"potential prognostic unfavorable (3.34e-5)"	"potential prognostic unfavorable (1.67e-4)"	"unprognostic (2.55e-2)"	"potential prognostic unfavorable (3.77e-7)"	"unprognostic (1.56e-1)"			"unprognostic (2.10e-1)"	"unprognostic (2.11e-3)"	"potential prognostic unfavorable (2.01e-4)"	"potential prognostic unfavorable (4.21e-5)"	"unprognostic (4.90e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.61e-2)"	"potential prognostic unfavorable (2.29e-4)"			"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"		"unprognostic (3.99e-2)"		"potential prognostic unfavorable (2.12e-5)"
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35213956-35253079	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"blood vessel: 42.6;thyroid gland: 25.9"	"Cell type enriched"	"Detected in many"	6	"Epicardial cells: 577.6"	"Cell type enhanced"	"Detected in all"		"LAMP5-LHX6 and Chandelier: 30.8"	"Cancer enhanced"	"Detected in many"		"Thyroid Carcinoma (TCGA): 12.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Brain cancer: 11.1;testis cancer: 9.4"	"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Smooth muscle cells, Lung - Smooth muscle cells, Minor Salivary Gland - Smooth muscle cells, Prostate - Smooth muscle cells, Skeletal muscle - Smooth muscle cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Supported	"Plasma membrane"	"Secreted to blood"	"No annotated function"	NA	NA	1890000	600000		"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 48: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 83: Epicardial mesothelial cells - Basic cellular functions"	1	"Plasma membrane"		"HPA040606: "	"unprognostic (4.59e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.79e-1)"		"unprognostic (1.11e-2)"	"unprognostic (1.71e-1)"		"unprognostic (2.09e-2)"					"unprognostic (2.64e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.52e-1)"		"unprognostic (2.17e-1)"	"unprognostic (1.00e-1)"		"unprognostic (3.08e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.48e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.06e-1)"	"potential prognostic unfavorable (7.73e-5)"	"unprognostic (9.60e-2)"
XRCC4		ENSG00000152422	"X-ray repair cross complementing 4"	Q13426	5	83077498-83353787	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Monocyte progenitors: 204.4;Neutrophil progenitors: 211.4;Neutrophils: 289.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"							"HPA006801, HPA051538"	Supported		Enhanced	Nucleoplasm			NA	NA			"Cluster 10: Non-specific - Membrane trafficking"	"Cluster 51: Lymphoid tissue - Adaptive immune response"	"Cluster 21: Non-specific - Metabolism"	"Cluster 22: Non-specific - mRNA splicing & Cell cycle"	"Cluster 29: Neutrophils - Innate immune cellular maintenance"	46	Nucleoplasm		"HPA006801: , HPA051538: "	"unprognostic (1.36e-2)"	"potential prognostic unfavorable (2.40e-5)"	"unprognostic (4.87e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.43e-3)"	"potential prognostic unfavorable (6.14e-4)"	"potential prognostic favorable (1.46e-6)"	"unprognostic (4.21e-1)"	"unprognostic (1.35e-1)"	"potential prognostic unfavorable (3.84e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.43e-2)"	"potential prognostic unfavorable (3.70e-5)"	"unprognostic (8.15e-2)"	"unprognostic (4.44e-3)"	"unprognostic (3.42e-3)"	"potential prognostic unfavorable (2.99e-5)"	"unprognostic (1.22e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.39e-3)"	"unprognostic (9.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"
XRCC5	"KARP-1, KU80, Ku86, KUB2"	ENSG00000079246	"X-ray repair cross complementing 5"	P13010	2	216107464-216206303	"Cancer-related genes, Essential proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004468, HPA025813, HPA064685"	Supported		Supported	Nucleoplasm			NA	NA		2600000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 61: Non-specific - Transcription"	"Cluster 34: Non-specific - Mixed function"	"Cluster 26: Non-specific - Mitochondria & RNA binding"	"Cluster 48: Neutrophils - Phagocytosis & degranulation"	182	Nucleoplasm		"CAB004468: , HPA025813: , HPA064685: "	"unprognostic (8.50e-3)"	"unprognostic (1.43e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.18e-2)"	"unprognostic (2.03e-3)"	"validated prognostic favorable (2.95e-5)"	"validated prognostic favorable (3.64e-4)"	"unprognostic (5.51e-2)"	"validated prognostic unfavorable (5.24e-5)"	"validated prognostic unfavorable (2.95e-4)"	"potential prognostic unfavorable (5.38e-4)"	"unprognostic (1.51e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.03e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.22e-2)"	"unprognostic (6.76e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.26e-1)"
XRCC6	"D22S671, D22S731, G22P1, KU70, ML8"	ENSG00000196419	"X-ray repair cross complementing 6"	P12956	22	41621163-41664048	"Cancer-related genes, Essential proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair, Host-virus interaction, Immunity, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Helicase, Hydrolase, Lyase, Multifunctional enzyme"	"Cancer-related genes, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 478.1;Early primary spermatocytes: 532.5;Late primary spermatocytes: 494.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004254, HPA047549, HPA062226"	Enhanced		Enhanced	Nucleoplasm			No	No		1600000	"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 39: Testis - Nuclear processes"	"Cluster 21: Non-specific - Metabolism"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 63: Cytotrophoblasts - Basic cellular functions"	292	Nucleoplasm		"CAB004254: , HPA047549: , HPA062226: "	"unprognostic (1.29e-2)"	"unprognostic (2.38e-2)"	"unprognostic (7.72e-2)"	"potential prognostic favorable (6.58e-4)"	"unprognostic (2.20e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.04e-3)"	"unprognostic (3.17e-1)"	"unprognostic (9.02e-3)"	"potential prognostic unfavorable (1.87e-4)"	"potential prognostic favorable (8.25e-6)"	"unprognostic (4.17e-3)"	"unprognostic (3.53e-1)"	"potential prognostic unfavorable (1.60e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.14e-3)"	"unprognostic (1.27e-1)"	"unprognostic (5.49e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.21e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.17e-1)"	"potential prognostic favorable (7.10e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.38e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.00e-1)"
ERCC4	"FANCQ, RAD1, XPF"	ENSG00000175595	"ERCC excision repair 4, endonuclease catalytic subunit"	Q92889	16	13920138-13952348	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Disease variant, Dwarfism, Fanconi anemia, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 17.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 264.6;Late spermatids: 220.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000156, HPA045828"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 30: Skeletal muscle - Striated muscle contraction"	"Cluster 31: Non-specific - Transcription"	"Cluster 54: Non-specific - Transcription"	"Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase"	27	"Nucleoplasm, Nuclear bodies"	"Plasma membrane"	"CAB000156: , HPA045828: "	"unprognostic (9.55e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.69e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.34e-1)"	"potential prognostic favorable (2.94e-4)"	"unprognostic (1.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (4.87e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.53e-1)"	"unprognostic (5.40e-2)"	"unprognostic (4.17e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.13e-2)"	"potential prognostic unfavorable (4.59e-4)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-2)"	"unprognostic (4.53e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.37e-1)"	"unprognostic (7.35e-3)"	"unprognostic (8.99e-2)"
IGHG1		ENSG00000211896	"Immunoglobulin heavy constant gamma 1 (G1m marker)"	P01857	14	105736343-105743071	"Disease related genes, FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"lymphoid tissue: 10950.9;urinary bladder: 3756.3"	"Cell type enriched"	"Detected in some"	47	"Plasma cells: 2491.1"	"Cell type enriched"	"Detected in some"	10	"leukocyte: 12.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	6	"memory B-cell: 768.6"	"Lineage enriched"	"Detected in many"	122	"B-cells: 768.6"	"Cancer enriched"	"Detected in some"	8	"Myeloma: 1184.5"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									"HPA001245, CAB008642"	Supported				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 67: Plasma cells - Plasma cell differentiation"	36			"CAB008642: , HPA001245: "	"unprognostic (3.44e-3)"	"unprognostic (4.44e-3)"		"unprognostic (2.33e-3)"	"unprognostic (1.17e-1)"	"unprognostic (3.60e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.87e-1)"	"potential prognostic favorable (2.46e-4)"	"unprognostic (1.14e-1)"	"potential prognostic unfavorable (3.50e-4)"	"unprognostic (9.46e-2)"	"unprognostic (3.38e-3)"	"unprognostic (3.58e-2)"		"unprognostic (5.34e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.26e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.70e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.77e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.65e-2)"
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276807-160286348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 14.1;Hepatic stellate cells: 6.5;Megakaryocytes: 6.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Breast - Adipocytes (Breast), Liver - Hepatocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044837, HPA051966"	Supported		Supported	Peroxisomes			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 27: Non-specific - Mixed function"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 89: Adipocytes - Lipid metabolism"	93	Peroxisomes		"HPA044837: , HPA051966: "	"unprognostic (4.04e-2)"	"unprognostic (5.04e-3)"	"unprognostic (3.24e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.42e-2)"	"potential prognostic favorable (6.86e-5)"	"unprognostic (7.05e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (1.03e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	"unprognostic (4.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.46e-1)"
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Parietal cells: 164.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Breast - Breast glandular cells, Heart muscle - Cardiomyocytes, Minor Salivary Gland - Minor salivary glandular cells, Stomach - Parietal cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 38: Non-specific - Basic cellular processes"	"Cluster 25: Non-specific - Transcription"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 97: Non-specific - Cellular respiration"	24	"Nucleoplasm, Vesicles"		"HPA049202: "	"unprognostic (1.94e-2)"	"unprognostic (2.08e-3)"	"unprognostic (5.87e-2)"	"unprognostic (3.56e-3)"	"unprognostic (3.50e-3)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.46e-1)"	"potential prognostic favorable (1.40e-8)"	"unprognostic (9.42e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.46e-3)"	"unprognostic (4.40e-1)"	"unprognostic (7.04e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.68e-1)"	"unprognostic (1.23e-1)"
RFX5		ENSG00000143390	"Regulatory factor X5"	P48382	1	151340640-151347326	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - B-cells (Spleen)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018519, HPA079241"	Supported		Supported	Nucleoplasm,Vesicles			NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 18: Lymphoid tissue - Immune response"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 82: Dendritic cells - Antigen presentation"	13	Nucleoplasm	Vesicles	"HPA018519: , HPA079241: "	"unprognostic (1.40e-2)"	"unprognostic (8.17e-2)"	"unprognostic (1.72e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.49e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.79e-2)"	"potential prognostic favorable (8.01e-4)"	"unprognostic (3.67e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.02e-2)"	"unprognostic (4.49e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.77e-1)"	"unprognostic (6.32e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.58e-2)"	"unprognostic (8.06e-2)"	"unprognostic (2.26e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.81e-1)"
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		Receptor	"Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 58.6;choroid plexus: 55.1"	"Cell type enriched"	"Detected in some"	6	"Hofbauer cells: 979.9"	"Cell type enriched"	"Detected in some"	61	"central nervous system macrophage: 127.5"	"Cancer enhanced"	"Detected in all"		"Glioblastoma Multiforme (TCGA): 181.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.0"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4;Leukemia: 2.6;testis cancer: 1.4"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Kidney - Macrophages, Lung - Macrophages, Pancreas - Macrophages, Prostate - Macrophages, Testis - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved		Uncertain	Vesicles	"Secreted in brain"	Receptor	NA	NA				"Cluster 3: Oligodendrocytes - Myelination"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 72: Macrophages - Phagocytosis & lysosomal degradation"	3	Vesicles		"HPA010917: , HPA012571: "	"unprognostic (5.16e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.78e-3)"	"unprognostic (2.62e-2)"	"unprognostic (4.31e-3)"	"unprognostic (1.24e-1)"	"unprognostic (3.25e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.08e-2)"	"potential prognostic unfavorable (7.39e-4)"	"unprognostic (1.17e-1)"	"unprognostic (1.39e-2)"	"unprognostic (6.95e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.52e-3)"	"unprognostic (5.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.87e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.50e-2)"	"unprognostic (3.89e-3)"	"unprognostic (1.97e-2)"	"unprognostic (5.52e-2)"	"unprognostic (7.31e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-3)"	"unprognostic (7.42e-2)"
XPC	"RAD4, XPCC"	ENSG00000154767	"XPC complex subunit, DNA damage recognition and repair factor"	Q01831	3	14145147-14178621	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009932, HPA035707, HPA069673"	Supported		Enhanced	"Nucleoplasm,Plasma membrane"			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 49: Non-specific - Transcription"	"Cluster 26: Oligodendrocytes - Mixed function"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 29: Neutrophils - Innate immune cellular maintenance"	60	Nucleoplasm	"Plasma membrane"	"CAB009932: , HPA035707: , HPA069673: "	"unprognostic (1.66e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.44e-2)"	"validated prognostic favorable (1.12e-7)"	"validated prognostic favorable (1.69e-4)"	"unprognostic (4.26e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.11e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.89e-1)"	"unprognostic (8.15e-3)"	"unprognostic (6.29e-2)"	"unprognostic (5.76e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.88e-1)"	"unprognostic (3.36e-2)"	"unprognostic (4.83e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.01e-2)"
XRCC2	FANCU	ENSG00000196584	"X-ray repair cross complementing 2"	O43543	7	152644776-152676193	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Fanconi anemia, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 5.5"	"Cell type enhanced"	"Detected in many"		"Differentiating spermatogonia: 21.5;Early primary spermatocytes: 41.6;Erythrocyte progenitors: 44.1;Extravillous trophoblasts: 31.9;Late primary spermatocytes: 21.9;Megakaryocyte progenitors: 101.9;Megakaryocyte-Erythroid progenitors: 20.9;Migrating cytotrophoblasts: 23.3;Monocyte progenitors: 23.7;Syncytiotrophoblasts: 20.1"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Lung - Mitotic cells (Lung), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065153			Approved	Nucleoplasm,Vesicles			NA	NA				"Cluster 44: Bone marrow - Nuclear processes"	"Cluster 9: Non-specific - Receptor signaling"	"Cluster 39: Non-specific - Transcription"	"Cluster 66: Erythroid cells - Erythroid differentiation and maturation"	13	"Nucleoplasm, Vesicles"		"HPA065153: "	"unprognostic (1.16e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.50e-2)"	"unprognostic (2.46e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.41e-2)"			"potential prognostic unfavorable (5.74e-4)"			"potential prognostic unfavorable (3.44e-4)"	"potential prognostic unfavorable (5.25e-4)"	"unprognostic (6.94e-3)"	"unprognostic (6.07e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.97e-1)"		"unprognostic (5.23e-3)"		"unprognostic (2.94e-2)"	"unprognostic (8.78e-3)"	"unprognostic (4.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.95e-1)"		"unprognostic (4.71e-2)"
A2M	"CPAMD5, FWP007, S863-7"	ENSG00000175899	Alpha-2-macroglobulin	P01023	12	9067664-9116229	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 1683.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 371.1;Fibroblasts: 333.8;Hepatocytes: 757.8;Hofbauer cells: 412.3;Mast cells: 302.4;Microglia: 848.5;Pericytes: 656.8;Pituicytes/FSCs: 349.9;Retinal horizontal cells: 681.1;Salivary myoepithelial cells: 314.6;Vascular endothelial cells: 1019.5;Vascular smooth muscle cells: 723.8"	"Group enriched"	"Detected in all"	10	"central nervous system macrophage: 1008.7;endothelial cell: 1846.2;pericyte: 487.5;vascular associated smooth muscle cell: 635.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.5"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.5"	"Cancer enhanced"	"Detected in many"		"Brain cancer: 48.1;liver cancer: 106.6;skin cancer: 72.1"	"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Fibroblasts, Breast - Endothelial cells, Colon - Endothelial cells, Kidney - Fibroblasts, Liver - Hepatocytes, Lung - Fibroblasts_1, Prostate - Fibroblasts, Skeletal muscle - Endothelial cells, Skin - Endothelial cells, Thyroid gland - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002265, CAB017621"	Supported				"Secreted to blood"	"Enzyme inhibitor"	NA	NA	1630000000000	420000000000	"Cluster 1: T-cells - Unknown function"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	71			"CAB017621: , HPA002265: "	"unprognostic (2.07e-2)"	"unprognostic (5.51e-2)"	"unprognostic (2.75e-1)"	"unprognostic (8.27e-3)"	"unprognostic (3.84e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.51e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.96e-1)"	"validated prognostic favorable (2.84e-7)"	"validated prognostic favorable (1.68e-4)"	"unprognostic (4.02e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.09e-1)"	"unprognostic (1.90e-3)"	"unprognostic (1.86e-1)"	"unprognostic (3.03e-3)"	"unprognostic (2.22e-2)"	"unprognostic (3.00e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.61e-2)"	"unprognostic (7.19e-3)"	"unprognostic (6.41e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (9.29e-2)"	"unprognostic (2.48e-2)"	"unprognostic (3.21e-1)"
ABCD2	"ALDL1, ALDR, ALDRP"	ENSG00000173208	"ATP binding cassette subfamily D member 2"	Q9UBJ2	12	39550033-39619803	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 14.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 376.3;Astrocytes: 115.3;Bergmann glia: 81.0;Brain excitatory neurons: 55.2;Cardiomyocytes: 50.3;Retinal bipolar cells: 215.2;Retinal ganglion cells: 88.8"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in single"	6	"Glioblastoma Multiforme (TCGA): 2.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in single"	4	"T-cells: 4.2"	"Group enriched"	"Detected in some"	8	"lymphoma: 2.2;Myeloma: 8.2;Neuroblastoma: 3.5"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Colon - Colon enteroendocrine cells, Heart muscle - Cardiomyocytes, Skin - Adipocytes (Skin)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 39: T-cells - T-cell receptor"	"Cluster 46: Brain & retina - Neuronal signaling"	"Cluster 2: Neurons - Nucleosome"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 86: Retinal bipolar cells - Synaptic signal transduction"	1						"unprognostic (1.12e-1)"				"unprognostic (2.35e-1)"	"unprognostic (5.11e-3)"																							
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood vessel: 165.3;bone marrow: 200.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 343.2;Hematopoietic stem cells: 504.1;Innate lymphoid cells: 524.8;Kupffer cells: 552.4;Mast cells: 362.4;Monocyte progenitors: 794.4;monocytes: 463.7;Neutrophil progenitors: 819.9;Neutrophils: 1296.2;NK-cells: 656.2;T-cells: 510.8"	"Cell type enriched"	"Detected in many"	7	"leukocyte: 256.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Adrenal gland - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013707	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	Receptor	NA	Yes	10000000	3300000	"Cluster 7: Non-specific - Innate immune response"	"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 11: White matter - Signal transduction"	"Cluster 23: Non-specific - Transcription"	"Cluster 29: Neutrophils - Innate immune cellular maintenance"	4	"Plasma membrane"	"Golgi apparatus"	"HPA013707: "	"unprognostic (2.90e-1)"	"unprognostic (5.56e-1)"		"unprognostic (9.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.93e-3)"	"unprognostic (8.66e-2)"	"potential prognostic unfavorable (1.02e-4)"	"unprognostic (3.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.06e-2)"	"unprognostic (8.73e-2)"	"potential prognostic unfavorable (3.63e-5)"		"unprognostic (2.30e-1)"	"unprognostic (3.54e-1)"	"potential prognostic unfavorable (7.31e-4)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.29e-1)"	"unprognostic (8.35e-3)"	"unprognostic (6.34e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.05e-2)"	"potential prognostic favorable (2.47e-5)"	"unprognostic (1.14e-1)"	"unprognostic (5.49e-2)"	"unprognostic (5.05e-2)"	"unprognostic (4.08e-2)"	"unprognostic (6.02e-2)"
ADIPOQ	"ACDC, ACRP30, adiponectin, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842704-186858463	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"adipose tissue: 843.2;breast: 252.6"	"Cell type enriched"	"Detected in some"	38	"Adipocytes: 482.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Breast Invasive Carcinoma (TCGA): 15.2;Pancreatic Adenocarcinoma (TCGA): 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Minor Salivary Gland - Adipocytes (Minor salivary gland), Skin - Adipocytes (Skin)"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	Hormone	NA	NA	8360000000	890000000		"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 48: Non-specific - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 89: Adipocytes - Lipid metabolism"	46			"CAB046467: , HPA051767: "	"unprognostic (5.31e-2)"	"unprognostic (1.56e-2)"	"potential prognostic favorable (6.80e-4)"		"unprognostic (1.57e-1)"	"unprognostic (7.54e-2)"																"unprognostic (8.12e-3)"				"unprognostic (1.59e-3)"		"unprognostic (4.21e-2)"			
AGO1	"EIF2C1, hAGO1"	ENSG00000092847	"Argonaute RISC component 1"	Q9UL18	1	35869808-35930532	"Predicted intracellular proteins"	"RNA-mediated gene silencing, Transcription, Transcription regulation, Translation regulation"	"Repressor, Ribonucleoprotein, RNA-binding"	"Disease variant, Epilepsy, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Neutrophils: 146.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Kidney - Fibroblasts"	"Low region specificity"	"Detected in all"							HPA067849			Supported	"Cytosol,Cytoplasmic bodies"			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 61: Non-specific - Transcription"	"Cluster 7: Non-specific - Ribosome"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 24: Neutrophils - Innate immunity signal integration"	52	"Cytoplasmic bodies"	Cytosol	"HPA067849: "	"unprognostic (4.01e-2)"	"unprognostic (1.39e-1)"		"unprognostic (6.85e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.59e-2)"	"unprognostic (6.93e-2)"	"unprognostic (7.40e-3)"	"validated prognostic favorable (2.04e-7)"	"validated prognostic favorable (3.25e-5)"	"unprognostic (3.09e-2)"	"potential prognostic unfavorable (8.96e-6)"		"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.41e-2)"	"unprognostic (3.00e-3)"	"potential prognostic unfavorable (3.22e-4)"	"unprognostic (7.71e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.00e-2)"	"unprognostic (5.85e-2)"
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3389.4"	"Cell type enriched"	"Detected in some"	12	"Hepatocytes: 4780.8"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	21	"Liver Hepatocellular Carcinoma (TCGA): 1149.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	10	"liver cancer: 14.2"	"Liver - Hepatocytes"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	"No annotated function"	NA	NA	27700000000	7600000000		"Cluster 53: Liver - Plasma proteins"		"Cluster 7: Liver cancer - Metabolism"	"Cluster 93: Hepatocytes - Bile production & excretion"	9			"CAB007817: , HPA053294: "											"unprognostic (8.21e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.45e-2)"	"potential prognostic favorable (1.23e-6)"							"unprognostic (2.42e-2)"	"potential prognostic unfavorable (1.18e-5)"								
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 362.0"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 1583.1;Neutrophil progenitors: 899.7;Neutrophils: 2305.7;Ocular epithelial cells: 1020.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.8"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Adrenal gland - Adrenal cortex cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"			NA	NA		850000	"Cluster 2: Dendritic cells - Unknown function"	"Cluster 63: Non-specific - Basic cellular processes"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 7: Liver cancer - Metabolism"	"Cluster 24: Neutrophils - Innate immunity signal integration"	77	"Endoplasmic reticulum"		"HPA055161: , HPA059303: "	"unprognostic (2.94e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.21e-1)"	"potential prognostic unfavorable (9.40e-7)"	"unprognostic (2.05e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.53e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.99e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.50e-2)"	"potential prognostic unfavorable (5.81e-6)"	"unprognostic (2.33e-2)"	"unprognostic (1.40e-3)"	"potential prognostic unfavorable (3.07e-5)"	"unprognostic (1.82e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.13e-2)"	"unprognostic (9.51e-3)"	"potential prognostic unfavorable (4.57e-5)"	"unprognostic (9.22e-3)"	"unprognostic (1.67e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.14e-3)"	"unprognostic (1.16e-1)"
BIVM-ERCC5		ENSG00000270181	"BIVM-ERCC5 readthrough"		13	102799110-102875994	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Epicardial cells: 4.5;Mucous neck cells: 3.2;Myonuclei: 6.4;Paneth cells: 3.9;Parietal cells: 3.5;Retinal amacrine cells: 3.4;Retinal pigment epithelial cells: 4.3"					"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"Kidney cancer: 1.0"										"HPA045845, HPA050126, HPA050374"	Uncertain		Approved	Nucleoplasm			NA	NA					"Cluster 37: Neurons - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 55: Myocytes - Oxidative muscle function"		Nucleoplasm		"HPA045845: , HPA050126: , HPA050374: "																															
C1QTNF1	"CTRP1, FLJ90694, GIP, ZSIG37"	ENSG00000173918	"C1q and TNF related 1"	Q9BXJ1	17	79022814-79049788	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood vessel: 292.8;heart muscle: 270.6"	"Cell type enhanced"	"Detected in many"		"Breast lactating cells: 114.8;Decidual stromal cells: 54.0;Epicardial cells: 104.6;Hepatic stellate cells: 154.9;Pericytes: 154.7;Syncytiotrophoblasts: 69.4;Vascular smooth muscle cells: 271.5"	"Group enriched"	"Detected in many"	6	"pericyte: 246.7;vascular associated smooth muscle cell: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Breast - Adipocytes (Breast), Pituitary gland - Endothelial cells, Prostate - Fibroblasts, Testis - Endothelial cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB025429, HPA051101"	Uncertain		Approved	Nucleoplasm,Cytosol	"Secreted to blood"	"Complement pathway"	NA	NA	314000000	35000		"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 110: Mural cells - ECM organization"	7	"Nucleoplasm, Cytosol"		"CAB025429: , HPA051101: "	"unprognostic (5.72e-3)"	"unprognostic (3.30e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.74e-2)"	"potential prognostic unfavorable (5.97e-5)"	"unprognostic (4.90e-2)"	"unprognostic (7.00e-3)"	"unprognostic (7.48e-2)"	"unprognostic (2.51e-2)"	"potential prognostic unfavorable (2.91e-5)"	"unprognostic (3.03e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.71e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.38e-2)"	"unprognostic (3.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.65e-2)"	"unprognostic (8.02e-2)"
C1QTNF3	"2310005P21Rik, Corcs, Cors, Cors-26, CTRP3"	ENSG00000082196	"C1q and TNF related 3"	Q9BXJ4	5	34017858-34043213	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 31.2;salivary gland: 49.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.5;Bergmann glia: 39.6;Brain excitatory neurons: 5.3;Brain inhibitory neurons: 7.4;Choroid plexus epithelial cells: 12.4;Early spermatids: 7.8;Ependymal cells: 10.1;Microglia: 8.1;Oligodendrocyte progenitor cells: 19.8;Oligodendrocytes: 32.0;Other brain neurons: 8.1"	"Cell type enhanced"	"Detected in all"		"Bergmann glia: 57.0"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 44.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Myeloma: 23.9;skin cancer: 12.0"	"Adipose subcutaneous - Adipose progenitor cells, Minor Salivary Gland - Minor salivary glandular cells, Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA064996, HPA066011"	Uncertain		Approved	"Golgi apparatus"	"Secreted to blood"	"Complement pathway"	NA	NA	44100000	13000000		"Cluster 42: Retina - Visual perception"	"Cluster 25: Non-specific - Transcription"	"Cluster 20: Myeloma - Immune response"	"Cluster 80: Oligodendrocytes - Myelination"	2	"Golgi apparatus"		"HPA064996: , HPA066011: "	"unprognostic (2.14e-2)"	"unprognostic (7.81e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.21e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.51e-1)"	"unprognostic (8.74e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.77e-1)"	"potential prognostic unfavorable (6.28e-6)"	"potential prognostic favorable (1.38e-6)"	"unprognostic (1.82e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.86e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.11e-3)"	"potential prognostic unfavorable (7.62e-4)"	"unprognostic (7.59e-2)"	"unprognostic (3.36e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.78e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.95e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.18e-1)"
C1QTNF4	"CTRP4, ZACRP4"	ENSG00000172247	"C1q and TNF related 4"	Q9BXJ3	11	47589667-47594411	"Predicted secreted proteins"		Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 129.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 48.0;Bergmann glia: 20.3;Brain excitatory neurons: 27.5;Brain inhibitory neurons: 47.0;Ependymal cells: 7.2;Oligodendrocyte progenitor cells: 7.4;Oligodendrocytes: 9.9;Other brain neurons: 31.4"	"Cell type enhanced"	"Detected in all"		"cerebellar inhibitory: 172.5"	"Group enriched"	"Detected in some"	4	"Glioblastoma Multiforme (TCGA): 1.9;Ovary Serous Cystadenocarcinoma (TCGA): 2.1;Testicular Germ Cell Tumor (TCGA): 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"Leukemia: 2.5"	"Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041032	Approved		Uncertain	"Golgi apparatus,Vesicles"	"Secreted in brain"	Cytokine	NA	NA				"Cluster 78: Brain - Neuronal signaling"	"Cluster 33: Neurons - Mixed function"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 98: Neurons - Neurotransmission & signaling"	3	"Golgi apparatus, Vesicles"		"HPA041032: "			"unprognostic (1.33e-1)"				"potential prognostic unfavorable (8.48e-4)"													"unprognostic (2.81e-1)"									"unprognostic (5.02e-2)"		
C1QTNF5	"CTRP5, DKFZp586B0621, LORD"	ENSG00000223953	"C1q and TNF related 5"	Q9BXJ0	11	119338942-119340940	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"choroid plexus: 554.7"	"Cell type enriched"	"Detected in some"	7	"Choroid plexus epithelial cells: 235.2"	"Cell type enriched"	"Detected in many"	8	"choroid plexus epithelial cell: 372.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Brain cancer: 6.7;Sarcoma: 4.1"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025607, HPA038604"	Uncertain				"Secreted to blood"	"Complement pathway"	NA	NA	219000000	580000		"Cluster 1: Choroid plexus - Transmembrane transport"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 101: Choroid plexus epithelial cells - Ion transport"	5			"CAB025607: , HPA038604: "	"unprognostic (9.75e-3)"	"unprognostic (1.35e-1)"		"unprognostic (7.76e-2)"	"potential prognostic unfavorable (7.56e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.03e-1)"		"unprognostic (9.31e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.40e-3)"	"unprognostic (1.08e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-2)"	"potential prognostic unfavorable (7.46e-4)"	"unprognostic (6.18e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.97e-2)"	"unprognostic (9.86e-3)"	"potential prognostic unfavorable (8.94e-5)"	"unprognostic (3.54e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.19e-1)"
C1QTNF6	"CTRP6, ZACRP6"	ENSG00000133466	"C1q and TNF related 6"	Q9BXI9	22	37180166-37199385	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 29.8;placenta: 27.9"	"Cell type enriched"	"Detected in many"	10	"Extravillous trophoblasts: 598.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002042	Enhanced		Approved	Nucleoplasm	"Secreted to blood"	"Complement pathway"	No	No	354000000		"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 75: Ovary - Mixed function"	"Cluster 11: White matter - Signal transduction"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio"	3	Nucleoplasm		"HPA002042: "	"unprognostic (1.22e-1)"	"unprognostic (8.88e-2)"	"unprognostic (6.85e-2)"	"potential prognostic unfavorable (1.73e-4)"	"unprognostic (7.42e-2)"	"unprognostic (9.07e-2)"	"unprognostic (7.82e-3)"	"unprognostic (2.93e-2)"	"unprognostic (3.01e-2)"	"unprognostic (8.33e-2)"	"potential prognostic unfavorable (4.16e-8)"	"unprognostic (1.45e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.46e-1)"	"potential prognostic unfavorable (2.55e-9)"	"unprognostic (2.23e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.89e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.21e-2)"	"unprognostic (7.33e-2)"	"potential prognostic unfavorable (2.92e-4)"	"unprognostic (7.85e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.87e-2)"	"unprognostic (6.67e-3)"	"unprognostic (8.24e-3)"	"unprognostic (9.72e-2)"	"unprognostic (6.66e-3)"	"unprognostic (5.88e-3)"
C1QTNF7	CTRP7	ENSG00000163145	"C1q and TNF related 7"	Q9BXJ2	4	15339818-15446167	"Plasma proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 268.7;Epicardial cells: 50.0;Fibro-adipogenic progenitors: 103.7;Fibroblasts: 67.3;Leydig cells: 46.9;Ovarian stromal cells: 41.8;Peritubular myoid cells: 60.5;Retinal bipolar cells: 151.3;Vascular smooth muscle cells: 68.2"	"Cell type enhanced"	"Detected in all"		"fibroblast: 55.0;pericyte: 53.1;vascular associated smooth muscle cell: 92.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Adrenal gland - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Minor Salivary Gland - Fibroblasts, Pancreas - Fibroblasts, Pituitary gland - Fibroblasts, Prostate - Fibroblasts, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB007055, HPA051797, HPA055392"	Uncertain		Approved	Vesicles	"Secreted to blood"	"Complement pathway"	NA	NA	238000000			"Cluster 75: Ovary - Mixed function"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 89: Adipocytes - Lipid metabolism"		Vesicles		"CAB007055: , HPA051797: , HPA055392: "	"unprognostic (2.44e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.78e-1)"			"unprognostic (1.14e-1)"					"potential prognostic favorable (5.98e-4)"					"unprognostic (3.50e-3)"	"unprognostic (3.33e-1)"		"unprognostic (1.35e-1)"	"unprognostic (8.80e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.86e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.68e-1)"		"unprognostic (6.68e-2)"		"unprognostic (2.00e-2)"	"unprognostic (2.30e-1)"		"unprognostic (2.39e-1)"
C1QTNF8	"CTRP8, UNQ5829"	ENSG00000184471	"C1q and TNF related 8"	P60827	16	1088226-1096244	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood vessel: 2.4;fallopian tube: 1.7;pituitary gland: 1.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.2;Cardiomyocytes: 4.7;Endometrial ciliated cells: 18.0;Ependymal cells: 13.7;Epicardial cells: 2.3;Epididymal efferent duct ciliated cells: 10.5;Fallopian tube ciliated cells: 5.0;Leydig cells: 3.2;Respiratory ciliated cells: 2.8"	"Group enriched"	"Detected in some"	5	"astrocyte: 4.8;ependymal cell: 15.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Lung - Respiratory ciliated cells"					"Not detected"	"Not detected"			HPA056438	Uncertain				"Secreted - unknown location"	"Complement pathway"	NA	NA				"Cluster 74: Non-specific - Signal transduction"	"Cluster 46: Brainstem - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 34: Ciliated cells - Cilia assembly & function"				"HPA056438: "																															
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 7.9"	"Cell type enhanced"	"Detected in some"		"Choroid plexus epithelial cells: 1.2;Early spermatids: 2.3;Late primary spermatocytes: 1.4;Late spermatids: 1.3;pDCs: 1.3;Undifferentiated spermatogonia: 2.0;Vascular endothelial cells: 5.3"	"Cell type enhanced"	"Detected in some"		"choroid plexus epithelial cell: 2.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"												HPA056632	Uncertain				"Secreted to blood"	"Complement pathway"	NA	NA	210000000	45000		"Cluster 62: Skeletal muscle - Muscle contraction"	"Cluster 29: Forebrain - Mixed function"	"Cluster 56: Non-specific - Sensory perception"	"Cluster 32: Endothelial cells - Angiogenesis & vascular immunity"	6			"HPA056632: "			"unprognostic (1.98e-2)"			"unprognostic (4.23e-1)"																				"unprognostic (3.60e-2)"					
C1QTNF9B	CTRP9B	ENSG00000205863	"C1q and TNF related 9B"	B2RNN3	13	23891099-23897502	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.5;skin 1: 16.9;testis: 8.3"	"Cell type enhanced"	"Detected in some"		"Brain excitatory neurons: 2.4;Cardiomyocytes: 3.3;Early spermatids: 1.9;Late spermatids: 3.2;Undifferentiated spermatogonia: 3.6"	"Cell type enhanced"	"Detected in some"		"hippocampal dentate gyrus: 12.9"	"Cancer enriched"	"Detected in many"	12	"Prostate Adenocarcinoma (TCGA): 37.5"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 17.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells"									HPA056632	Uncertain				"Secreted - unknown location"	"Complement pathway"	NA	NA				"Cluster 47: Testis - Mixed function"	"Cluster 29: Forebrain - Mixed function"	"Cluster 27: Breast cancer - Unknown function"	"Cluster 35: Neurons - Synaptic function & neurogenesis"	19			"HPA056632: "	"unprognostic (6.35e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.21e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.50e-1)"		"unprognostic (7.28e-2)"	"unprognostic (3.93e-1)"	"potential prognostic favorable (3.66e-4)"	"unprognostic (4.57e-2)"	"unprognostic (4.42e-3)"		"potential prognostic unfavorable (6.35e-4)"	"potential prognostic favorable (4.82e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.45e-3)"		"unprognostic (7.21e-2)"		"unprognostic (3.32e-2)"		"unprognostic (6.73e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.58e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.28e-1)"
CALR	"cC1qR, CRT, FLJ26680, RO, SSA"	ENSG00000179218	Calreticulin	P27797	19	12938578-12944489	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Esophageal apical cells: 1119.4;Extravillous trophoblasts: 2366.5;Syncytiotrophoblasts: 1173.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Stomach - Mitotic cells (Stomach)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001513, HPA002242, CAB019952, CAB079775, CAB080301"	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	Other	NA	NA		120000000	"Cluster 13: Non-specific - Mitochondria"	"Cluster 70: Non-specific - Protein processing"	"Cluster 21: Non-specific - Metabolism"	"Cluster 63: Non-specific - Protein processing"	"Cluster 8: Non-specific - Secretory pathway"	125	"Endoplasmic reticulum"		"CAB001513: , CAB019952: , CAB079775: , CAB080301: , HPA002242: "	"unprognostic (3.27e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.09e-3)"	"unprognostic (7.72e-2)"	"unprognostic (8.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (7.91e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.57e-3)"	"potential prognostic unfavorable (1.06e-4)"	"unprognostic (1.03e-3)"	"unprognostic (2.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.73e-1)"	"unprognostic (8.85e-3)"	"unprognostic (3.34e-1)"	"unprognostic (8.56e-2)"	"potential prognostic favorable (6.30e-4)"	"unprognostic (2.09e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.07e-1)"
CBLN1		ENSG00000102924	"Cerebellin 1 precursor"	P23435	16	49277917-49281838	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	14	"brain: 425.4"	"Cell type enhanced"	"Detected in some"		"Brain excitatory neurons: 64.0;Early spermatids: 86.4;Late primary spermatocytes: 153.3;Late spermatids: 522.6"	"Cell type enriched"	"Detected in many"	12	"upper rhombic lip: 168.6"	"Group enriched"	"Detected in many"	4	"Testicular Germ Cell Tumor (TCGA): 8.0;Thyroid Carcinoma (TCGA): 15.5"	"Region enriched"	"Detected in all"	4	"cerebellum: 239.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Bone cancer: 12.2;Neuroblastoma: 18.5"	"Testis - Early spermatids, Testis - Late spermatids"	"Region enriched"	"Detected in all"	9	"cerebellum: 613.4"	"Region enriched"	"Detected in all"	13	"cerebellum: 493.5"	HPA056335			Approved	"Cytosol,Perinuclear theca,Calyx,Flagellar centriole,Mid piece,Principal piece"	"Secreted in brain"	"No annotated function"	NA	NA		2100000		"Cluster 71: Cerebellum - Nervous system development"	"Cluster 35: Non-specific - DNA binding"	"Cluster 1: Neuronal - Visual perception"	"Cluster 2: Cerebellar granular cells - Neuronal signaling"		"Cytosol, Flagellar centriole, Mid piece, Principal piece"	"Perinuclear theca, Calyx"	"HPA056335: "			"unprognostic (1.30e-1)"	"unprognostic (6.76e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-1)"	"potential prognostic favorable (2.69e-6)"						"unprognostic (2.48e-2)"	"unprognostic (1.94e-1)"							"unprognostic (1.06e-1)"			"unprognostic (3.37e-1)"	"unprognostic (3.50e-1)"	"unprognostic (7.33e-3)"		"unprognostic (1.01e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.64e-1)"
CD19		ENSG00000177455	"CD19 molecule"	P15391	16	28931965-28939342	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 31.2;lymphoid tissue: 70.8"	"Cell type enhanced"	"Detected in some"		"B-cells: 83.9;Early primary spermatocytes: 7.7;Early spermatids: 21.4;Epicardial cells: 6.8;Epididymal efferent duct ciliated cells: 10.1;Late primary spermatocytes: 39.0;Late spermatids: 9.4;Plasma cells: 19.5"	"Cell type enhanced"	"Detected in some"		"central nervous system macrophage: 1.0;endothelial cell: 1.2;leukocyte: 1.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	81	"memory B-cell: 138.6;naive B-cell: 172.5"	"Lineage enriched"	"Detected in many"	90	"B-cells: 172.5"	"Group enriched"	"Detected in some"	13	"Leukemia: 37.8;lymphoma: 71.1"	"Lung - B-cells (Lung), Spleen - B-cells (Spleen), Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB016110	Enhanced						NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 18: Lymphoid tissue - Immune response"		"Cluster 6: Leukemia - Signal transduction"	"Cluster 87: B-cells - Adaptive immunity: Humoral response"	7			"CAB016110: "	"unprognostic (3.23e-1)"	"potential prognostic favorable (7.75e-5)"	"unprognostic (3.31e-2)"			"unprognostic (1.01e-1)"			"potential prognostic favorable (1.36e-5)"						"unprognostic (3.05e-1)"	"potential prognostic favorable (1.29e-4)"	"unprognostic (4.37e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.03e-1)"			"unprognostic (1.93e-1)"						"unprognostic (2.59e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-1)"	
CDC42	"CDC42Hs, G25K"	ENSG00000070831	"Cell division cycle 42"	P60953	1	22052627-22101360	"Disease related genes, Enzymes, Essential proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins"	"Differentiation, Neurogenesis"	Hydrolase	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Brain excitatory neurons: 90.8;Microglia: 123.1;Oligodendrocytes: 97.3;Other brain neurons: 129.6;Papillary tip epithelial cells: 153.4;Renal collecting duct intercalated cells: 91.4;Renal collecting duct principal cells: 107.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004360, HPA069590"	Approved		Supported	"Microtubules,Cytokinetic bridge"			Yes	No		2900000	"Cluster 28: Neutrophils - Unknown function"	"Cluster 68: Non-specific - Basic cellular processes"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 37: Non-specific - mRNA processing"	"Cluster 98: Neurons - Neurotransmission & signaling"	239	Microtubules	"Cytokinetic bridge"	"CAB004360: , HPA069590: "	"potential prognostic unfavorable (9.26e-4)"	"unprognostic (7.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.05e-2)"	"potential prognostic favorable (6.82e-4)"	"unprognostic (3.44e-1)"	"unprognostic (9.37e-2)"	"unprognostic (3.17e-1)"	"unprognostic (6.27e-2)"	"unprognostic (4.52e-2)"	"potential prognostic favorable (1.93e-8)"	"unprognostic (1.66e-2)"	"unprognostic (3.84e-1)"	"validated prognostic unfavorable (1.23e-5)"	"validated prognostic unfavorable (3.25e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.31e-2)"	"unprognostic (9.55e-3)"	"unprognostic (9.15e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.31e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.71e-2)"
COLEC10	"CL-10, CL-L1"	ENSG00000184374	"Collectin subfamily member 10"	Q9Y6Z7	8	118995452-119108455	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"liver: 61.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 15.9;Hepatic stellate cells: 83.9;Loop of henle epithelial cells: 78.3;Oocytes: 50.7;Papillary tip epithelial cells: 22.8;Renal collecting duct principal cells: 20.9;Renal connecting tubule cells: 29.5"	"Cell type enhanced"	"Detected in many"		"mammillary body: 29.7"	"Cancer enhanced"	"Detected in some"		"Kidney Renal Papillary Cell Carcinoma (TCGA): 2.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Kidney cancer: 7.8;Neuroblastoma: 8.8"	"Liver - Hepatic stellate cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted to blood"	"No annotated function"	NA	NA	1870000000	71000000		"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 64: Renal epithelial cells - Ion transport & homeostasis"																"unprognostic (9.75e-2)"	"unprognostic (3.05e-1)"	"potential prognostic favorable (8.74e-4)"	"unprognostic (2.60e-3)"																
CSMD2	KIAA1884	ENSG00000121904	"CUB and Sushi multiple domains 2"	Q7Z408	1	33513998-34165842	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.4;pancreas: 1.3"	"Cell type enhanced"	"Detected in many"		"Brain excitatory neurons: 232.0;Brain inhibitory neurons: 263.3;Corticotrophs: 86.0;Early spermatids: 77.2;Oligodendrocyte progenitor cells: 543.9;Oligodendrocytes: 122.5;Other brain neurons: 353.9;Retinal amacrine cells: 95.5;Retinal bipolar cells: 126.8"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in single"		"Glioblastoma Multiforme (TCGA): 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"Brain cancer: 3.9"	"Colon - Enteric glia cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 73: Brain - Neuronal signaling"	"Cluster 1: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 109: Neurons - Neuronal signaling"	1						"unprognostic (1.22e-1)"			"unprognostic (4.58e-1)"	"unprognostic (3.08e-2)"	"potential prognostic favorable (1.07e-5)"															"unprognostic (1.19e-2)"			"unprognostic (8.08e-2)"					
CSMD3		ENSG00000164796	"CUB and Sushi multiple domains 3"	Q7Z407	8	112222928-113436939	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.6"	"Group enriched"	"Detected in many"	5	"Brain excitatory neurons: 1241.8;Brain inhibitory neurons: 1428.7;Ependymal cells: 1548.8;Oligodendrocyte progenitor cells: 2465.0;Other brain neurons: 1019.8"	"Low cell type specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enteroendocrine cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029007, HPA029008"	Uncertain		Approved	"Plasma membrane"			NA	NA				"Cluster 73: Brain - Neuronal signaling"	"Cluster 29: Forebrain - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 35: Neurons - Synaptic function & neurogenesis"		"Plasma membrane"		"HPA029007: , HPA029008: "			"unprognostic (3.96e-1)"					"potential prognostic favorable (5.38e-5)"																							
DPH2	DPH2L2	ENSG00000132768	"Diphthamide biosynthesis 2"	Q9BQC3	1	43970000-43973369	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Dwarfism, Ectodermal dysplasia, Hypotrichosis, Intellectual disability"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Differentiating spermatogonia: 38.9;Esophageal basal cells: 28.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028119, HPA061083"	Approved		Approved	"Endoplasmic reticulum,Cytosol"			NA	No			"Cluster 13: Non-specific - Mitochondria"	"Cluster 63: Non-specific - Basic cellular processes"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 37: Non-specific - mRNA processing"	"Cluster 17: Non-specific - RNA processing"	13	Cytosol	"Endoplasmic reticulum"	"HPA028119: , HPA061083: "	"unprognostic (1.17e-3)"	"unprognostic (5.43e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.94e-3)"	"unprognostic (2.85e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.55e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.95e-1)"	"validated prognostic unfavorable (4.44e-10)"	"validated prognostic unfavorable (5.20e-6)"	"unprognostic (1.37e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.54e-2)"	"unprognostic (9.62e-3)"	"unprognostic (2.98e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (9.97e-3)"	"unprognostic (1.05e-1)"
EFEMP2	"FBLN4, UPH1"	ENSG00000172638	"EGF containing fibulin extracellular matrix protein 2"	O95967	11	65866441-65873592	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 65.4;Decidual stromal cells: 272.6;Fibroblasts: 96.9;Granulosa cells: 65.7;Hepatic stellate cells: 148.5;Late primary spermatocytes: 107.4;Ovarian stromal cells: 95.4;Peritubular myoid cells: 99.6;Smooth muscle cells: 70.3"	"Cell type enhanced"	"Detected in many"		"astrocyte: 32.9;fibroblast: 36.7;pericyte: 48.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 1.7"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Adrenal gland - Fibroblasts, Breast - Fibroblasts, Colon - Enteric glia cells, Kidney - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Spleen - Fibroblasts_1, Stomach - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023270	Approved				"Secreted to extracellular matrix"	"No annotated function"	NA	NA		3800000	"Cluster 21: Neutrophils - Unknown function"	"Cluster 74: Non-specific - Signal transduction"	"Cluster 44: Non-specific - Mixed function"	"Cluster 64: Connective tissue cells - ECM organization"	"Cluster 108: Fibroblasts - ECM organization"	93			"HPA023270: "	"unprognostic (9.67e-2)"	"unprognostic (1.46e-1)"	"unprognostic (2.56e-1)"	"unprognostic (5.41e-3)"	"unprognostic (5.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.12e-3)"	"potential prognostic unfavorable (9.75e-7)"	"unprognostic (1.32e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.85e-2)"	"potential prognostic favorable (5.78e-4)"	"unprognostic (7.72e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.93e-1)"	"unprognostic (1.63e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.72e-2)"	"unprognostic (1.62e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.79e-1)"
ELP4	"C11orf19, PAXNEB"	ENSG00000109911	"Elongator acetyltransferase complex subunit 4"	Q96EB1	11	31509755-31790324	"Disease related genes, Essential proteins, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038572, HPA038573"	Approved		Supported	Nucleoplasm			NA	NA			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 27: Cerebellum - Synaptic function"	"Cluster 15: Non-specific - Transcription"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 7: Non-specific - Transcription"	8	Nucleoplasm		"HPA038572: , HPA038573: "	"unprognostic (9.68e-3)"	"unprognostic (6.62e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.34e-3)"	"unprognostic (8.02e-3)"	"unprognostic (1.40e-3)"	"unprognostic (8.30e-2)"	"unprognostic (2.14e-1)"	"potential prognostic unfavorable (1.78e-4)"	"unprognostic (1.79e-3)"	"potential prognostic unfavorable (1.72e-4)"	"unprognostic (1.14e-1)"	"potential prognostic favorable (7.01e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.70e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.60e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.05e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.31e-2)"	"unprognostic (4.54e-1)"	"unprognostic (2.28e-1)"
ENSG00000275063		ENSG00000275063		P0DP08	Unmapped	41444-41876	"Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 583.6;lymphoid tissue: 715.9;urinary bladder: 406.8"	"Cell type enriched"	"Detected in some"	9	"Plasma cells: 30.7"	"Not detected"	"Not detected"							"Region enhanced"	"Detected in some"		"cerebral cortex: 2.2"	"Group enriched"	"Detected in some"	368	"memory B-cell: 404.4;naive B-cell: 260.3"	"Lineage enriched"	"Detected in single"	447	"B-cells: 404.4"	"Cancer enriched"	"Detected in some"	4	"lymphoma: 47.9"															"Secreted to blood"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 13: Non-specific - Mixed function"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"																																			
ENSG00000278263		ENSG00000278263	"Novel protein, identical to IGHV4-4"		15	21742364-21742799	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 48.8;lymphoid tissue: 53.9;urinary bladder: 91.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"memory B-cell: 24.1;naive B-cell: 7.8"	"Lineage enriched"	"Detected in single"	45	"B-cells: 24.1"	"Not detected"	"Not detected"			"Adipose visceral - Plasma cells, Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 46: Lymphoma - Humoral immune response"						"unprognostic (2.55e-1)"	"unprognostic (1.12e-1)"		"unprognostic (2.31e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"			"potential prognostic favorable (3.94e-4)"		"unprognostic (1.76e-2)"	"unprognostic (2.10e-1)"	"unprognostic (9.69e-2)"			"unprognostic (4.27e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.20e-2)"		"unprognostic (6.35e-2)"		"unprognostic (1.80e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.15e-1)"
ENSG00000281179		ENSG00000281179	"Novel gene identicle to IGHV1OR15-1"		15	21717808-21718245	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 73.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 94.7;naive B-cell: 112.0"	"Group enriched"	"Detected in many"	18	"B-cells: 112.0;T-cells: 61.1"	"Group enriched"	"Detected in some"	23	"Leukemia: 7.2;lymphoma: 3.2;Myeloma: 3.5"	"Breast - Plasma cells, Minor Salivary Gland - Plasma cells, Stomach - Plasma cells"																NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 51: Lymphoid tissue - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"							"potential prognostic favorable (7.49e-4)"		"unprognostic (5.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.57e-2)"			"potential prognostic favorable (1.15e-4)"		"unprognostic (1.77e-2)"	"unprognostic (8.41e-2)"				"unprognostic (1.20e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.16e-1)"			"unprognostic (1.09e-1)"		"unprognostic (2.03e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.96e-1)"		"unprognostic (7.79e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.38e-2)"	
ENSG00000289692		ENSG00000289692	"Novel protein"		1	22636506-22644067	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 18.1;lymphoid tissue: 16.3"	"Group enriched"	"Detected in some"	4	"Hofbauer cells: 6.5;Kupffer cells: 15.4;Macrophages: 7.0"									"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	38	"intermediate monocyte: 10.7;non-classical monocyte: 9.5"	"Lineage enriched"	"Detected in single"	48	"monocytes: 10.7"	"Not detected"	"Not detected"																			NA	NA			"Cluster 40: Monocytes - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 1: Neuronal - Visual perception"	"Cluster 72: Macrophages - Phagocytosis & lysosomal degradation"																																			
ERCC1	RAD10	ENSG00000012061	"ERCC excision repair 1, endonuclease non-catalytic subunit"	P07992	19	45407334-45478828	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Cataract"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Epicardial cells: 5321.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004390, HPA029773, HPA050182, CAB072859, CAB072860"	Supported		Supported	Nucleoplasm			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 35: Non-specific - Mixed function"	"Cluster 45: Non-specific - Mixed function"	"Cluster 69: Skin cancer - ECM organization"	"Cluster 83: Epicardial mesothelial cells - Basic cellular functions"	31	Nucleoplasm		"CAB004390: , CAB072859: , CAB072860: , HPA029773: , HPA050182: "	"unprognostic (2.39e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.28e-1)"	"potential prognostic favorable (8.42e-4)"	"unprognostic (1.51e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.42e-3)"	"potential prognostic favorable (7.51e-4)"	"potential prognostic unfavorable (5.03e-4)"	"unprognostic (1.16e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.27e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.79e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.04e-1)"
FCN2	"EBP-37, FCNL, ficolin-2, P35"	ENSG00000160339	"Ficolin 2"	Q15485	9	134880810-134887523	"Plasma proteins, Predicted secreted proteins"	"Complement activation lectin pathway, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"adrenal gland: 24.2;liver: 93.1"	"Group enriched"	"Detected in some"	4	"Breast lactating cells: 50.6;Hepatic stellate cells: 38.7;Kupffer cells: 53.3;Vascular endothelial cells: 42.9"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Liver Hepatocellular Carcinoma (TCGA): 2.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.5;intermediate monocyte: 4.6"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Prostate - Prostate glandular cells"					"Region enriched"	"Detected in some"	24	"spinal cord: 51.0"						"Secreted to blood"	Immunity	NA	NA	8100000000	430000000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 53: Liver - Plasma proteins"		"Cluster 10: Ciliated cells - Ion channel activity"	"Cluster 32: Endothelial cells - Angiogenesis & vascular immunity"	4					"unprognostic (2.45e-1)"	"unprognostic (3.78e-2)"								"potential prognostic favorable (1.88e-4)"	"unprognostic (1.68e-2)"		"unprognostic (3.69e-2)"	"unprognostic (8.70e-3)"									"unprognostic (8.94e-2)"							
GALNT4	GalNAc-T4	ENSG00000257594	"Polypeptide N-acetylgalactosaminyltransferase 4"	Q8N4A0	12	89519412-89524796	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 29.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076116			Approved	"Golgi apparatus"			NA	NA		640000	"Cluster 42: Non-specific - Vesicular transport"	"Cluster 17: Intestine - Digestion"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"		3	"Golgi apparatus"		"HPA076116: "	"unprognostic (7.13e-2)"	"unprognostic (1.53e-1)"	"potential prognostic favorable (3.92e-4)"	"unprognostic (3.64e-2)"	"unprognostic (4.36e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.78e-2)"		"unprognostic (3.09e-2)"	"unprognostic (1.04e-1)"	"potential prognostic favorable (4.58e-8)"	"unprognostic (2.92e-3)"	"unprognostic (1.92e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.12e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.42e-1)"	"unprognostic (5.63e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.39e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.20e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.46e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.15e-3)"
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 43.1"	"Cell type enhanced"	"Detected in many"		"Adrenal medulla cells: 63.8;Brain excitatory neurons: 71.1;Brain inhibitory neurons: 70.6;Cardiomyocytes: 82.9;Cone photoreceptor cells: 105.6;Hepatocytes: 213.5;Myonuclei: 62.8;Other brain neurons: 68.7"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in some"	7	"Liver Hepatocellular Carcinoma (TCGA): 13.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"lymphoma: 6.3"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Liver - Hepatocytes, Prostate - Smooth muscle cells, Skin - Keratinocyte (granular), Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	Enzyme	NA	NA	103000000000	3300000000		"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 2: Neurons - Nucleosome"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	2			"CAB008625: , HPA012500: "	"unprognostic (2.48e-2)"		"unprognostic (1.76e-2)"			"unprognostic (1.16e-1)"	"unprognostic (8.85e-2)"	"unprognostic (2.60e-1)"						"validated prognostic favorable (6.73e-5)"	"validated prognostic favorable (6.67e-8)"		"unprognostic (2.82e-2)"	"unprognostic (3.30e-2)"	"unprognostic (1.96e-2)"				"unprognostic (1.11e-1)"			"unprognostic (1.30e-2)"			"unprognostic (3.01e-1)"	"unprognostic (8.73e-2)"	
IGHA1	AL928768.3	ENSG00000211895	"Immunoglobulin heavy constant alpha 1"	P01876	14	105703995-105708665	"Disease related genes, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 6976.0;lymphoid tissue: 5886.0;salivary gland: 8576.2;stomach 1: 6273.4"	"Cell type enriched"	"Detected in some"	18	"Plasma cells: 9025.7"	"Cell type enriched"	"Detected in single"	253	"leukocyte: 25.4"	"Cancer enhanced"	"Detected in all"		"Lung Adenocarcinoma (TCGA): 2831.3"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	203	"memory B-cell: 2579.2;naive B-cell: 1123.4"	"Lineage enriched"	"Detected in many"	282	"B-cells: 2579.2"	"Cancer enriched"	"Detected in some"	20	"Myeloma: 1517.6"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 17: Intestine - Digestion"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 67: Plasma cells - Plasma cell differentiation"	29			"HPA001217: , HPA006013: "	"unprognostic (2.06e-1)"	"potential prognostic favorable (1.77e-5)"		"unprognostic (4.87e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.64e-1)"	"unprognostic (6.39e-3)"	"unprognostic (2.52e-2)"	"potential prognostic favorable (1.23e-4)"	"unprognostic (1.43e-1)"	"unprognostic (1.12e-2)"	"unprognostic (7.50e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.50e-1)"		"unprognostic (3.01e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.00e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.11e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.17e-2)"	"unprognostic (9.53e-2)"	"unprognostic (6.81e-2)"
IGHA2		ENSG00000211890	"Immunoglobulin heavy constant alpha 2 (A2m marker)"	P01877	14	105583731-105588395	"Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"intestine: 5009.9;salivary gland: 3590.5"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 8042.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	878	"memory B-cell: 280.4;naive B-cell: 124.8"	"Lineage enriched"	"Detected in single"	1215	"B-cells: 280.4"	"Cancer enriched"	"Detected in some"	5	"Myeloma: 47.8"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									"HPA001217, HPA006013"	Approved				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 77: Intestine - Digestion"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 67: Plasma cells - Plasma cell differentiation"	17			"HPA001217: , HPA006013: "	"unprognostic (5.24e-2)"	"unprognostic (1.79e-3)"		"potential prognostic favorable (6.50e-5)"	"unprognostic (3.36e-1)"	"unprognostic (1.99e-1)"		"unprognostic (5.28e-2)"	"unprognostic (1.09e-3)"		"unprognostic (5.05e-3)"	"unprognostic (9.02e-3)"	"potential prognostic unfavorable (3.47e-4)"	"unprognostic (2.49e-1)"		"unprognostic (8.14e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.80e-2)"	"unprognostic (7.91e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.95e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.31e-2)"	"unprognostic (4.24e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.34e-3)"	"unprognostic (3.82e-1)"
IGHE		ENSG00000211891	"Immunoglobulin heavy constant epsilon"	P01854	14	105597691-105601728	"Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 1.7;lymphoid tissue: 4.4;thyroid gland: 2.5"	"Group enriched"	"Detected in some"	4	"Epididymal principal cells: 8.4;Oocytes: 23.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	29	"Myeloma: 138.8"	"Minor Salivary Gland - Plasma cells, Skin - Sebaceous gland cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 5: Spleen - Immune response"		"Cluster 20: Myeloma - Immune response"	"Cluster 41: Oocytes - Oogenesis"																																			
IGHG2		ENSG00000211893	"Immunoglobulin heavy constant gamma 2 (G2m marker)"	P01859	14	105639559-105644790	"FDA approved drug targets, Immunoglobulin genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"lymphoid tissue: 4045.9"	"Cell type enriched"	"Detected in some"	32	"Plasma cells: 1009.8"	"Cell type enriched"	"Detected in single"	11	"leukocyte: 4.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	460	"memory B-cell: 344.6;naive B-cell: 128.5"	"Lineage enriched"	"Detected in single"	670	"B-cells: 344.6"	"Group enriched"	"Detected in some"	9	"lymphoma: 19.2;Myeloma: 54.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									HPA001245	Approved				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 5: Spleen - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 44: Plasma cells - Antibody production & secretion"	28			"HPA001245: "	"unprognostic (9.17e-3)"	"unprognostic (1.01e-1)"		"potential prognostic favorable (3.62e-5)"	"unprognostic (3.20e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.85e-3)"	"unprognostic (1.78e-3)"	"potential prognostic favorable (8.19e-5)"	"unprognostic (2.87e-2)"	"potential prognostic unfavorable (3.60e-4)"	"unprognostic (6.22e-3)"	"unprognostic (1.44e-2)"	"unprognostic (4.10e-2)"		"unprognostic (3.87e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.76e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.18e-2)"	"unprognostic (3.02e-1)"	"unprognostic (4.52e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.27e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.90e-3)"	"unprognostic (8.31e-2)"	"unprognostic (2.96e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.65e-2)"
IGHG4		ENSG00000211892	"Immunoglobulin heavy constant gamma 4 (G4m marker)"	P01861	14	105620506-105626066	"FDA approved drug targets, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 2337.9"	"Cell type enriched"	"Detected in some"	7	"Plasma cells: 120.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	457	"memory B-cell: 123.0;naive B-cell: 74.3"	"Lineage enriched"	"Detected in single"	569	"B-cells: 123.0"	"Group enriched"	"Detected in some"	43	"lymphoma: 133.6;Myeloma: 34.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Mesothelial cells, Adrenal gland - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Lung - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells"									HPA001245	Approved				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 18: Lymphoid tissue - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"	20			"HPA001245: "	"unprognostic (3.88e-2)"	"unprognostic (4.37e-3)"		"unprognostic (5.42e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.18e-3)"	"unprognostic (5.65e-2)"	"potential prognostic favorable (6.88e-4)"	"unprognostic (2.10e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.31e-2)"	"potential prognostic unfavorable (6.78e-5)"	"unprognostic (3.95e-1)"		"unprognostic (6.49e-3)"	"unprognostic (9.67e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.76e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.38e-2)"	"potential prognostic favorable (4.51e-6)"	"unprognostic (2.15e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.43e-2)"	"unprognostic (3.77e-1)"
IGHM		ENSG00000211899	"Immunoglobulin heavy constant mu"	P01871	14	105851705-105856218	"Disease related genes, Immunoglobulin genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 1239.2;lymphoid tissue: 3964.5"	"Group enriched"	"Detected in some"	8	"B-cells: 476.0;Plasma cells: 485.8"	"Cell type enriched"	"Detected in single"	110	"leukocyte: 69.0"	"Cancer enhanced"	"Detected in all"		"Testicular Germ Cell Tumor (TCGA): 760.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	16	"memory B-cell: 4293.6;naive B-cell: 6750.1"	"Lineage enriched"	"Detected in all"	19	"B-cells: 6750.1"	"Cancer enriched"	"Detected in some"	4	"lymphoma: 1665.3"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB008643	Uncertain				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 18: Non-specific - Translation"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 67: Plasma cells - Plasma cell differentiation"				"CAB008643: "	"potential prognostic favorable (4.88e-4)"	"potential prognostic favorable (7.49e-4)"		"potential prognostic favorable (3.70e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.09e-3)"	"potential prognostic favorable (5.16e-6)"	"unprognostic (4.67e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-2)"	"unprognostic (3.30e-3)"		"unprognostic (2.72e-3)"	"unprognostic (3.44e-2)"	"unprognostic (4.97e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.62e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.81e-2)"	"unprognostic (8.32e-2)"	"unprognostic (3.82e-1)"	"unprognostic (4.86e-2)"	"unprognostic (5.96e-2)"
IGHV1-18		ENSG00000211945	"Immunoglobulin heavy variable 1-18"	A0A0C4DH31	14	106184901-106185394	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 231.7;lymphoid tissue: 455.7;salivary gland: 235.9"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 30.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	21	"memory B-cell: 73.4"	"Lineage enriched"	"Detected in many"	21	"B-cells: 73.4"	"Cancer enriched"	"Detected in single"	121	"lymphoma: 41.4"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 5: Spleen - Immune response"	"Cluster 6: Non-specific - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (1.02e-1)"	"unprognostic (4.33e-1)"		"unprognostic (6.03e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.10e-1)"		"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.37e-1)"	"unprognostic (2.75e-2)"	"unprognostic (5.26e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.51e-1)"		"unprognostic (1.28e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.13e-2)"	"unprognostic (5.52e-1)"		"unprognostic (2.78e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.09e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.19e-2)"	"unprognostic (3.65e-1)"
IGHV1-2	V35	ENSG00000211934	"Immunoglobulin heavy variable 1-2"	P23083	14	105986582-105987083	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 432.4;lymphoid tissue: 1081.5"	"Cell type enriched"	"Detected in some"	6	"Plasma cells: 16.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	51	"memory B-cell: 286.5;naive B-cell: 348.4"	"Lineage enriched"	"Detected in many"	56	"B-cells: 348.4"	"Cancer enriched"	"Detected in some"	8	"Myeloma: 578.3"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 18: Non-specific - Translation"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 20: Myeloma - Immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (5.52e-2)"	"potential prognostic favorable (2.68e-4)"		"unprognostic (1.29e-3)"	"unprognostic (1.92e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.37e-2)"	"unprognostic (7.61e-2)"	"potential prognostic favorable (9.19e-5)"	"unprognostic (3.00e-1)"	"unprognostic (7.08e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.07e-3)"	"unprognostic (3.59e-1)"		"unprognostic (5.45e-2)"	"unprognostic (2.67e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.54e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.03e-2)"
IGHV1-24		ENSG00000211950	"Immunoglobulin heavy variable 1-24"	A0A0C4DH33	14	106276548-106277043	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 180.1;salivary gland: 71.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 2.3;Late primary spermatocytes: 2.0;Late spermatids: 1.0;Parietal cells: 1.8;Plasma cells: 7.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 223.7"	"Group enriched"	"Detected in some"	4	"cerebral cortex: 1.3;medulla oblongata: 2.7"	"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"B-cells: 2.8"	"Cancer enriched"	"Detected in single"	6	"Leukemia: 1.2"	"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Testis - Early spermatids, Testis - Late spermatids, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 5: Spleen - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (1.38e-2)"	"unprognostic (7.32e-3)"		"potential prognostic favorable (8.04e-4)"	"unprognostic (7.76e-2)"	"unprognostic (1.84e-1)"			"unprognostic (6.38e-3)"		"unprognostic (7.09e-3)"	"unprognostic (3.58e-1)"	"unprognostic (7.53e-3)"	"unprognostic (3.31e-2)"		"unprognostic (3.10e-2)"	"unprognostic (3.33e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.57e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.37e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (4.33e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.85e-1)"
IGHV1-3	VI-3B	ENSG00000211935	"Immunoglobulin heavy variable 1-3"	A0A0C4DH29	14	106005095-106005574	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 208.7;lymphoid tissue: 585.6"	"Group enriched"	"Detected in some"	4	"Plasma cells: 5.4;Platelets: 2.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"memory B-cell: 52.9;naive B-cell: 27.9"	"Lineage enriched"	"Detected in many"	9	"B-cells: 52.9"	"Cancer enriched"	"Detected in some"	30	"Myeloma: 733.0"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (2.80e-2)"	"unprognostic (9.10e-3)"		"unprognostic (2.31e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.82e-1)"			"unprognostic (3.61e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.09e-3)"	"unprognostic (9.34e-2)"	"unprognostic (4.10e-3)"	"unprognostic (1.16e-3)"		"unprognostic (6.26e-2)"	"unprognostic (1.37e-2)"	"unprognostic (6.55e-2)"	"potential prognostic unfavorable (5.59e-5)"	"unprognostic (9.79e-2)"	"unprognostic (6.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.32e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.06e-1)"
IGHV1-45		ENSG00000211961	"Immunoglobulin heavy variable 1-45"	A0A0A0MS14	14	106506996-106507491	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 17.5;lymphoid tissue: 28.2;salivary gland: 10.9;stomach 1: 16.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Lung Adenocarcinoma (TCGA): 6.4;Lung Squamous Cell Carcinoma (TCGA): 20.4"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in single"		"Gallbladder cancer: 1.1"	"Adipose visceral - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 44: Plasma cells - Antibody production & secretion"						"unprognostic (1.47e-3)"				"unprognostic (2.98e-2)"			"unprognostic (2.12e-3)"			"unprognostic (1.48e-1)"				"unprognostic (1.38e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.05e-2)"	"unprognostic (9.05e-2)"				"unprognostic (3.30e-2)"			"unprognostic (1.29e-1)"		"unprognostic (4.81e-3)"	"unprognostic (2.28e-1)"		
IGHV1-46		ENSG00000211962	"Immunoglobulin heavy variable 1-46"	P01743	14	106511117-106511856	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 70.3;lymphoid tissue: 117.9;salivary gland: 65.7"	"Group enriched"	"Detected in some"	4	"Gastric chief cells: 4.4;Plasma cells: 10.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"Myeloma: 18.8"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 5: Spleen - Immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (2.96e-2)"	"unprognostic (5.15e-3)"		"unprognostic (1.52e-2)"	"unprognostic (8.79e-3)"	"unprognostic (6.53e-2)"			"unprognostic (9.98e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.92e-3)"	"unprognostic (1.96e-1)"		"unprognostic (3.09e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.11e-1)"	"unprognostic (3.64e-1)"	"unprognostic (9.30e-3)"	"unprognostic (1.28e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.81e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.40e-1)"
IGHV1-58		ENSG00000211968	"Immunoglobulin heavy variable 1-58"	A0A0C4DH39	14	106622357-106622855	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"urinary bladder: 192.5"	"Cell type enhanced"	"Detected in some"		"Gastric chief cells: 1.1;Plasma cells: 2.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	49	"memory B-cell: 8.7;naive B-cell: 12.8"	"Lineage enriched"	"Detected in single"	58	"B-cells: 12.8"	"Not detected"	"Not detected"			"Adipose visceral - Plasma cells, Breast - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 6: Leukemia - Signal transduction"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (1.26e-1)"	"unprognostic (8.91e-3)"		"unprognostic (6.27e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.13e-2)"			"potential prognostic favorable (3.45e-4)"		"unprognostic (2.89e-3)"	"unprognostic (5.33e-2)"	"unprognostic (5.19e-3)"	"unprognostic (2.15e-1)"		"unprognostic (2.26e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.88e-3)"	"unprognostic (1.86e-2)"		"unprognostic (1.25e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.49e-1)"
IGHV1-69	IGHV1-E	ENSG00000211973	"Immunoglobulin heavy variable 1-69"	P01742	14	106714684-106715181	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 129.8;lymphoid tissue: 158.0;urinary bladder: 155.9"	"Cell type enriched"	"Detected in single"	14	"Parietal cells: 1.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	18	"medulla oblongata: 4.9;pons: 5.9"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in many"			"Cancer enriched"	"Detected in single"	9	"lymphoma: 2.7"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 5: Spleen - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 97: Non-specific - Cellular respiration"					"unprognostic (1.41e-1)"	"unprognostic (2.87e-1)"		"unprognostic (5.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (9.69e-2)"		"unprognostic (3.94e-1)"	"unprognostic (2.83e-2)"		"unprognostic (1.09e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.26e-1)"		"unprognostic (1.85e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.65e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.96e-1)"	"unprognostic (1.10e-1)"
IGHV1-69-2	IGHV1-F	ENSG00000281990	"Immunoglobulin heavy variable 1-69-2"	A0A0G2JMI3	14	106737110-106737547	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;lymphoid tissue: 44.6;salivary gland: 15.4"	"Cell type enriched"	"Detected in single"	13	"Plasma cells: 1.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"memory B-cell: 6.7;naive B-cell: 5.5"	"Lineage enriched"	"Detected in many"	6	"B-cells: 6.7"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.4"	"Breast - Plasma cells, Kidney - Plasma cells, Minor Salivary Gland - Plasma cells, Prostate - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 34: B-cells - Unknown function"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 6: Leukemia - Signal transduction"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (1.19e-1)"	"unprognostic (5.19e-2)"		"unprognostic (5.95e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.40e-1)"			"unprognostic (4.82e-2)"		"unprognostic (6.76e-3)"		"unprognostic (1.81e-2)"	"unprognostic (1.48e-1)"		"unprognostic (3.32e-3)"	"unprognostic (3.88e-1)"	"unprognostic (7.35e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.06e-2)"		"unprognostic (9.05e-2)"			"unprognostic (1.18e-3)"	"unprognostic (3.60e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.75e-1)"
IGHV1-69D		ENSG00000280411	"Immunoglobulin heavy variable 1-69D"	A0A0B4J2H0	14	106762092-106762588	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 2700.4;stomach 1: 929.5"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 25.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Lung Squamous Cell Carcinoma (TCGA): 576.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	225	"memory B-cell: 185.4;naive B-cell: 435.3"	"Lineage enriched"	"Detected in many"	316	"B-cells: 435.3"	"Cancer enriched"	"Detected in some"	8	"lymphoma: 278.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 7: Non-specific - Innate immune response"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (1.56e-2)"	"unprognostic (1.21e-3)"		"unprognostic (5.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.62e-1)"	"unprognostic (2.38e-3)"		"unprognostic (5.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.62e-1)"		"unprognostic (1.97e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.58e-1)"	"unprognostic (9.23e-3)"		"unprognostic (4.18e-1)"		"unprognostic (7.20e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.50e-1)"
IGHV1OR15-1	IGHV1/OR15-1	ENSG00000270505	"Immunoglobulin heavy variable 1/OR15-1 (non-functional)"		15	22160431-22160868	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	5	"lymphoid tissue: 73.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 94.7;naive B-cell: 112.0"	"Group enriched"	"Detected in many"	18	"B-cells: 112.0;T-cells: 61.1"	"Group enriched"	"Detected in some"	23	"Leukemia: 7.2;lymphoma: 3.2;Myeloma: 3.5"	"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 51: Lymphoid tissue - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"							"potential prognostic favorable (7.49e-4)"		"unprognostic (5.65e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.57e-2)"		"unprognostic (3.73e-2)"	"potential prognostic favorable (1.15e-4)"		"unprognostic (1.77e-2)"	"unprognostic (8.41e-2)"				"unprognostic (1.20e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.16e-1)"			"unprognostic (1.09e-1)"		"unprognostic (2.03e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.96e-1)"		"unprognostic (7.79e-2)"	"unprognostic (3.66e-1)"	"unprognostic (9.38e-2)"	
IGHV1OR15-9	"IGHV1/OR15-9, IGHV1OR159, VSIG7"	ENSG00000188403	"Immunoglobulin heavy variable 1/OR15-9 (non-functional)"		15	19964666-19965101	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	13	"breast: 3.8;intestine: 8.0;lymphoid tissue: 8.1;stomach 1: 7.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Lung Adenocarcinoma (TCGA): 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA				"Cluster 34: Lymphoid tissue - Adaptive immune response"													"unprognostic (3.48e-2)"										"unprognostic (1.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.07e-3)"							"unprognostic (1.87e-1)"		"unprognostic (2.36e-1)"			
IGHV1OR21-1	IGHV1/OR21-1	ENSG00000277282	"Immunoglobulin heavy variable 1/OR21-1 (non-functional)"		21	10649400-10649835	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 3.0;lymphoid tissue: 5.9;stomach 1: 3.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"memory B-cell: 2.0;naive B-cell: 1.7"	"Lineage enriched"	"Detected in single"	15	"B-cells: 2.0"	"Not detected"	"Not detected"			"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA				"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 20: Myeloma - Immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"								"unprognostic (5.74e-1)"		"unprognostic (4.40e-3)"			"unprognostic (2.32e-3)"							"unprognostic (2.70e-3)"	"unprognostic (1.18e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.92e-2)"			"unprognostic (2.99e-1)"				"unprognostic (2.48e-1)"			"unprognostic (3.26e-1)"		
IGHV2-26		ENSG00000211951	"Immunoglobulin heavy variable 2-26"	A0A0B4J1V2	14	106301396-106301862	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 120.9;lymphoid tissue: 91.9;urinary bladder: 214.8"	"Cell type enriched"	"Detected in single"	8	"Plasma cells: 1.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in some"	14	"memory B-cell: 14.1"	"Lineage enriched"	"Detected in single"	141	"B-cells: 14.1"	"Not detected"	"Not detected"			"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (1.35e-1)"	"unprognostic (3.88e-3)"		"unprognostic (4.71e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.47e-2)"			"unprognostic (1.02e-1)"	"unprognostic (5.27e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.98e-3)"	"unprognostic (1.37e-1)"		"unprognostic (1.09e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.04e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.68e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.33e-2)"	"unprognostic (8.04e-2)"	"unprognostic (3.53e-1)"	"unprognostic (2.98e-2)"
IGHV2-5		ENSG00000211937	"Immunoglobulin heavy variable 2-5"	P01817	14	106037902-106038365	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 435.1;lymphoid tissue: 1331.1;stomach 1: 665.2"	"Cell type enhanced"	"Detected in some"		"Foveolar cells: 1.4;Gastric chief cells: 6.6;Mucous neck cells: 2.8;Parietal cells: 8.8;Plasma cells: 14.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	22	"memory B-cell: 67.0;naive B-cell: 67.6"	"Lineage enriched"	"Detected in many"	22	"B-cells: 67.6"	"Cancer enriched"	"Detected in some"	32	"Myeloma: 1988.3"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (4.17e-3)"	"unprognostic (4.11e-3)"		"unprognostic (2.76e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.57e-3)"	"unprognostic (4.46e-1)"	"potential prognostic favorable (2.14e-4)"	"unprognostic (1.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.57e-2)"		"unprognostic (7.08e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.96e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.13e-3)"	"unprognostic (8.19e-2)"	"unprognostic (6.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.02e-1)"
IGHV2-70		ENSG00000274576	"Immunoglobulin heavy variable 2-70"	P01814	14	106770577-106771020	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"lymphoid tissue: 678.8;stomach 1: 472.0"	"Cell type enhanced"	"Detected in single"		"Plasma cells: 2.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 8.4"	"Group enriched"	"Detected in some"	242	"memory B-cell: 24.7;naive B-cell: 23.5"	"Lineage enriched"	"Detected in single"	248	"B-cells: 24.7"	"Cancer enriched"	"Detected in some"	5	"lymphoma: 124.6"	"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (2.50e-1)"	"unprognostic (1.01e-3)"		"unprognostic (3.02e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.58e-1)"			"unprognostic (1.06e-2)"		"unprognostic (1.96e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.15e-1)"		"unprognostic (4.57e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.53e-1)"		"unprognostic (1.41e-1)"		"unprognostic (3.06e-1)"	"unprognostic (1.02e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.60e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.12e-1)"
IGHV2-70D		ENSG00000211974	"Immunoglobulin heavy variable 2-70D"	A0A0C4DH43	14	106723574-106724093	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.4;lymphoid tissue: 85.3;stomach 1: 44.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	68	"memory B-cell: 9.7;naive B-cell: 3.8"	"Lineage enriched"	"Detected in single"	98	"B-cells: 9.7"	"Cancer enriched"	"Detected in single"	5	"lymphoma: 2.7"	"Adrenal gland - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Prostate - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (2.35e-1)"	"unprognostic (2.40e-3)"		"unprognostic (1.29e-2)"	"unprognostic (7.14e-2)"	"unprognostic (1.08e-1)"		"unprognostic (2.45e-1)"	"unprognostic (2.23e-2)"		"unprognostic (3.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.01e-2)"			"unprognostic (1.05e-2)"	"unprognostic (4.49e-1)"	"unprognostic (4.00e-2)"	"unprognostic (2.61e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.06e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.38e-1)"
IGHV2OR16-5	IGHV2/OR16-5	ENSG00000259303	"Immunoglobulin heavy variable 2/OR16-5 (non-functional)"		16	32847713-32848156	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	6	"epididymis: 4.5;intestine: 1.7;lymphoid tissue: 3.0;salivary gland: 1.3;stomach 1: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Skin Cutaneous Melanoma (TCGA): 2.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Minor Salivary Gland - Plasma cells"																NA	NA				"Cluster 17: Intestine - Digestion"		"Cluster 9: Skin cancer - Melanin biosynthesis"																						"unprognostic (6.61e-2)"	"unprognostic (5.85e-2)"	"unprognostic (2.25e-1)"												
IGHV3-11		ENSG00000211941	"Immunoglobulin heavy variable 3-11"	P01762	14	106116635-106117204	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 205.9;lymphoid tissue: 572.8;stomach 1: 194.3"	"Group enriched"	"Detected in some"	9	"Gastric chief cells: 3.3;Plasma cells: 12.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	446	"memory B-cell: 43.2;naive B-cell: 45.9"	"Lineage enriched"	"Detected in single"	459	"B-cells: 45.9"	"Cancer enriched"	"Detected in some"	14	"lymphoma: 17.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (1.68e-2)"	"unprognostic (1.33e-3)"		"unprognostic (2.16e-1)"	"unprognostic (1.51e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.40e-3)"	"unprognostic (2.84e-1)"	"potential prognostic favorable (3.02e-5)"	"unprognostic (1.81e-1)"	"unprognostic (4.81e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.00e-1)"		"unprognostic (1.08e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.37e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.78e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.65e-1)"
IGHV3-13		ENSG00000211942	"Immunoglobulin heavy variable 3-13"	P01766	14	106129540-106130072	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 63.0;lymphoid tissue: 128.3;urinary bladder: 85.0"	"Cell type enriched"	"Detected in single"	21	"Plasma cells: 2.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 48.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	194	"memory B-cell: 18.9;naive B-cell: 19.7"	"Lineage enriched"	"Detected in single"	197	"B-cells: 19.7"	"Not detected"	"Not detected"			"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (6.06e-3)"	"potential prognostic favorable (5.42e-5)"		"unprognostic (1.82e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.98e-1)"		"unprognostic (1.59e-2)"	"potential prognostic favorable (8.85e-7)"	"unprognostic (6.92e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.90e-2)"	"unprognostic (1.87e-1)"		"unprognostic (2.37e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.24e-2)"	"unprognostic (4.33e-3)"	"unprognostic (9.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (9.61e-3)"	"unprognostic (5.82e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (3.34e-1)"	"unprognostic (4.21e-1)"
IGHV3-15		ENSG00000211943	"Immunoglobulin heavy variable 3-15"	A0A0B4J1V0	14	106153624-106154163	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 181.2;lymphoid tissue: 357.6;salivary gland: 174.5;stomach 1: 109.1;urinary bladder: 166.5"	"Cell type enriched"	"Detected in single"	1427	"Plasma cells: 470.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	9	"MAIT T-cell: 21.7;memory B-cell: 26.1"	"Group enriched"	"Detected in many"	9	"B-cells: 26.1;T-cells: 21.7"	"Group enriched"	"Detected in some"	65	"Leukemia: 13.6;lymphoma: 27.0"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 5: Spleen - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (3.41e-3)"	"unprognostic (5.69e-3)"		"unprognostic (7.78e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-1)"		"unprognostic (9.22e-2)"	"unprognostic (4.76e-3)"	"unprognostic (3.30e-1)"	"unprognostic (4.97e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.11e-2)"		"unprognostic (3.62e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.27e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.19e-3)"	"unprognostic (3.67e-2)"	"unprognostic (3.52e-1)"	"unprognostic (9.75e-2)"	"unprognostic (9.56e-3)"	"unprognostic (1.73e-1)"
IGHV3-16		ENSG00000211944	"Immunoglobulin heavy variable 3-16 (non-functional)"	A0A0C4DH30	14	106165205-106165730	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA						"Cluster 59: Leukemia - T-cell receptor"																																				
IGHV3-20		ENSG00000211946	"Immunoglobulin heavy variable 3-20"	A0A0C4DH32	14	106210936-106211453	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 93.4;lymphoid tissue: 202.4;stomach 1: 115.1;urinary bladder: 76.9"	"Cell type enriched"	"Detected in single"	16	"Plasma cells: 1.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	243	"memory B-cell: 28.6;naive B-cell: 19.9"	"Lineage enriched"	"Detected in single"	287	"B-cells: 28.6"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.5"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 35: RS4;11 - Unknown function"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (4.23e-2)"	"potential prognostic favorable (6.37e-6)"		"unprognostic (4.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.85e-2)"			"potential prognostic favorable (6.50e-4)"	"unprognostic (4.32e-2)"	"unprognostic (8.33e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.70e-1)"		"unprognostic (1.06e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.44e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.64e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.29e-2)"	"unprognostic (5.49e-1)"
IGHV3-21		ENSG00000211947	"Immunoglobulin heavy variable 3-21"	A0A0B4J1V1	14	106235064-106235594	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 212.4;lymphoid tissue: 372.5;salivary gland: 204.5"	"Cell type enriched"	"Detected in some"	17	"Plasma cells: 18.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma (TCGA): 197.7"	"Region enhanced"	"Detected in single"		"white matter: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	18	"lymphoma: 60.7"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 5: Spleen - Immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (4.32e-2)"	"unprognostic (1.06e-2)"		"unprognostic (9.09e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.49e-2)"		"unprognostic (5.29e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.97e-3)"	"unprognostic (2.94e-2)"	"unprognostic (3.48e-3)"	"unprognostic (6.32e-2)"	"unprognostic (4.49e-2)"		"potential prognostic favorable (9.91e-4)"	"unprognostic (5.74e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.86e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.05e-1)"	"unprognostic (6.18e-1)"	"unprognostic (3.11e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.84e-2)"
IGHV3-23		ENSG00000211949	"Immunoglobulin heavy variable 3-23"	P01764	14	106268606-106269140	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1574.2;lymphoid tissue: 2792.2;stomach 1: 995.6"	"Cell type enriched"	"Detected in some"	48	"Plasma cells: 105.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	404	"memory B-cell: 550.6;naive B-cell: 338.3"	"Lineage enriched"	"Detected in many"	501	"B-cells: 550.6"	"Cancer enriched"	"Detected in some"	18	"Myeloma: 724.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"	1				"unprognostic (4.82e-2)"	"unprognostic (1.28e-3)"		"unprognostic (9.79e-2)"	"unprognostic (6.53e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.57e-3)"	"unprognostic (6.65e-2)"	"unprognostic (9.47e-3)"	"unprognostic (3.35e-1)"		"unprognostic (4.67e-2)"	"unprognostic (5.47e-3)"	"unprognostic (5.93e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.71e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.38e-1)"
IGHV3-30		ENSG00000270550	"Immunoglobulin heavy variable 3-30"	"P01768, P0DP03"	14	106335082-106335613	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 499.5;lymphoid tissue: 1208.7;salivary gland: 438.6;stomach 1: 538.1;urinary bladder: 355.8"	"Cell type enriched"	"Detected in some"	5	"Plasma cells: 11.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	408	"memory B-cell: 164.7;naive B-cell: 137.2"	"Lineage enriched"	"Detected in single"	445	"B-cells: 164.7"	"Cancer enriched"	"Detected in some"	7	"Myeloma: 279.8"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (1.68e-1)"	"potential prognostic favorable (2.75e-4)"		"unprognostic (2.05e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.71e-3)"		"potential prognostic favorable (1.09e-4)"	"unprognostic (2.88e-2)"	"potential prognostic unfavorable (7.69e-4)"	"unprognostic (8.73e-2)"	"potential prognostic unfavorable (5.58e-4)"	"unprognostic (1.41e-1)"		"unprognostic (6.65e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.27e-2)"		"unprognostic (1.47e-1)"		"unprognostic (2.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (7.70e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.08e-1)"
IGHV3-33		ENSG00000211955	"Immunoglobulin heavy variable 3-33"	P01772	14	106359793-106360324	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 997.3;lymphoid tissue: 2217.4;stomach 1: 1673.0"	"Cell type enriched"	"Detected in some"	43	"Plasma cells: 64.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.6"	"Group enriched"	"Detected in many"	101	"memory B-cell: 380.3;naive B-cell: 365.8"	"Lineage enriched"	"Detected in many"	103	"B-cells: 380.3"	"Cancer enriched"	"Detected in some"	6	"lymphoma: 24.3"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (1.17e-1)"	"unprognostic (1.30e-3)"		"unprognostic (1.50e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.07e-1)"	"potential prognostic unfavorable (3.31e-4)"	"unprognostic (1.89e-1)"	"potential prognostic favorable (3.60e-5)"	"unprognostic (3.06e-1)"	"unprognostic (4.14e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.37e-1)"		"unprognostic (5.31e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.30e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.60e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.41e-1)"
IGHV3-35		ENSG00000211957	"Immunoglobulin heavy variable 3-35 (non-functional)"	A0A0C4DH35	14	106389392-106389858	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 13.2;lymphoid tissue: 12.1;salivary gland: 7.1;stomach 1: 15.7;urinary bladder: 19.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Thyroid Carcinoma (TCGA): 9.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	16	"memory B-cell: 3.7"	"Lineage enriched"	"Detected in single"	35	"B-cells: 3.7"	"Not detected"	"Not detected"			"Adipose visceral - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 51: Myeloma - Immunoglobulins"							"potential prognostic favorable (5.52e-4)"		"unprognostic (1.23e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.79e-2)"			"unprognostic (1.59e-3)"		"unprognostic (6.60e-2)"	"unprognostic (9.05e-2)"				"unprognostic (5.38e-2)"	"unprognostic (8.70e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.90e-1)"		"unprognostic (4.54e-2)"			"unprognostic (7.97e-2)"	"unprognostic (1.46e-1)"		"unprognostic (8.00e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.78e-2)"	
IGHV3-38		ENSG00000211958	"Immunoglobulin heavy variable 3-38 (non-functional)"	A0A0C4DH36	14	106410493-106411021	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.4;lymphoid tissue: 9.7;stomach 1: 5.5;urinary bladder: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"memory B-cell: 3.4;naive B-cell: 1.5"	"Lineage enriched"	"Detected in single"	34	"B-cells: 3.4"	"Cancer enriched"	"Detected in single"	5	"prostate cancer: 1.4"	"Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 60: Prostate cancer - Unknown function"							"potential prognostic favorable (3.58e-7)"		"unprognostic (7.81e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.43e-1)"			"unprognostic (3.65e-3)"		"unprognostic (1.46e-1)"	"unprognostic (8.33e-2)"				"unprognostic (2.96e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.71e-2)"			"unprognostic (7.72e-2)"			"unprognostic (4.64e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.27e-1)"	"unprognostic (7.82e-2)"	"unprognostic (6.04e-1)"
IGHV3-43		ENSG00000232216	"Immunoglobulin heavy variable 3-43"	A0A0B4J1X8	14	106470264-106470800	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 198.3;stomach 1: 296.0;urinary bladder: 143.8"	"Cell type enriched"	"Detected in single"	75	"Plasma cells: 29.0"					"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"medulla oblongata: 1.5"	"Group enriched"	"Detected in some"	319	"memory B-cell: 29.5;naive B-cell: 39.2"	"Lineage enriched"	"Detected in single"	364	"B-cells: 39.2"	"Not detected"	"Not detected"			"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (4.47e-3)"	"potential prognostic favorable (1.97e-4)"		"unprognostic (1.66e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.77e-1)"			"unprognostic (4.67e-3)"	"unprognostic (5.32e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.81e-2)"	"unprognostic (2.09e-2)"		"unprognostic (8.62e-2)"	"unprognostic (8.48e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.84e-3)"	"unprognostic (3.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.10e-2)"	"unprognostic (7.30e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.99e-1)"
IGHV3-48		ENSG00000211964	"Immunoglobulin heavy variable 3-48"	P01763	14	106537810-106538344	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 484.5;lymphoid tissue: 801.3;stomach 1: 380.8"	"Cell type enriched"	"Detected in some"	12	"Plasma cells: 15.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 2.7;medulla oblongata: 1.5;pons: 1.5"	"Group enriched"	"Detected in some"	527	"memory B-cell: 187.8;naive B-cell: 97.9"	"Lineage enriched"	"Detected in single"	692	"B-cells: 187.8"	"Group enriched"	"Detected in some"	285	"lymphoma: 65.7;Myeloma: 21.6"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 55: Lymphoma - Immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (1.63e-2)"	"unprognostic (7.03e-3)"		"unprognostic (1.40e-2)"	"unprognostic (9.91e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.35e-2)"	"unprognostic (7.19e-2)"	"potential prognostic favorable (3.17e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.88e-3)"	"unprognostic (6.12e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.86e-2)"		"unprognostic (7.07e-3)"	"unprognostic (6.40e-2)"	"unprognostic (9.48e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.43e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.43e-1)"
IGHV3-49		ENSG00000211965	"Immunoglobulin heavy variable 3-49"	A0A0A0MS15	14	106556936-106557477	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 197.1;lymphoid tissue: 348.9;stomach 1: 171.2"	"Cell type enriched"	"Detected in some"	8	"Plasma cells: 30.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	186	"memory B-cell: 59.6;naive B-cell: 42.4"	"Lineage enriched"	"Detected in single"	217	"B-cells: 59.6"	"Not detected"	"Not detected"			"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Testis - Late spermatids, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 13: Non-specific - Mixed function"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (5.27e-2)"	"potential prognostic favorable (3.42e-4)"		"unprognostic (2.16e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.25e-2)"		"unprognostic (3.47e-1)"	"potential prognostic favorable (5.41e-5)"		"unprognostic (5.18e-2)"	"unprognostic (2.15e-1)"	"potential prognostic unfavorable (1.06e-4)"	"unprognostic (4.94e-2)"		"unprognostic (7.91e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.40e-1)"
IGHV3-53		ENSG00000211967	"Immunoglobulin heavy variable 3-53"	P01767	14	106592676-106593347	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 76.7;lymphoid tissue: 121.2;salivary gland: 30.4;stomach 1: 40.9"	"Cell type enriched"	"Detected in single"	16	"Plasma cells: 1.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	98	"memory B-cell: 54.9;naive B-cell: 52.9"	"Lineage enriched"	"Detected in single"	100	"B-cells: 54.9"	"Group enriched"	"Detected in some"	113	"Leukemia: 8.2;lymphoma: 19.1"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (2.03e-1)"	"unprognostic (2.44e-3)"		"unprognostic (2.14e-2)"	"unprognostic (7.37e-2)"	"unprognostic (4.44e-1)"			"potential prognostic favorable (3.32e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.21e-3)"	"unprognostic (8.00e-2)"		"unprognostic (3.08e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.03e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.11e-3)"	"unprognostic (3.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (4.54e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.07e-1)"	"unprognostic (4.40e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.07e-1)"
IGHV3-64		ENSG00000223648	"Immunoglobulin heavy variable 3-64"	A0A075B6Q5	14	106657725-106658258	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 18.4;lymphoid tissue: 30.3;salivary gland: 20.7"	"Cell type enriched"	"Detected in single"	24	"Plasma cells: 2.4"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	20	"memory B-cell: 11.1"	"Lineage enriched"	"Detected in single"	111	"B-cells: 11.1"	"Not detected"	"Not detected"			"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 5: Spleen - Immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (2.12e-1)"	"unprognostic (7.44e-2)"		"unprognostic (3.06e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.57e-3)"			"unprognostic (1.50e-2)"		"unprognostic (2.36e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.22e-3)"			"unprognostic (8.97e-2)"	"unprognostic (4.03e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.13e-3)"	"unprognostic (3.14e-2)"	"unprognostic (7.59e-2)"	"unprognostic (2.66e-2)"		"unprognostic (1.42e-1)"	"unprognostic (2.35e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.29e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.45e-1)"
IGHV3-64D		ENSG00000282639	"Immunoglobulin heavy variable 3-64D"	A0A0J9YX35	14	106088122-106088573	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 135.5;lymphoid tissue: 253.1"	"Group enriched"	"Detected in some"	15	"Parietal cells: 1.8;Plasma cells: 2.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	301	"memory B-cell: 43.4;naive B-cell: 18.8"	"Lineage enriched"	"Detected in single"	420	"B-cells: 43.4"	"Cancer enhanced"	"Detected in single"		"Leukemia: 1.5"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (3.56e-1)"	"potential prognostic favorable (9.41e-4)"		"unprognostic (1.12e-3)"	"unprognostic (9.84e-2)"	"unprognostic (2.66e-2)"			"unprognostic (2.50e-3)"		"unprognostic (9.62e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.93e-1)"		"unprognostic (3.75e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.46e-1)"	"unprognostic (8.83e-2)"	"unprognostic (8.06e-2)"		"unprognostic (8.72e-2)"		"unprognostic (3.59e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"unprognostic (2.05e-1)"
IGHV3-66		ENSG00000211972	"Immunoglobulin heavy variable 3-66"	A0A0C4DH42	14	106675017-106675544	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 44.4;intestine: 53.6;urinary bladder: 97.5"	"Cell type enriched"	"Detected in single"	14	"Plasma cells: 12.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	135	"memory B-cell: 39.3"	"Lineage enriched"	"Detected in single"	135	"B-cells: 39.3"	"Group enriched"	"Detected in some"	17	"Leukemia: 20.0;lymphoma: 26.7;Myeloma: 7.2"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 55: Lymphoma - Immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (2.47e-2)"	"unprognostic (9.99e-3)"		"unprognostic (1.98e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.45e-3)"			"unprognostic (3.00e-3)"	"unprognostic (5.45e-1)"	"unprognostic (2.52e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.64e-3)"	"unprognostic (6.25e-2)"		"unprognostic (1.26e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.45e-1)"	"potential prognostic unfavorable (7.84e-4)"	"unprognostic (7.48e-3)"	"unprognostic (4.40e-1)"	"unprognostic (6.95e-3)"	"unprognostic (6.36e-3)"	"unprognostic (9.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.86e-1)"	"unprognostic (4.02e-2)"	"unprognostic (3.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.26e-1)"
IGHV3-7		ENSG00000211938	"Immunoglobulin heavy variable 3-7"	P01780	14	106062151-106062683	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 433.4;lymphoid tissue: 899.2"	"Cell type enriched"	"Detected in some"	18	"Plasma cells: 102.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	148	"memory B-cell: 136.5;naive B-cell: 108.1"	"Lineage enriched"	"Detected in single"	165	"B-cells: 136.5"	"Group enriched"	"Detected in some"	327	"Leukemia: 220.1;lymphoma: 166.2;Myeloma: 182.7"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (4.27e-2)"	"unprognostic (2.11e-3)"		"unprognostic (1.99e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.52e-2)"	"unprognostic (4.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (1.08e-3)"	"unprognostic (1.91e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.20e-2)"	"unprognostic (9.49e-3)"		"unprognostic (2.79e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.87e-1)"	"unprognostic (8.03e-2)"	"unprognostic (2.08e-3)"	"unprognostic (4.67e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.86e-1)"
IGHV3-72		ENSG00000225698	"Immunoglobulin heavy variable 3-72"	A0A0B4J1Y9	14	106790694-106791233	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.5;lymphoid tissue: 114.1;urinary bladder: 89.3"	"Cell type enriched"	"Detected in single"	76	"Plasma cells: 7.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	7	"memory B-cell: 48.4"	"Lineage enriched"	"Detected in single"	249	"B-cells: 48.4"	"Cancer enriched"	"Detected in single"	4	"lymphoma: 2.6"	"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 5: Spleen - Immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (1.25e-1)"	"unprognostic (1.32e-2)"		"unprognostic (7.12e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.17e-1)"			"potential prognostic favorable (3.80e-4)"		"unprognostic (2.37e-1)"	"unprognostic (1.02e-1)"	"potential prognostic unfavorable (6.53e-4)"	"unprognostic (2.28e-2)"		"unprognostic (1.36e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.05e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.94e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (6.25e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.28e-1)"
IGHV3-73		ENSG00000211976	"Immunoglobulin heavy variable 3-73"	A0A0B4J1V6	14	106802694-106803233	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.5;lymphoid tissue: 76.8;urinary bladder: 76.6"	"Cell type enriched"	"Detected in single"	1075	"Plasma cells: 107.5"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Lung Adenocarcinoma (TCGA): 130.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	87	"memory B-cell: 70.1;naive B-cell: 43.3"	"Lineage enriched"	"Detected in single"	107	"B-cells: 70.1"	"Group enriched"	"Detected in some"	232	"lymphoma: 13.6;Myeloma: 32.8"	"Adipose visceral - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 77: Intestine - Digestion"		"Cluster 55: Lymphoma - Immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (1.84e-1)"	"unprognostic (3.79e-2)"		"unprognostic (7.29e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.61e-2)"			"potential prognostic favorable (8.72e-4)"		"unprognostic (5.16e-2)"	"unprognostic (1.70e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.95e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-1)"	"unprognostic (8.52e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.38e-1)"	"unprognostic (9.71e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.00e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.55e-1)"
IGHV3-74		ENSG00000224650	"Immunoglobulin heavy variable 3-74"	A0A0B4J1X5	14	106810442-106811131	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 81.9;intestine: 102.7;lymphoid tissue: 291.0;salivary gland: 100.2"	"Cell type enriched"	"Detected in some"	17	"Plasma cells: 19.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.2"	"Low lineage specificity"	"Detected in single"			"Cancer enriched"	"Detected in some"	5	"lymphoma: 39.4"	"Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 5: Spleen - Immune response"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (5.53e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.43e-1)"	"unprognostic (3.20e-1)"	"unprognostic (1.94e-1)"		"unprognostic (4.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"		"unprognostic (1.55e-1)"	"unprognostic (7.20e-3)"	"unprognostic (3.87e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.57e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.86e-2)"
IGHV3OR15-7	IGHV3/OR15-7	ENSG00000259490	"Immunoglobulin heavy variable 3/OR15-7 (pseudogene)"		15	19987656-19988117	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.9;stomach 1: 1.7"	"Cell type enriched"	"Detected in single"	12	"Plasma cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA				"Cluster 7: Small intestine - Absorption and Digestion"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"																																			
IGHV3OR16-10	IGHV3/OR16-10	ENSG00000233732	"Immunoglobulin heavy variable 3/OR16-10 (non-functional)"		16	32995048-32995505	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 7.4;lymphoid tissue: 9.6;salivary gland: 8.4;stomach 1: 8.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.7"	"Lineage enriched"	"Detected in single"	18	"B-cells: 1.7"	"Cancer enriched"	"Detected in single"	19	"lymphoma: 1.9"	"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 52: Neurons & Synapses - Synaptic function"	"Cluster 51: Myeloma - Immunoglobulins"										"unprognostic (3.46e-1)"	"unprognostic (5.09e-1)"										"unprognostic (3.38e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.96e-1)"			"unprognostic (1.25e-1)"				"unprognostic (3.37e-1)"		"unprognostic (2.34e-2)"			
IGHV3OR16-12	IGHV3/OR16-12	ENSG00000270467	"Immunoglobulin heavy variable 3/OR16-12 (non-functional)"		16	33802764-33803217	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	4	"intestine: 12.9;lymphoid tissue: 18.9;stomach 1: 9.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Stomach Adenocarcinoma (TCGA): 8.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"memory B-cell: 4.6"	"Lineage enriched"	"Detected in single"	46	"B-cells: 4.6"	"Not detected"	"Not detected"			"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 5: Rhabdoid - Unknown function"						"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"		"unprognostic (3.63e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.48e-1)"			"unprognostic (8.68e-3)"			"unprognostic (5.67e-3)"				"unprognostic (5.27e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.18e-2)"						"unprognostic (2.05e-1)"	"unprognostic (3.37e-1)"		"unprognostic (1.90e-1)"	"unprognostic (5.62e-1)"	"unprognostic (2.99e-1)"	
IGHV3OR16-13	IGHV3/OR16-13	ENSG00000271178	"Immunoglobulin heavy variable 3/OR16-13 (non-functional)"		16	33827214-33827661	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 6.6;lymphoid tissue: 27.8;salivary gland: 7.0"	"Cell type enhanced"	"Detected in single"		"Gastric chief cells: 1.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	27	"memory B-cell: 18.2"	"Lineage enriched"	"Detected in single"	182	"B-cells: 18.2"	"Cancer enriched"	"Detected in single"	70	"lymphoma: 6.9"	"Adipose visceral - Plasma cells, Breast - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 5: Spleen - Immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"						"unprognostic (1.88e-2)"		"unprognostic (1.59e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.79e-1)"			"unprognostic (7.01e-3)"			"unprognostic (7.75e-2)"				"unprognostic (3.10e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.02e-1)"			"unprognostic (3.75e-1)"			"unprognostic (1.13e-1)"	"unprognostic (2.59e-1)"		"unprognostic (1.69e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.46e-1)"	
IGHV3OR16-17	IGHV3/OR16-17	ENSG00000259680	"Immunoglobulin heavy variable 3/OR16-17 (non-functional)"		16	33844784-33845229	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 10.7;lymphoid tissue: 22.7;stomach 1: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	21	"memory B-cell: 1.6;naive B-cell: 2.6"	"Lineage enriched"	"Detected in single"	26	"B-cells: 2.6"	"Cancer enriched"	"Detected in single"	42	"Myeloma: 8.4"	"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA				"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 44: Plasma cells - Antibody production & secretion"						"unprognostic (2.16e-3)"		"unprognostic (2.72e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.59e-1)"			"potential prognostic favorable (3.85e-4)"			"unprognostic (2.87e-2)"				"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.47e-2)"			"unprognostic (2.48e-1)"			"unprognostic (1.67e-1)"	"unprognostic (1.90e-1)"		"unprognostic (1.52e-1)"	"unprognostic (6.26e-1)"	"unprognostic (6.01e-2)"	
IGHV3OR16-8	IGHV3/OR16-8	ENSG00000271130	"Immunoglobulin heavy variable 3/OR16-8 (non-functional)"		16	33009175-33009620	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"intestine: 30.0;lymphoid tissue: 46.5;stomach 1: 32.0;urinary bladder: 38.9"	"Not detected"	"Not detected"							"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"memory B-cell: 7.5"	"Lineage enriched"	"Detected in single"	75	"B-cells: 7.5"	"Cancer enriched"	"Detected in single"	13	"Myeloma: 3.1"	"Adipose visceral - Plasma cells, Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"																NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (3.02e-1)"	"potential prognostic favorable (4.04e-4)"		"unprognostic (5.47e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.43e-1)"			"unprognostic (2.84e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.14e-3)"				"unprognostic (6.51e-3)"	"unprognostic (3.24e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.25e-3)"			"unprognostic (2.50e-1)"			"unprognostic (3.34e-2)"	"unprognostic (1.38e-1)"		"unprognostic (1.85e-1)"	"unprognostic (5.13e-2)"	"unprognostic (4.57e-1)"	
IGHV4-28		ENSG00000211952	"Immunoglobulin heavy variable 4-28"	A0A0C4DH34	14	106324254-106324760	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 42.3;lymphoid tissue: 81.7;salivary gland: 37.4;stomach 1: 28.9;urinary bladder: 115.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	6	"spinal cord: 2.5"	"Group enriched"	"Detected in some"	207	"memory B-cell: 28.8;naive B-cell: 12.5"	"Lineage enriched"	"Detected in single"	289	"B-cells: 28.8"	"Cancer enriched"	"Detected in single"	10	"Myeloma: 3.4"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 7: Non-specific - Ribosome"	"Cluster 55: Lymphoma - Immune response"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (1.83e-1)"	"potential prognostic favorable (4.92e-4)"		"unprognostic (1.60e-2)"	"unprognostic (4.50e-1)"	"unprognostic (3.50e-2)"			"potential prognostic favorable (1.54e-4)"	"unprognostic (2.22e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.78e-2)"	"unprognostic (4.40e-3)"	"unprognostic (3.37e-2)"		"unprognostic (6.73e-2)"	"potential prognostic favorable (1.99e-5)"	"unprognostic (1.52e-2)"	"unprognostic (3.26e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.25e-3)"	"unprognostic (2.42e-1)"	"unprognostic (4.40e-2)"	"unprognostic (4.52e-2)"	"unprognostic (2.44e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.11e-1)"
IGHV4-31		ENSG00000231475	"Immunoglobulin heavy variable 4-31"	A0A087WSY4	14	106349283-106349792	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 436.1;urinary bladder: 179.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Lung Squamous Cell Carcinoma (TCGA): 128.0"	"Region enhanced"	"Detected in some"		"spinal cord: 2.8"	"Group enriched"	"Detected in some"	48	"memory B-cell: 43.7;naive B-cell: 19.4"	"Lineage enriched"	"Detected in single"	66	"B-cells: 43.7"	"Cancer enriched"	"Detected in some"	12	"Myeloma: 35.4"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 7: Non-specific - Ribosome"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (5.21e-2)"	"potential prognostic favorable (1.58e-4)"		"unprognostic (3.32e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.50e-1)"			"potential prognostic favorable (1.02e-4)"		"potential prognostic unfavorable (1.50e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.36e-3)"	"unprognostic (8.69e-2)"		"unprognostic (8.57e-2)"	"unprognostic (2.86e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.32e-1)"	"unprognostic (8.65e-2)"	"unprognostic (9.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.88e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.26e-1)"
IGHV4-34		ENSG00000211956	"Immunoglobulin heavy variable 4-34"	P06331	14	106373663-106374145	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 264.8;urinary bladder: 253.2"	"Group enriched"	"Detected in some"	5	"Gastric chief cells: 7.6;Mucous neck cells: 2.4;Plasma cells: 8.1;Platelets: 2.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"white matter: 2.5"	"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Cancer enriched"	"Detected in some"	100	"lymphoma: 476.9"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 2: Dendritic cells - Unknown function"	"Cluster 5: Spleen - Immune response"	"Cluster 22: Non-specific - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (2.70e-2)"	"unprognostic (2.91e-2)"		"unprognostic (2.65e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.83e-1)"		"unprognostic (7.43e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.84e-2)"	"potential prognostic favorable (1.85e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.02e-2)"		"unprognostic (4.67e-3)"	"unprognostic (3.69e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.14e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.98e-2)"	"unprognostic (2.46e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.03e-1)"	"unprognostic (3.09e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.72e-2)"
IGHV4-39		ENSG00000211959	"Immunoglobulin heavy variable 4-39"	P01824	14	106421711-106422218	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 257.3;lymphoid tissue: 453.6;salivary gland: 243.9;urinary bladder: 506.1"	"Group enriched"	"Detected in some"	4	"Gastric chief cells: 8.7;Plasma cells: 26.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.6;naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	40	"lymphoma: 89.4;Myeloma: 52.8"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 5: Spleen - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 13: Non-specific - Mixed function"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (1.62e-1)"	"unprognostic (3.37e-1)"		"unprognostic (9.13e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.46e-1)"		"unprognostic (2.56e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.89e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.08e-1)"		"unprognostic (4.46e-2)"	"unprognostic (5.35e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.76e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.24e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.21e-2)"
IGHV4-4		ENSG00000276775	"Immunoglobulin heavy variable 4-4"	A0A075B6R2	14	106011922-106012420	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 529.6;urinary bladder: 722.3"	"Cell type enriched"	"Detected in some"	18	"Plasma cells: 32.3"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in single"	10	"midbrain: 9.4"	"Group enriched"	"Detected in some"	23	"memory B-cell: 56.8;naive B-cell: 31.4"	"Lineage enriched"	"Detected in many"	29	"B-cells: 56.8"	"Group enriched"	"Detected in some"	49	"lymphoma: 23.3;Myeloma: 69.5"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 46: Brainstem - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"					"unprognostic (4.75e-2)"	"unprognostic (1.27e-2)"		"unprognostic (8.05e-2)"	"unprognostic (5.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (4.61e-2)"		"potential prognostic favorable (1.11e-5)"	"unprognostic (3.30e-1)"	"unprognostic (4.11e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.20e-2)"		"unprognostic (1.91e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.74e-3)"	"unprognostic (1.19e-1)"		"unprognostic (1.56e-1)"		"unprognostic (1.49e-1)"	"unprognostic (6.80e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-1)"
IGHV4-59		ENSG00000224373	"Immunoglobulin heavy variable 4-59"	P01825	14	106627249-106627825	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 492.0;lymphoid tissue: 851.1;urinary bladder: 659.9"	"Cell type enhanced"	"Detected in some"		"Foveolar cells: 6.8;Gastric chief cells: 16.4;Mucous neck cells: 4.3;Parietal cells: 7.1;Plasma cells: 24.5"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in some"		"spinal cord: 3.7"	"Group enriched"	"Detected in some"	37	"memory B-cell: 169.4;naive B-cell: 77.5"	"Lineage enriched"	"Detected in many"	51	"B-cells: 169.4"	"Cancer enriched"	"Detected in some"	9	"lymphoma: 98.0"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (4.31e-2)"	"potential prognostic favorable (7.85e-5)"		"unprognostic (6.57e-2)"	"unprognostic (9.84e-2)"	"unprognostic (1.90e-1)"	"potential prognostic unfavorable (7.22e-4)"		"potential prognostic favorable (3.28e-5)"	"unprognostic (1.58e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.50e-3)"	"unprognostic (8.03e-2)"		"unprognostic (1.94e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.84e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.30e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.09e-1)"
IGHV4-61		ENSG00000211970	"Immunoglobulin heavy variable 4-61"	A0A0C4DH41	14	106639119-106639657	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 193.1;lymphoid tissue: 360.0;stomach 1: 134.4"	"Group enriched"	"Detected in some"	19	"Foveolar cells: 1.2;Gastric chief cells: 1.1;Mucous neck cells: 1.6;Plasma cells: 4.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	43	"memory B-cell: 39.1;naive B-cell: 25.6"	"Lineage enriched"	"Detected in single"	52	"B-cells: 39.1"	"Cancer enriched"	"Detected in single"	47	"lymphoma: 20.7"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (3.27e-1)"	"potential prognostic favorable (4.41e-4)"		"unprognostic (7.27e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.80e-1)"			"potential prognostic favorable (1.11e-4)"		"unprognostic (2.27e-2)"	"unprognostic (1.12e-1)"	"potential prognostic unfavorable (5.09e-4)"	"unprognostic (1.81e-1)"		"unprognostic (6.99e-2)"	"unprognostic (7.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.46e-3)"	"unprognostic (8.75e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.83e-3)"	"unprognostic (2.97e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.82e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.18e-1)"
IGHV4OR15-8	"IGHV4/OR15-8, IGHV4OR158, VSIG6"	ENSG00000259261	"Immunoglobulin heavy variable 4/OR15-8 (non-functional)"		15	22184967-22185402	"Immunoglobulin genes, Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"intestine: 1.8;lymphoid tissue: 1.3;urinary bladder: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Breast - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells"																NA	NA				"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 59: Leukemia - T-cell receptor"																										"unprognostic (4.01e-1)"		"unprognostic (1.35e-2)"								
IGHV5-10-1	IGHV5-A	ENSG00000282651	"Immunoglobulin heavy variable 5-10-1"	A0A0J9YXX1	14	106107972-106108464	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 296.2;lymphoid tissue: 528.5"	"Cell type enriched"	"Detected in single"	14	"Plasma cells: 4.7"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in all"		"Lung Squamous Cell Carcinoma (TCGA): 180.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"memory B-cell: 75.0;naive B-cell: 67.0"	"Lineage enriched"	"Detected in many"	16	"B-cells: 75.0"	"Group enriched"	"Detected in some"	9	"Leukemia: 1.6;lymphoma: 3.4"	"Adrenal gland - Plasma cells, Colon - Plasma cells, Liver - Plasma cells, Minor Salivary Gland - Plasma cells, Prostate - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									HPA006014	Approved				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"				"HPA006014: "	"unprognostic (8.59e-2)"	"unprognostic (9.67e-2)"		"unprognostic (3.34e-1)"	"unprognostic (9.73e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.61e-1)"		"unprognostic (7.38e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.39e-3)"	"unprognostic (3.86e-2)"	"unprognostic (4.06e-1)"		"unprognostic (8.34e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.20e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.07e-1)"		"unprognostic (1.74e-1)"		"unprognostic (3.66e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.18e-1)"	"unprognostic (9.17e-2)"	"unprognostic (7.99e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.17e-1)"
IGHV5-51		ENSG00000211966	"Immunoglobulin heavy variable 5-51"	A0A0C4DH38	14	106578744-106579236	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 252.4;lymphoid tissue: 511.7;salivary gland: 215.5;urinary bladder: 326.3"	"Cell type enriched"	"Detected in some"	9	"Plasma cells: 51.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 147.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	567	"lymphoma: 67.9"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									HPA006014	Approved				"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 5: Spleen - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 78: Plasma cells - Antibody production & ER-stress response"				"HPA006014: "	"unprognostic (3.44e-3)"	"unprognostic (6.05e-3)"		"unprognostic (1.63e-1)"	"unprognostic (7.19e-2)"	"unprognostic (3.08e-1)"		"unprognostic (1.97e-1)"	"unprognostic (9.77e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.27e-2)"		"unprognostic (1.02e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.99e-3)"	"unprognostic (5.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.05e-1)"	"potential prognostic favorable (1.81e-5)"	"unprognostic (8.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.56e-1)"
IGHV6-1		ENSG00000211933	"Immunoglobulin heavy variable 6-1"	A0A0B4J1U7	14	105939756-105940253	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 414.8;lymphoid tissue: 146.9"	"Cell type enriched"	"Detected in some"	7	"Plasma cells: 8.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	6	"naive B-cell: 20.0"	"Lineage enriched"	"Detected in single"	53	"B-cells: 20.0"	"Not detected"	"Not detected"			"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA				"Cluster 17: Intestine - Digestion"			"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (2.78e-1)"	"unprognostic (1.99e-1)"		"unprognostic (1.88e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.44e-1)"		"unprognostic (1.80e-1)"	"unprognostic (1.52e-1)"		"unprognostic (1.91e-2)"		"unprognostic (1.00e-2)"			"unprognostic (1.48e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.92e-1)"	"unprognostic (5.43e-1)"	"unprognostic (3.83e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (4.34e-3)"	"unprognostic (8.54e-2)"	"unprognostic (7.83e-2)"	"unprognostic (3.00e-1)"	"unprognostic (9.13e-2)"	"unprognostic (1.62e-1)"
IGHV7-4-1		ENSG00000282122	"Immunoglobulin heavy variable 7-4-1"	A0A0J9YVY3	14	106025145-106025630	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 91.3;lymphoid tissue: 124.4"	"Cell type enriched"	"Detected in single"	7	"Plasma cells: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 83.5"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.2;white matter: 1.1"	"Group enriched"	"Detected in some"	110	"memory B-cell: 8.3;naive B-cell: 13.6"	"Lineage enriched"	"Detected in single"	137	"B-cells: 13.6"	"Cancer enriched"	"Detected in single"	97	"lymphoma: 18.4"	"Breast - Plasma cells, Minor Salivary Gland - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 21: Non-specific - Metabolism"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (3.03e-3)"	"unprognostic (2.33e-3)"		"unprognostic (3.67e-2)"	"unprognostic (4.89e-1)"	"unprognostic (1.40e-1)"			"potential prognostic favorable (9.14e-4)"		"unprognostic (1.06e-1)"	"unprognostic (3.58e-1)"	"unprognostic (2.22e-2)"	"unprognostic (3.66e-1)"		"unprognostic (2.32e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.09e-2)"	"unprognostic (7.47e-2)"	"unprognostic (3.19e-1)"		"unprognostic (3.27e-1)"		"unprognostic (1.78e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.81e-1)"	"unprognostic (7.99e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.29e-1)"
IGHV7-81		ENSG00000211979	"Immunoglobulin heavy variable 7-81 (non-functional)"	A0A0B4J1V7	14	106874583-106875071	"Immunoglobulin genes, Predicted secreted proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.8;lymphoid tissue: 17.1;stomach 1: 11.6"	"Group enriched"	"Detected in some"	12	"Gastric chief cells: 1.1;Plasma cells: 1.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Testicular Germ Cell Tumor (TCGA): 57.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"memory B-cell: 5.5;naive B-cell: 4.0"	"Lineage enriched"	"Detected in single"	14	"B-cells: 5.5"	"Cancer enhanced"	"Detected in some"		"lymphoma: 8.1;Rhabdoid: 3.8"	"Breast - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"		"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 44: Plasma cells - Antibody production & secretion"					"unprognostic (6.13e-3)"	"unprognostic (1.58e-2)"		"unprognostic (1.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.53e-2)"			"potential prognostic favorable (5.07e-4)"	"unprognostic (3.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.56e-1)"		"unprognostic (1.14e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.29e-1)"			"potential prognostic favorable (7.13e-4)"	"unprognostic (4.50e-1)"	"unprognostic (9.59e-2)"	"unprognostic (8.27e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.09e-1)"
IGLC2	IGLC	ENSG00000211677	"Immunoglobulin lambda constant 2"	P0DOY2	22	22900976-22901437	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 9136.9;lymphoid tissue: 18672.4;stomach 1: 10196.8"	"Cell type enriched"	"Detected in many"	9	"Plasma cells: 62189.1"	"Cell type enriched"	"Detected in some"	14	"leukocyte: 23.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	36	"memory B-cell: 11410.9;naive B-cell: 10729.1"	"Lineage enriched"	"Detected in all"	37	"B-cells: 11410.9"	"Cancer enriched"	"Detected in many"	10	"Myeloma: 14457.7"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Kidney - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"														"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 20: Myeloma - Immune response"	"Cluster 67: Plasma cells - Plasma cell differentiation"					"unprognostic (4.70e-2)"	"potential prognostic favorable (6.65e-6)"		"unprognostic (3.41e-3)"	"unprognostic (8.27e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.09e-3)"	"unprognostic (3.33e-1)"	"potential prognostic favorable (2.12e-4)"	"unprognostic (2.30e-1)"	"unprognostic (2.13e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-3)"	"unprognostic (4.63e-2)"		"unprognostic (3.05e-2)"	"unprognostic (1.67e-2)"	"unprognostic (6.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.05e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.31e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.94e-2)"
IGLC3	IGLC	ENSG00000211679	"Immunoglobulin lambda constant 3 (Kern-Oz+ marker)"	P0DOY3	22	22906342-22906803	"Immunoglobulin genes, Predicted intracellular proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity"	"Bence-Jones protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 3846.9;lymphoid tissue: 7642.8;stomach 1: 3884.7;urinary bladder: 3496.7"	"Cell type enriched"	"Detected in some"	31	"Plasma cells: 25604.9"	"Cell type enriched"	"Detected in single"	245	"leukocyte: 24.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	34	"memory B-cell: 7287.2;naive B-cell: 6162.3"	"Lineage enriched"	"Detected in all"	37	"B-cells: 7287.2"	"Cancer enriched"	"Detected in many"	19	"Myeloma: 12802.2"	"Adipose subcutaneous - Plasma cells, Adipose visceral - Plasma cells, Adrenal gland - Plasma cells, Breast - Plasma cells, Colon - Plasma cells, Heart muscle - Plasma cells, Liver - Plasma cells, Lung - Plasma cells, Minor Salivary Gland - Plasma cells, Pancreas - Plasma cells, Pituitary gland - Plasma cells, Prostate - Plasma cells, Skeletal muscle - Plasma cells, Skin - Plasma cells, Spleen - Plasma cells, Stomach - Plasma cells, Thyroid gland - Plasma cells"									"CAB000050, CAB016533"	Supported				"Immunoglobulin genes"	Immunity	NA	NA			"Cluster 17: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 67: Plasma cells - Plasma cell differentiation"				"CAB000050: , CAB016533: "	"unprognostic (1.27e-2)"	"potential prognostic favorable (7.64e-5)"		"unprognostic (4.45e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.07e-1)"	"potential prognostic favorable (4.07e-4)"	"unprognostic (2.78e-2)"	"potential prognostic unfavorable (6.38e-5)"	"unprognostic (7.22e-3)"	"potential prognostic unfavorable (6.01e-5)"	"unprognostic (5.04e-2)"		"unprognostic (5.03e-3)"	"unprognostic (7.16e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.90e-2)"	"unprognostic (3.91e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.07e-2)"	"unprognostic (4.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.20e-1)"
IGLL1	"14.1, CD179B, IGL5, IGLL, IGVPB"	ENSG00000128322	"Immunoglobulin lambda like polypeptide 1"	P15814	22	23573125-23580302	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 66.3;testis: 24.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 98.1;Late primary spermatocytes: 57.6;Late spermatids: 274.4;Neutrophil progenitors: 18.7;Thymocytes: 116.0"	"Cell type enhanced"	"Detected in single"		"choroid plexus epithelial cell: 3.1"	"Cancer enhanced"	"Detected in single"		"Stomach Adenocarcinoma (TCGA): 3.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"memory B-cell: 12.0;naive B-cell: 14.9"	"Lineage enriched"	"Detected in many"	11	"B-cells: 14.9"	"Group enriched"	"Detected in some"	13	"Leukemia: 379.0;lymphoma: 146.4"	"Breast - Plasma cells, Minor Salivary Gland - Plasma cells, Stomach - Plasma cells, Testis - Early spermatids, Testis - Late spermatids"					"Not detected"	"Not detected"			"HPA051134, HPA071406"	Enhanced		Approved	"Endoplasmic reticulum"	"Secreted to blood"	"No annotated function"	NA	NA		1200000000	"Cluster 17: B-cells - Immunoglobulins"	"Cluster 44: Bone marrow - Nuclear processes"		"Cluster 35: RS4;11 - Unknown function"	"Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization"	3	"Endoplasmic reticulum"		"HPA051134: , HPA071406: "																												"unprognostic (1.95e-2)"			
IGLL5		ENSG00000254709	"Immunoglobulin lambda like polypeptide 5"	B9A064	22	22887780-22896111	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 384.8;lymphoid tissue: 632.7;salivary gland: 263.6;stomach 1: 290.6"	"Cell type enriched"	"Detected in some"	100	"Plasma cells: 4048.5"	"Cell type enriched"	"Detected in single"	164	"leukocyte: 34.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	227	"memory B-cell: 517.6;naive B-cell: 619.6"	"Lineage enriched"	"Detected in many"	247	"B-cells: 619.6"	"Cancer enriched"	"Detected in some"	4	"Myeloma: 1179.4"															"Secreted to blood"	"No annotated function"	NA	NA		22000000000	"Cluster 23: B-cells - Immunoglobulins"	"Cluster 34: Lymphoid tissue - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 51: Myeloma - Immunoglobulins"	"Cluster 67: Plasma cells - Plasma cell differentiation"	36				"unprognostic (1.09e-2)"	"unprognostic (1.76e-3)"		"unprognostic (3.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-3)"	"unprognostic (1.62e-1)"	"potential prognostic favorable (5.40e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-3)"	"unprognostic (6.57e-2)"	"unprognostic (4.75e-3)"	"unprognostic (4.06e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.67e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.95e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836816	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 190.0;urinary bladder: 117.2"	"Cell type enhanced"	"Detected in many"		"cDC: 1016.3;Macrophages: 1016.8;monocytes: 4378.2;Neutrophils: 2506.4"	"Group enriched"	"Detected in some"	39	"central nervous system macrophage: 27.1;leukocyte: 6.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 94.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 177.9;Sarcoma: 319.5"	"Kidney - Macrophages, Stomach - Gastric mucous cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	Interleukin	NA	NA	2330		"Cluster 28: Neutrophils - Unknown function"	"Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 44: Non-specific - Mixed function"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 40: Monocytes & Neutrophils - Inflammatory signaling"	7				"unprognostic (2.08e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.31e-2)"	"potential prognostic unfavorable (5.36e-5)"	"unprognostic (5.84e-3)"	"unprognostic (6.84e-2)"	"unprognostic (4.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.36e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.93e-3)"	"unprognostic (1.16e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.24e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.52e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.61e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"
ISM2	"FLJ32147, TAIL1, THSD3"	ENSG00000100593	"Isthmin 2"	Q6H9L7	14	77474394-77498816	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	57	"placenta: 200.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 334.1;Extravillous trophoblasts: 1122.8;Migrating cytotrophoblasts: 494.0;Syncytiotrophoblasts: 192.9"	"Group enriched"	"Detected in some"	4	"eccentric medium spiny neuron: 10.0;medium spiny neuron: 6.9"	"Cancer enhanced"	"Detected in some"		"Kidney Chromophobe (TCGA): 7.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Bone cancer: 3.7"	"Adipose visceral - Mesothelial cells, Skin - Hair cortex cells, Skin - Inner root sheath cells, Skin - Outer root sheath cells"	"Not detected"	"Not detected"							"HPA039314, HPA039742"	Supported		Approved	Nucleoplasm,Centrosome,Cytosol	"Secreted in female reproductive system"	"No annotated function"	NA	NA		900000		"Cluster 43: Placenta - Pregnancy hormone signaling"	"Cluster 56: Hypothalamus - Neuropeptide signaling"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio"	1	Nucleoplasm	"Centrosome, Cytosol"	"HPA039314: , HPA039742: "	"unprognostic (9.45e-3)"									"unprognostic (3.63e-3)"								"potential prognostic favorable (7.13e-5)"							"unprognostic (9.07e-2)"	"unprognostic (1.79e-1)"			"unprognostic (2.97e-1)"		
ITGAX	CD11C	ENSG00000140678	"Integrin subunit alpha X"	P20702	16	31355134-31382999	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 45.4;lung: 56.9;lymphoid tissue: 66.2"	"Cell type enhanced"	"Detected in some"		"cDC: 292.5;Macrophages: 204.2;Mast cells: 195.6;Microglia: 386.4;monocytes: 557.7;Neutrophils: 1628.0"	"Cell type enriched"	"Detected in some"	5	"central nervous system macrophage: 457.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.3"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in some"		"Leukemia: 7.5;lymphoma: 7.8"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Kidney - T-cells, Liver - Neutrophils, Skeletal muscle - Neutrophils, Spleen - Neutrophils_2, Thyroid gland - T-cells"	"Not detected"	"Not detected"							"CAB004458, HPA004723, CAB072871, CAB080214"	Enhanced		Supported	"Vesicles,Plasma membrane"			NA	NA			"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 12: Non-specific - Vasculature"	"Cluster 49: HMC-1 - Innate immune response"	"Cluster 31: Neutrophils - Chemotaxis & Apoptosis"	2	"Vesicles, Plasma membrane"		"CAB004458: , CAB072871: , CAB080214: , HPA004723: "	"unprognostic (1.92e-1)"	"unprognostic (5.48e-3)"	"unprognostic (1.24e-2)"	"unprognostic (3.52e-1)"	"unprognostic (8.23e-2)"	"unprognostic (5.35e-2)"	"unprognostic (9.77e-2)"	"unprognostic (9.55e-2)"	"unprognostic (8.97e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.02e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.37e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.16e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.64e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.77e-3)"	"unprognostic (2.49e-2)"	"unprognostic (3.41e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.62e-1)"
ITGB2	"CD18, LFA-1, MAC-1, MFI7"	ENSG00000160255	"Integrin subunit beta 2"	P05107	21	44885953-44931989	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Phagocytosis"	"Integrin, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 343.1;lymphoid tissue: 162.7"	"Cell type enhanced"	"Detected in many"		"cDC: 399.5;Hofbauer cells: 522.8;Kupffer cells: 222.4;Macrophages: 344.6;Monocyte progenitors: 358.2;monocytes: 613.7;Neutrophil progenitors: 309.9;Neutrophils: 726.1;NK-cells: 269.4;T-cells: 148.4"	"Group enriched"	"Detected in some"	15	"central nervous system macrophage: 126.3;leukocyte: 200.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Bone cancer: 64.2;Leukemia: 194.5;lymphoma: 74.0"	"Adipose subcutaneous - Macrophages, Adipose visceral - Macrophages, Adrenal gland - Macrophages, Breast - Macrophages, Colon - Macrophages, Heart muscle - Macrophages, Kidney - Macrophages, Minor Salivary Gland - Macrophages, Pancreas - Macrophages, Pituitary gland - Macrophages, Prostate - Macrophages, Skeletal muscle - Macrophages, Spleen - Neutrophils_2, Stomach - Macrophages, Testis - Macrophages, Thyroid gland - Macrophages"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008877, HPA016894"	Enhanced		Supported	"Plasma membrane,Rods & Rings"			NA	NA		5100000	"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 29: Lymphoid tissue & Bone marrow - Innate immune response"	"Cluster 20: Macrophages & Microglia - Immune response"	"Cluster 14: Myeloid leukemia - Innate immune response"	"Cluster 40: Monocytes & Neutrophils - Inflammatory signaling"	34	"Plasma membrane"	"Rods & Rings"	"HPA008877: , HPA016894: "	"unprognostic (4.81e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.34e-2)"	"unprognostic (5.75e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.22e-1)"	"unprognostic (8.19e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.33e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.12e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-2)"
KRT1	"EHK1, KRT1A"	ENSG00000167768	"Keratin 1"	P04264	12	52674736-52680407	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, Ichthyosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"skin 1: 12288.0"	"Cell type enriched"	"Detected in some"	10	"Suprabasal keratinocytes: 6388.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Head and Neck Squamous Cell Carcinoma (TCGA): 456.5;Skin Cutaneous Melanoma (TCGA): 862.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory CD4 T-cell: 2.3"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.3"	"Group enriched"	"Detected in some"	5	"Bladder cancer: 10.9;Esophageal cancer: 23.0;head and neck cancer: 17.4"	"Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB002153, HPA017917, HPA062908"	Enhanced						NA	NA		10000000000	"Cluster 11: T-cells - Unknown function"	"Cluster 37: Skin - Keratinization"		"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 26: Keratinocytes - Keratinization"	48			"CAB002153: , HPA017917: , HPA062908: "	"unprognostic (1.58e-1)"	"unprognostic (2.45e-1)"		"unprognostic (2.30e-3)"					"unprognostic (2.00e-1)"									"unprognostic (1.25e-1)"	"unprognostic (2.02e-1)"								"unprognostic (7.31e-2)"		"unprognostic (3.71e-2)"		
MEGF10	"KIAA1780, SR-F3"	ENSG00000145794	"Multiple EGF like domains 10"	Q96KG7	5	127290796-127465737	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis, Phagocytosis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 12.2;retina: 7.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 300.8;Ependymal cells: 70.4;Müller glia: 186.0;Myosatellite cells: 365.0;Oligodendrocyte progenitor cells: 108.9;Oligodendrocytes: 455.9;Other brain neurons: 109.2;Pituicytes/FSCs: 127.5;Pituitary stem cells: 80.8"	"Cell type enhanced"	"Detected in all"		"astrocyte: 343.9;cerebellar inhibitory: 510.3;oligodendrocyte: 637.4"	"Cancer enhanced"	"Detected in some"		"Glioblastoma Multiforme (TCGA): 6.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Sarcoma: 10.0;skin cancer: 6.9"	"Adrenal gland - Adrenal cortex cells, Breast - Breast myoepithelial cells, Colon - Enteric glia cells, Liver - Hepatocytes, Minor Salivary Gland - Smooth muscle cells, Pituitary gland - Undifferentiated cells (Pituitary gland), Skin - Eccrine sweat gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011401			Supported	"Plasma membrane"	"Intracellular and membrane"	"Cell adhesion"	NA	NA		8100000		"Cluster 3: Oligodendrocytes - Myelination"	"Cluster 13: Oligodendrocytes - Mixed function"	"Cluster 33: Sarcoma - Muscle contraction"	"Cluster 80: Oligodendrocytes - Myelination"	1	"Plasma membrane"		"HPA011401: "		"unprognostic (6.64e-2)"	"unprognostic (1.87e-1)"				"unprognostic (5.66e-2)"	"potential prognostic unfavorable (6.09e-4)"	"unprognostic (6.15e-2)"									"unprognostic (1.35e-3)"	"unprognostic (4.93e-2)"								"unprognostic (1.12e-1)"				
MFAP4		ENSG00000166482	"Microfibril associated protein 4"	P55083	17	19383442-19387190	"Plasma proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood vessel: 1055.6"	"Cell type enhanced"	"Detected in many"		"Decidual stromal cells: 309.6;Fibroblasts: 590.2;Hepatic stellate cells: 225.9;Müller glia: 82.2;Ovarian stromal cells: 136.1;Pericytes: 83.5;Peritubular myoid cells: 206.9;Smooth muscle cells: 238.5;Vascular smooth muscle cells: 164.5"	"Group enriched"	"Detected in some"	49	"fibroblast: 140.1;vascular associated smooth muscle cell: 61.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	11	"eosinophil: 1.0;intermediate monocyte: 1.8;non-classical monocyte: 1.9"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.0;monocytes: 1.9"	"Cancer enhanced"	"Detected in many"		"Bone cancer: 118.8;Neuroblastoma: 110.6"	"Adipose subcutaneous - Adipose progenitor cells, Breast - Fibroblasts, Colon - Fibroblasts, Heart muscle - Fibroblasts, Kidney - Fibroblasts, Liver - Hepatic stellate cells, Lung - Fibroblasts_1, Minor Salivary Gland - Fibroblasts, Pancreas - Fibroblasts, Pituitary gland - Fibroblasts, Prostate - Fibroblasts, Skeletal muscle - Fibroblasts, Stomach - Fibroblasts, Testis - Peritubular cells, Thyroid gland - Fibroblasts"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA054097	Supported		Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	"Cell adhesion"	NA	NA		15000000		"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 39: Astrocytes - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 108: Fibroblasts - ECM organization"	74	"Endoplasmic reticulum"		"HPA054097: "	"unprognostic (2.39e-3)"	"unprognostic (4.63e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.73e-2)"	"unprognostic (3.66e-2)"	"potential prognostic favorable (3.73e-4)"	"unprognostic (3.67e-2)"	"unprognostic (8.85e-2)"	"unprognostic (2.62e-2)"	"potential prognostic unfavorable (7.70e-5)"	"unprognostic (2.81e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.19e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.61e-1)"	"potential prognostic unfavorable (2.68e-4)"	"unprognostic (3.66e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.03e-2)"	"unprognostic (4.85e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.73e-2)"
OTOL1	"C1QTNF15, C1QTNF16"	ENSG00000182447	"Otolin 1"	A6NHN0	3	161496808-161503942	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"deep-layer corticothalamic and 6b: 1.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	6	"cerebral cortex: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	21	"cervical cancer: 8.9"		"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041030	Uncertain				"Secreted in other tissues"	"No annotated function"	NA	NA					"Cluster 51: Neurons - Mixed function"	"Cluster 5: Rhabdoid - Unknown function"	"Cluster 35: Neurons - Synaptic function & neurogenesis"	1			"HPA041030: "																															
PEX12		ENSG00000108733	"Peroxisomal biogenesis factor 12"	O00623	17	35574795-35578863	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 15.1;Early primary spermatocytes: 22.8;Early spermatids: 26.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Testis - Spermatocytes, Testis - Spermatogonia, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069386	Enhanced						NA	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 22: Epididymis - Mixed function"	"Cluster 55: Non-specific - Transcription"	"Cluster 58: Non-specific - Nuclear processes"	"Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase"	36			"HPA069386: "	"unprognostic (8.51e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.47e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.74e-1)"	"unprognostic (3.67e-2)"	"unprognostic (2.00e-1)"	"potential prognostic favorable (3.12e-7)"	"unprognostic (1.81e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.67e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.27e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.41e-1)"
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adrenal cortex cells: 113.3;Pituitary stem cells: 121.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Testis - Early spermatids, Testis - Spermatocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 76: Non-specific - Metabolism"	"Cluster 31: Non-specific - Transcription"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 32: Endothelial cells - Angiogenesis & vascular immunity"	36	"Nucleoplasm, Peroxisomes"		"HPA042830: , HPA058006: "	"unprognostic (2.65e-1)"	"unprognostic (1.17e-3)"	"potential prognostic unfavorable (1.90e-4)"	"unprognostic (1.56e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.49e-1)"	"unprognostic (7.24e-2)"	"potential prognostic favorable (1.67e-8)"	"unprognostic (1.26e-1)"	"unprognostic (1.23e-3)"	"unprognostic (9.21e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.00e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-3)"	"unprognostic (8.99e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.77e-3)"	"potential prognostic favorable (2.99e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.35e-1)"	"unprognostic (8.97e-2)"	"unprognostic (7.29e-2)"
PEX5	"PTS1R, PXR1"	ENSG00000139197	"Peroxisomal biogenesis factor 5"	P50542	12	7188685-7218574	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Translocation, Transport"		"Disease variant, Peroxisome biogenesis disorder, Rhizomelic chondrodysplasia punctata, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Early spermatids: 244.4;Late primary spermatocytes: 64.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Adipocytes (Visceral)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039259, HPA039260"	Enhanced		Supported	"Golgi apparatus,Cytosol"			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 42: Early spermatids - Spermiogenesis: Acrosomal phase"	48	"Golgi apparatus, Cytosol"		"HPA039259: , HPA039260: "	"unprognostic (5.02e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.32e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.80e-3)"	"potential prognostic favorable (1.23e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.28e-3)"	"unprognostic (6.13e-3)"	"unprognostic (3.61e-2)"	"unprognostic (3.73e-1)"	"unprognostic (5.15e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.38e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.31e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.93e-1)"
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"	Hydrolase	"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 71.9"	"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025924	Supported		Approved	"Golgi apparatus,Cytosol"			NA	NA			"Cluster 30: Non-specific - DNA binding"	"Cluster 70: Non-specific - Protein processing"	"Cluster 18: Non-specific - Mixed function"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 86: Retinal bipolar cells - Synaptic signal transduction"	23	"Golgi apparatus"	Cytosol	"HPA025924: "	"unprognostic (2.85e-2)"	"unprognostic (3.39e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.60e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.31e-1)"	"unprognostic (4.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.99e-1)"	"unprognostic (6.78e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.50e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.41e-1)"	"potential prognostic favorable (7.58e-4)"	"unprognostic (3.91e-2)"	"unprognostic (4.13e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.69e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.93e-1)"
PLEK2		ENSG00000100558	"Pleckstrin 2"	Q9NYT0	14	67386984-67412167	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 48.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 125.3;Enteric stem cells: 51.8;Enteric transient amplifying cells: 56.1;Enterocytes: 49.2;Epididymal clear cells: 44.9;Epididymal principal cells: 48.3;Esophageal basal cells: 73.7;Gastric progenitor cells: 67.9;Goblet cells: 59.7;Oocytes: 41.4;Paneth cells: 61.9;Suprabasal keratinocytes: 78.9"	"Cell type enriched"	"Detected in single"	4	"fibroblast: 3.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	6	"memory CD4 T-cell: 2.0;naive CD4 T-cell: 3.1"	"Lineage enriched"	"Detected in single"	7	"T-cells: 3.1"	"Low cancer specificity"	"Detected in many"			"Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal cortex cells, Colon - Colon enterocytes, Prostate - Prostate basal glandular cells, Skin - Keratinocyte (other), Spleen - Erythrocytes, Testis - Leydig cells, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA001208	Enhanced		Uncertain	Vesicles,Cytosol			NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 77: Intestine - Digestion"	"Cluster 15: Non-specific - Transcription"	"Cluster 30: Non-specific - Gene expression regulation"	"Cluster 26: Keratinocytes - Keratinization"	3	Vesicles	Cytosol	"HPA001208: "	"unprognostic (1.97e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.76e-2)"	"unprognostic (2.28e-3)"	"unprognostic (3.21e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.03e-1)"	"potential prognostic unfavorable (4.21e-5)"	"unprognostic (4.41e-3)"	"unprognostic (5.79e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.96e-3)"	"unprognostic (2.67e-1)"	"potential prognostic unfavorable (2.01e-4)"	"unprognostic (2.18e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.18e-2)"	"unprognostic (7.25e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.82e-1)"	"unprognostic (7.02e-2)"	"unprognostic (3.34e-2)"
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 26.9;lung: 15.5;lymphoid tissue: 46.4"	"Cell type enriched"	"Detected in some"	5	"NK-cells: 737.8"	"Cell type enriched"	"Detected in some"	233	"leukocyte: 262.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.8;MAIT T-cell: 628.8;memory CD8 T-cell: 498.2;naive CD8 T-cell: 313.2;NK-cell: 657.0"	"Group enriched"	"Detected in all"	50	"NK-cells: 657.0;T-cells: 900.8"	"Cancer enriched"	"Detected in some"	7	"lymphoma: 61.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Lung - NK-cells (Lung), Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Stomach - T-cells, Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	Other	NA	NA		480000	"Cluster 15: NK-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 71: Lymphoma - Inflammatory response"	"Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity"	32	Cytosol		"CAB002436: , HPA037940: "	"unprognostic (6.99e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.69e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.96e-2)"	"potential prognostic favorable (4.55e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.60e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.71e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.51e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.95e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.55e-3)"	"unprognostic (6.26e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.79e-1)"
RASAL2	nGAP	ENSG00000075391	"RAS protein activator like 2"	Q9UJF2	1	178094104-178484147	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Esophageal apical cells: 1058.9;Rod photoreceptor cells: 1144.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Adipose visceral - Endothelial cells, Liver - Vascular endothelial cells, Lung - Endothelial cells, Spleen - Endothelial cells, Stomach - Endothelial cells, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018805, HPA020453"	Enhanced		Approved	"Plasma membrane,Focal adhesion sites"			NA	Yes				"Cluster 42: Retina - Visual perception"	"Cluster 40: Astrocytes - Astrocyte-neuron interactions"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis"	35	"Plasma membrane, Focal adhesion sites"		"HPA018805: , HPA020453: "	"unprognostic (1.76e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.32e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.70e-1)"	"potential prognostic favorable (5.61e-4)"	"unprognostic (8.31e-2)"	"unprognostic (1.44e-2)"	"potential prognostic favorable (8.87e-6)"	"unprognostic (1.19e-3)"	"unprognostic (9.29e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.93e-1)"	"unprognostic (3.09e-3)"	"potential prognostic unfavorable (9.38e-6)"	"unprognostic (3.49e-2)"	"unprognostic (3.15e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.95e-3)"	"potential prognostic unfavorable (1.16e-4)"	"unprognostic (1.39e-1)"	"unprognostic (7.30e-2)"	"unprognostic (9.32e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"
SEZ6		ENSG00000063015	"Seizure related 6 homolog"	Q53EL9	17	28954901-29006440	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 109.8"	"Cell type enhanced"	"Detected in many"		"Brain excitatory neurons: 41.0;Brain inhibitory neurons: 69.9;Cone photoreceptor cells: 37.3;Lactotrophs: 20.1;Other brain neurons: 33.8;Pancreatic islet cells: 20.3;Retinal amacrine cells: 70.7;Retinal bipolar cells: 69.7;Retinal ganglion cells: 50.2;Retinal horizontal cells: 30.1;Thyrotrophs: 25.5"	"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in many"	11	"Glioblastoma Multiforme (TCGA): 53.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 1.1;neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.0"	"Cancer enhanced"	"Detected in many"		"lung cancer: 13.1;Neuroblastoma: 14.3;thyroid cancer: 21.0"	"Adrenal gland - Adrenal medulla cells, Colon - Colon enteroendocrine cells, Pancreas - Alpha cells, Stomach - Gastric enteroendocrine cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011777	Enhanced						NA	NA		180000		"Cluster 27: Cerebellum - Synaptic function"	"Cluster 33: Neurons - Mixed function"	"Cluster 16: Thyroid cancer - Neuronal signaling"	"Cluster 86: Retinal bipolar cells - Synaptic signal transduction"	1			"HPA011777: "	"unprognostic (4.47e-2)"	"unprognostic (4.05e-2)"					"unprognostic (3.53e-2)"	"unprognostic (1.28e-2)"						"unprognostic (1.31e-1)"	"unprognostic (6.61e-2)"					"unprognostic (3.32e-1)"		"unprognostic (5.54e-3)"				"unprognostic (2.29e-2)"		"unprognostic (3.36e-2)"	"unprognostic (3.91e-1)"		
THSD1	TMTSP	ENSG00000136114	"Thrombospondin type 1 domain containing 1"	Q9NS62	13	52377167-52416373	"Disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 42.0;Epididymal basal cells: 39.6;Fibro-adipogenic progenitors: 30.7;Lymphatic endothelial cells: 74.7;Myosatellite cells: 21.7;Retinal bipolar cells: 27.5;Retinal ganglion cells: 46.4;Vascular endothelial cells: 43.3"	"Group enriched"	"Detected in all"	4	"astrocyte: 28.8;endothelial cell: 105.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose visceral - Endothelial cells, Colon - Endothelial cells, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012611, CAB020796, HPA071106"	Supported		Supported	Cytosol	"Intracellular and membrane"	"No annotated function"	No	No		260000		"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 51: Neurons - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 32: Endothelial cells - Angiogenesis & vascular immunity"		Cytosol		"CAB020796: , HPA012611: , HPA071106: "	"unprognostic (6.78e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.75e-3)"	"potential prognostic favorable (7.89e-5)"	"unprognostic (5.07e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.45e-3)"	"unprognostic (1.05e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.18e-2)"			"unprognostic (1.13e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.25e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (6.57e-2)"	"unprognostic (8.61e-2)"
TRBC1	"BV05S1J2.2, TCRBC1"	ENSG00000211751	"T cell receptor beta constant 1"	P01850	7	142791694-142793368	"Predicted membrane proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	28	"lymphoid tissue: 1415.2"	"Group enriched"	"Detected in some"	11	"Innate lymphoid cells: 165.4;NK-cells: 147.9;T-cells: 232.0"	"Cell type enriched"	"Detected in some"	165	"leukocyte: 170.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"T-reg: 3241.7"	"Lineage enriched"	"Detected in all"	9	"T-cells: 3241.7"	"Cancer enriched"	"Detected in some"	6	"Leukemia: 101.3"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Heart muscle - T-cells, Kidney - T-cells, Liver - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Skin - T-cells, Spleen - T-cells, Thyroid gland - T-cells"																NA	NA			"Cluster 31: T-cells - T-cell receptor"	"Cluster 80: Thymus - Adaptive immune response"	"Cluster 8: Immune cells - Immune response"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 9: T-cells - Adaptive immunity: Regulation"					"unprognostic (1.28e-2)"	"unprognostic (2.34e-3)"		"unprognostic (2.46e-3)"	"unprognostic (3.61e-1)"	"unprognostic (5.30e-2)"	"unprognostic (1.21e-2)"		"potential prognostic favorable (4.91e-5)"	"unprognostic (3.45e-1)"	"unprognostic (4.21e-2)"	"unprognostic (6.66e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.38e-2)"		"unprognostic (3.32e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.11e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.21e-2)"		"unprognostic (5.02e-2)"		"unprognostic (2.26e-1)"	"unprognostic (4.44e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.42e-3)"
TRBC2	TCRBC2	ENSG00000211772	"T cell receptor beta constant 2"	A0A5B9	7	142801041-142802748	"Predicted membrane proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 107.2;lymphoid tissue: 180.6"	"Cell type enhanced"	"Detected in some"		"B-cells: 54.1;Innate lymphoid cells: 59.3;Leydig cells: 38.3;NK-cells: 89.9;Peritubular myoid cells: 44.6;T-cells: 292.6;Thymocytes: 33.9"	"Cell type enriched"	"Detected in some"	8	"leukocyte: 156.9"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"T-reg: 76.2"	"Lineage enriched"	"Detected in many"	7	"T-cells: 76.2"	"Cancer enriched"	"Detected in single"	15	"Leukemia: 11.7"	"Adipose subcutaneous - T-cells, Adipose visceral - T-cells, Adrenal gland - T-cells, Breast - T-cells, Colon - T-cells, Kidney - T-cells, Liver - T-cells, Lung - T-cells, Minor Salivary Gland - T-cells, Pancreas - T-cells, Pituitary gland - T-cells, Prostate - T-cells, Spleen - T-cells, Stomach - T-cells, Thyroid gland - T-cells"																NA	NA			"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 66: Lymphoid tissue - Immune response"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 9: T-cells - Adaptive immunity: Regulation"										"unprognostic (3.21e-1)"		"unprognostic (4.82e-2)"				"unprognostic (3.92e-2)"					"unprognostic (3.31e-1)"		"unprognostic (4.80e-2)"		"unprognostic (9.65e-2)"		"unprognostic (3.26e-3)"			"unprognostic (1.07e-1)"		"unprognostic (3.06e-2)"			
TRDC		ENSG00000211829	"T cell receptor delta constant"	B7Z8K6	14	22462932-22465787	"Predicted membrane proteins, T-cell receptor genes"	"Adaptive immunity, Immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	15	"lymphoid tissue: 376.4"	"Cell type enhanced"	"Detected in some"		"Innate lymphoid cells: 109.3;Lacrimal acinar cells: 39.0;NK-cells: 203.3;T-cells: 49.1;Thymocytes: 168.5"	"Cell type enriched"	"Detected in some"	38	"leukocyte: 39.7"	"Cancer enhanced"	"Detected in all"		"Thyroid Carcinoma (TCGA): 66.9"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	87	"gdT-cell: 5889.0;NK-cell: 2250.7"	"Group enriched"	"Detected in all"	150	"NK-cells: 2250.7;T-cells: 5889.0"	"Cancer enhanced"	"Detected in some"		"breast cancer: 16.9;Leukemia: 51.9"	"Heart muscle - T-cells, Kidney - T-cells, Liver - NK-cells (Liver), Lung - NK-cells (Lung), Thyroid gland - T-cells"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"										NA	NA			"Cluster 15: NK-cells - Unknown function"	"Cluster 80: Thymus - Adaptive immune response"	"Cluster 15: Non-specific - Transcription"	"Cluster 70: DU4475 - Unknown function"	"Cluster 92: NK-cells & T-cells - Adaptive immunity: Cytotoxicity"					"unprognostic (2.53e-1)"	"potential prognostic favorable (1.25e-4)"		"unprognostic (9.32e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.80e-2)"	"unprognostic (3.87e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.53e-1)"		"potential prognostic favorable (1.28e-4)"	"unprognostic (2.33e-1)"	"unprognostic (5.29e-2)"	"unprognostic (4.54e-1)"	"unprognostic (9.86e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.21e-1)"
UNC119	"HRG4, POC7, POC7A"	ENSG00000109103	"Unc-119 lipid binding chaperone"	Q13432	17	28546708-28552631	"Disease related genes, Essential proteins, Human disease related genes, Predicted intracellular proteins"	"Endocytosis, Protein transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	17	"retina: 1084.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.3;Bergmann glia: 6.8;Brain excitatory neurons: 10.2;Brain inhibitory neurons: 11.1;Choroid plexus epithelial cells: 14.7;Cone photoreceptor cells: 8.3;Ependymal cells: 4.5;Microglia: 9.9;Oligodendrocyte progenitor cells: 9.9;Other brain neurons: 17.1;Retinal pigment epithelial cells: 4.3;Rod photoreceptor cells: 11.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Fibroblasts, Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041912	Enhanced						NA	NA			"Cluster 25: Non-specific - Unknown function"	"Cluster 42: Retina - Visual perception"	"Cluster 1: Neurons - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 22: Non-specific - Basic cellular functions"	56			"HPA041912: "	"unprognostic (6.72e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.14e-3)"	"potential prognostic unfavorable (8.67e-5)"	"unprognostic (7.05e-2)"	"unprognostic (3.76e-1)"	"unprognostic (2.65e-2)"	"validated prognostic unfavorable (1.72e-5)"	"validated prognostic unfavorable (1.13e-4)"	"unprognostic (7.07e-2)"	"unprognostic (7.40e-3)"	"unprognostic (7.75e-2)"	"unprognostic (8.28e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.54e-3)"	"unprognostic (1.89e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.12e-2)"	"potential prognostic unfavorable (2.70e-4)"	"unprognostic (2.07e-1)"	"unprognostic (5.15e-2)"	"potential prognostic unfavorable (1.34e-5)"	"unprognostic (1.13e-1)"
VTN	VN	ENSG00000109072	Vitronectin	P04004	17	28367284-28373091	"Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"liver: 5644.8"	"Group enriched"	"Detected in some"	60	"Cholangiocytes: 898.8;Hepatocytes: 2941.5"	"Low cell type specificity"	"Detected in many"			"Cancer enriched"	"Detected in many"	62	"Liver Hepatocellular Carcinoma (TCGA): 4796.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"liver cancer: 132.3"	"Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB016695, CAB016765, HPA060933, HPA068011"	Supported		Supported	"Endoplasmic reticulum,Vesicles"	"Secreted to blood"	"Cell adhesion"	NA	NA	606000000000	46000000000		"Cluster 53: Liver - Plasma proteins"	"Cluster 15: Non-specific - Transcription"	"Cluster 18: Liver cancer - Metabolism"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	21	"Endoplasmic reticulum, Vesicles"		"CAB016695: , CAB016765: , HPA060933: , HPA068011: "	"unprognostic (1.27e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.08e-2)"		"unprognostic (6.31e-2)"	"unprognostic (3.43e-2)"				"potential prognostic unfavorable (4.22e-5)"	"unprognostic (8.05e-2)"	"potential prognostic unfavorable (1.00e-4)"	"validated prognostic favorable (3.70e-4)"	"validated prognostic favorable (8.61e-5)"	"unprognostic (1.78e-1)"	"unprognostic (1.49e-1)"	"potential prognostic unfavorable (1.07e-5)"		"unprognostic (1.49e-1)"		"unprognostic (6.85e-3)"		"unprognostic (5.96e-3)"		"unprognostic (5.46e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.69e-3)"	"unprognostic (2.47e-1)"		
XPA	"XP1, XPAC"	ENSG00000136936	"XPA, DNA damage recognition and repair factor"	P23025	9	97674909-97697340	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000155, HPA068327"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"			NA	No			"Cluster 12: Non-specific - Mitochondrial translation"	"Cluster 74: Non-specific - Signal transduction"	"Cluster 16: Non-specific - Transcription"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 71: Non-specific - Cardiac endocrine signaling & maintenanc"	41	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"CAB000155: , HPA068327: "	"unprognostic (5.25e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.86e-3)"	"unprognostic (3.73e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.31e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.03e-1)"	"potential prognostic favorable (5.85e-8)"	"unprognostic (1.17e-3)"	"unprognostic (3.24e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.97e-3)"	"unprognostic (6.06e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.21e-1)"
XRCC1	RCC	ENSG00000073050	"X-ray repair cross complementing 1"	P18887	19	43543311-43580473	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Pituitary gland - Lactotropes, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005427, HPA006717"	Supported		Enhanced	Nucleoplasm			NA	NA			"Cluster 21: Neutrophils - Unknown function"	"Cluster 54: Non-specific - Ribosome"	"Cluster 15: Non-specific - Transcription"	"Cluster 4: Non-specific - Transcription"	"Cluster 63: Cytotrophoblasts - Basic cellular functions"	63	Nucleoplasm		"CAB005427: , HPA006717: "	"unprognostic (2.44e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.12e-2)"	"unprognostic (1.40e-3)"	"potential prognostic unfavorable (4.58e-5)"	"unprognostic (1.61e-2)"	"unprognostic (6.29e-2)"	"unprognostic (4.40e-3)"	"potential prognostic favorable (9.87e-5)"	"unprognostic (7.45e-3)"	"unprognostic (1.52e-1)"	"unprognostic (4.63e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.69e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.03e-1)"
YKT6		ENSG00000106636	"YKT6 v-SNARE homolog"	O15498	7	44200959-44214294	"Essential proteins, Metabolic proteins, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Esophageal apical cells: 170.3;Extravillous trophoblasts: 85.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030817, HPA030818"	Approved		Approved	Mitochondria,Cytosol			No	No		11000	"Cluster 45: Eosinophils - Unknown function"	"Cluster 25: Non-specific - Basic cellular processes"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 67: Non-specific - Unknown function"	"Cluster 8: Non-specific - Secretory pathway"	37	Cytosol	Mitochondria	"HPA030817: , HPA030818: "	"unprognostic (2.19e-3)"	"unprognostic (1.31e-2)"	"unprognostic (5.14e-1)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.80e-1)"	"unprognostic (3.20e-2)"	"unprognostic (8.87e-2)"	"potential prognostic unfavorable (2.92e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.18e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.11e-1)"	"validated prognostic unfavorable (1.39e-6)"	"validated prognostic unfavorable (8.35e-5)"	"potential prognostic unfavorable (3.58e-4)"	"unprognostic (4.79e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.76e-1)"	"potential prognostic unfavorable (7.53e-4)"	"unprognostic (3.48e-1)"	"unprognostic (1.12e-1)"	"potential prognostic unfavorable (8.23e-4)"	"unprognostic (2.99e-1)"	"unprognostic (5.80e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.21e-3)"	"unprognostic (7.59e-3)"
YME1L1	YME1L	ENSG00000136758	"YME1 like 1 ATPase"	Q96TA2	10	27110111-27155266	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"							HPA066953	Approved		Supported	"Nuclear bodies,Mitochondria"			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 63: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Metabolism"	"Cluster 52: Non-specific - Mitochondria"	"Cluster 29: Neutrophils - Innate immune cellular maintenance"	13	Mitochondria	"Nuclear bodies"	"HPA066953: "	"unprognostic (4.73e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.20e-3)"	"unprognostic (2.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-1)"	"potential prognostic favorable (9.54e-5)"	"unprognostic (1.45e-1)"	"unprognostic (4.31e-3)"	"potential prognostic favorable (2.66e-6)"	"unprognostic (3.06e-2)"	"unprognostic (3.88e-2)"	"potential prognostic unfavorable (1.02e-4)"	"unprognostic (2.65e-3)"	"unprognostic (8.05e-2)"	"unprognostic (1.31e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.77e-2)"	"potential prognostic unfavorable (8.17e-4)"	"unprognostic (2.97e-3)"	"unprognostic (3.30e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.28e-3)"	"unprognostic (2.30e-1)"
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 216.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 213.9;Breast lactating cells: 235.5;Early spermatids: 247.6;Esophageal apical cells: 197.6;Esophageal basal cells: 184.4;Esophageal suprabasal cells: 223.5;Late spermatids: 190.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary gland basal cells, Prostate - Prostate glandular cells, Skin - Sebaceous gland cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol			NA	NA		2500000	"Cluster 3: Non-specific - Nuclear processes"	"Cluster 45: Liver - Metabolism & Coagulation"	"Cluster 49: Hindbrain - Mixed function"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	3	Cytosol	Nucleoplasm	"CAB021106: , HPA025736: , HPA025765: , HPA025811: "	"unprognostic (5.58e-2)"	"unprognostic (1.77e-1)"	"potential prognostic unfavorable (2.34e-5)"	"unprognostic (1.95e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.50e-1)"	"potential prognostic unfavorable (8.27e-4)"	"unprognostic (3.83e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.31e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.35e-3)"	"unprognostic (1.77e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.19e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.69e-3)"	"unprognostic (4.39e-2)"
APOBEC1	"APOBEC-1, BEDP, CDAR1, HEPR"	ENSG00000111701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 1"	P41238	12	7649400-7665908	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"intestine: 27.3"	"Cell type enriched"	"Detected in some"	7	"Enterocytes: 161.8"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Colon Adenocarcinoma (TCGA): 2.9;Pancreatic Adenocarcinoma (TCGA): 2.9;Rectum Adenocarcinoma (TCGA): 2.5;Stomach Adenocarcinoma (TCGA): 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	4	"colorectal cancer: 1.4"	"Stomach - Gastric mucous cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA				"Cluster 7: Small intestine - Absorption and Digestion"		"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 1: Enterocytes - Absorption and Digestion"	10								"unprognostic (1.94e-1)"	"unprognostic (1.43e-1)"																"unprognostic (1.62e-3)"	"unprognostic (7.42e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.56e-1)"		"unprognostic (1.38e-1)"			
ASNS		ENSG00000070669	"Asparagine synthetase (glutamine-hydrolyzing)"	P08243	7	97851677-97872542	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Amino-acid biosynthesis, Asparagine biosynthesis"	Ligase	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 114.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 18.6;Bergmann glia: 16.0;Brain excitatory neurons: 59.7;Brain inhibitory neurons: 50.2;Choroid plexus epithelial cells: 13.1;Ependymal cells: 11.4;Loop of henle epithelial cells: 9.8;Microglia: 10.0;Oligodendrocyte progenitor cells: 31.0;Oligodendrocytes: 21.4;Other brain neurons: 46.1;Podocytes: 17.3;Renal connecting tubule cells: 11.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 9.0;T-cells: 14.2"	"Low cancer specificity"	"Detected in all"			"Kidney - Endothelial cells, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004924, HPA029318, HPA064737"	Approved		Supported	Cytosol			No	No		110000	"Cluster 43: Non-specific - Transcription & Translation"	"Cluster 70: Non-specific - Protein processing"	"Cluster 37: Neurons - Mixed function"	"Cluster 13: Non-specific - Mixed function"	"Cluster 98: Neurons - Neurotransmission & signaling"	14	Cytosol		"HPA004924: , HPA029318: , HPA064737: "	"unprognostic (3.74e-1)"	"unprognostic (3.27e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.88e-1)"	"unprognostic (4.12e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.72e-1)"	"potential prognostic unfavorable (9.03e-5)"	"unprognostic (2.45e-3)"	"potential prognostic unfavorable (9.15e-8)"	"unprognostic (9.14e-3)"	"unprognostic (9.02e-2)"	"potential prognostic unfavorable (8.91e-6)"	"unprognostic (5.99e-2)"	"unprognostic (7.18e-2)"	"unprognostic (3.74e-3)"	"unprognostic (4.73e-2)"	"unprognostic (1.61e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.65e-3)"	"unprognostic (1.16e-2)"	"unprognostic (5.07e-1)"	"unprognostic (9.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.33e-1)"
CDCA7	"FLJ14736, JPO1"	ENSG00000144354	"Cell division cycle associated 7"	Q9BWT1	2	173354820-173368997	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Transcription, Transcription regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 26.5;lymphoid tissue: 41.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 56.6;Decidual stromal cells: 63.0;Enteric stem cells: 206.7;Enteric transient amplifying cells: 109.7;Esophageal basal cells: 48.7;Gastric progenitor cells: 103.8;Leydig cells: 92.6;Megakaryocyte progenitors: 52.7;Migrating cytotrophoblasts: 52.0;Monocyte progenitors: 57.6;Mucous neck cells: 60.0;Paneth cells: 170.2"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 35.7;LAMP5-LHX6 and Chandelier: 37.4"	"Cancer enhanced"	"Detected in all"		"Rectum Adenocarcinoma (TCGA): 92.1"	"Region enriched"	"Detected in many"	6	"choroid plexus: 12.2"	"Immune cell enhanced"	"Detected in many"		"T-reg: 8.8"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005565			Supported	Nucleoplasm,Cytosol			No	Yes			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 6: Leukemia - Signal transduction"	"Cluster 27: Non-specific - Cell proliferation"	2	"Nucleoplasm, Cytosol"		"HPA005565: "	"unprognostic (2.03e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.25e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.42e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.32e-2)"	"potential prognostic unfavorable (1.16e-7)"	"unprognostic (2.06e-3)"	"potential prognostic unfavorable (7.85e-6)"	"unprognostic (2.66e-3)"	"unprognostic (3.32e-3)"	"unprognostic (8.00e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.64e-1)"	"unprognostic (2.02e-2)"	"unprognostic (4.08e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.06e-1)"
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305707-190322446	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 289.7;skin 1: 275.6"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 425.7;Epididymal basal cells: 2094.0;Epididymal efferent duct ciliated cells: 443.2;Fallopian secretory cells: 412.8;Ocular epithelial cells: 2742.1;Pancreatic duct cells: 502.7;Suprabasal keratinocytes: 879.7;Urothelial cells: 810.5"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 97.5;oligodendrocyte precursor cell: 31.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	8	"choroid plexus: 43.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Smooth muscle cells, Adipose visceral - Mesothelial cells, Pancreas - Ductal cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"spinal cord: 33.6"	"CAB002602, HPA048319"	Enhanced						NA	NA				"Cluster 58: Skin - Keratinization"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 100: Stratified epithelial cells - Barrier functions"	7			"CAB002602: , HPA048319: "	"unprognostic (5.06e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.36e-3)"	"unprognostic (2.84e-2)"	"potential prognostic unfavorable (1.14e-4)"	"unprognostic (1.17e-1)"	"unprognostic (3.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-1)"	"unprognostic (4.88e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.70e-2)"	"unprognostic (4.78e-2)"	"unprognostic (9.21e-2)"	"unprognostic (5.11e-3)"	"potential prognostic unfavorable (1.90e-4)"	"unprognostic (7.06e-3)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.07e-2)"	"unprognostic (4.79e-2)"
CLDN14	DFNB29	ENSG00000159261	"Claudin 14"	O95500	21	36460621-36576569	"Disease related genes, Human disease related genes, Predicted membrane proteins"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 39.4"	"Cell type enhanced"	"Detected in many"		"Distal convoluted tubule cells: 19.6;Early spermatids: 17.5;Epididymal principal cells: 43.9;Hepatocytes: 34.4;Loop of henle epithelial cells: 117.7;Myonuclei: 17.7;Pancreatic duct cells: 13.4;Plasma cells: 17.7"	"Cell type enhanced"	"Detected in some"		"endothelial cell: 3.6"	"Group enriched"	"Detected in many"	4	"Liver Hepatocellular Carcinoma (TCGA): 18.6;Skin Cutaneous Melanoma (TCGA): 5.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"lymphoma: 7.9"	"Liver - Hepatocytes, Skin - Hair cortex cells, Skin - Inner root sheath cells"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054707			Uncertain	Vesicles			NA	NA				"Cluster 31: Liver - Metabolism & Coagulation"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 21: Lymphoma - Adaptive immune response"	"Cluster 50: Renal epithelial cells - Ion transport and pH regulation"	4	Vesicles		"HPA054707: "		"unprognostic (9.14e-2)"	"unprognostic (2.57e-1)"	"potential prognostic favorable (3.29e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-1)"			"unprognostic (7.62e-2)"	"unprognostic (1.37e-1)"	"potential prognostic unfavorable (4.48e-4)"	"unprognostic (5.31e-2)"	"unprognostic (4.42e-2)"	"potential prognostic favorable (1.87e-4)"	"unprognostic (2.63e-2)"							"unprognostic (1.84e-2)"	"unprognostic (1.87e-1)"		"unprognostic (1.43e-1)"	"unprognostic (7.75e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.83e-2)"			"unprognostic (3.94e-2)"
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 59.3"	"Cell type enhanced"	"Detected in many"		"Choroid plexus epithelial cells: 83.1;Epicardial cells: 34.1;Epididymal basal cells: 122.2;Epididymal efferent duct ciliated cells: 66.7;Loop of henle epithelial cells: 89.9;Ocular epithelial cells: 194.0;Respiratory ciliated cells: 99.2"	"Cell type enhanced"	"Detected in many"		"choroid plexus epithelial cell: 64.3"	"Group enriched"	"Detected in many"	13	"Ovary Serous Cystadenocarcinoma (TCGA): 68.9;Thyroid Carcinoma (TCGA): 59.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	10	"ovarian cancer: 120.3;Uterine cancer: 175.0"	"Adipose visceral - Mesothelial cells, Adrenal gland - Adrenal cortex cells, Kidney - Ascending Loop of Henle cells, Lung - Respiratory ciliated cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced						NA	NA				"Cluster 72: Kidney - Transmembrane transport"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 15: Kidney cancer - Membrane components"	"Cluster 100: Stratified epithelial cells - Barrier functions"				"HPA056020: "	"unprognostic (5.24e-2)"			"unprognostic (8.85e-2)"							"unprognostic (4.20e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.73e-2)"					"unprognostic (3.11e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.58e-1)"	"unprognostic (8.49e-2)"		"unprognostic (5.61e-3)"							"unprognostic (3.69e-2)"	"unprognostic (3.62e-3)"
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 248.6;pancreas: 92.7;thyroid gland: 110.9"	"Cell type enhanced"	"Detected in many"		"Breast secretory cells: 680.6;Colonocytes: 2780.7;Endometrial ciliated cells: 975.5;Endometrial glandular cells: 1468.5;Endometrial luminal cells: 1459.2;Enteric stem cells: 1410.9;Enteric transient amplifying cells: 1531.7;Enterocytes: 2815.1;Fallopian tube ciliated cells: 768.0;Goblet cells: 1660.3;Paneth cells: 935.9"	"Group enriched"	"Detected in some"	4	"choroid plexus epithelial cell: 27.3;ependymal cell: 16.9"	"Cancer enhanced"	"Detected in many"		"Ovary Serous Cystadenocarcinoma (TCGA): 710.4"	"Region enriched"	"Detected in all"	8	"choroid plexus: 81.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 169.1"	"Breast - Breast glandular cells, Colon - Colon enterocytes, Minor Salivary Gland - Minor salivary glandular cells, Prostate - Prostate glandular cells, Skin - Eccrine sweat gland cells, Stomach - Gastric enteroendocrine cells"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"					HPA014361	Enhanced		Supported	"Cell Junctions"			NA	NA				"Cluster 17: Intestine - Digestion"	"Cluster 36: Choroid plexus - Mixed function"	"Cluster 57: Stomach & Colon cancer - Digestion"	"Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier"		"Cell Junctions"		"HPA014361: "	"unprognostic (1.55e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.79e-1)"	"potential prognostic favorable (6.55e-4)"	"unprognostic (2.58e-1)"	"unprognostic (8.50e-3)"			"unprognostic (8.09e-2)"	"potential prognostic favorable (8.51e-6)"	"potential prognostic favorable (6.29e-5)"	"unprognostic (7.53e-3)"	"potential prognostic favorable (3.39e-5)"	"unprognostic (3.00e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.77e-1)"	"unprognostic (9.94e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.86e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.58e-1)"		"unprognostic (3.00e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.58e-2)"	"unprognostic (9.35e-3)"
CLDN6		ENSG00000184697	"Claudin 6"	P56747	16	3014712-3020071	"Predicted intracellular proteins, Predicted membrane proteins"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.0;pancreas: 1.0"	"Group enriched"	"Detected in many"	4	"Extravillous trophoblasts: 174.3;Migrating cytotrophoblasts: 156.7"	"Low cell type specificity"	"Detected in single"			"Group enriched"	"Detected in many"	5	"Ovary Serous Cystadenocarcinoma (TCGA): 143.3;Testicular Germ Cell Tumor (TCGA): 231.0;Uterine Corpus Endometrial Carcinoma (TCGA): 67.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in many"	5	"testis cancer: 303.0"	"Pancreas - Ductal cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"										NA	NA				"Cluster 70: Non-specific - Protein processing"	"Cluster 15: Non-specific - Transcription"	"Cluster 34: Testis cancer - Unknown function"	"Cluster 21: Extravillous trophoblasts - Placental invasion & endocrine regulatio"	7				"unprognostic (4.94e-3)"	"unprognostic (2.61e-1)"		"unprognostic (1.08e-1)"					"unprognostic (1.13e-1)"						"unprognostic (3.16e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.49e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.83e-3)"					"unprognostic (1.32e-3)"	"unprognostic (1.47e-1)"		"unprognostic (2.76e-2)"
CRISP1	"AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP"	ENSG00000124812	"Cysteine rich secretory protein 1"	P54107	6	49834257-49877096	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"epididymis: 1486.0"	"Cell type enriched"	"Detected in some"	6	"Epididymal principal cells: 940.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Minor Salivary Gland - Minor salivary glandular cells, Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA028445, HPA030534"	Enhanced				"Secreted in male reproductive system"	"No annotated function"	NA	NA		16000		"Cluster 50: Epididymis - Male reproductive secretion"		"Cluster 34: Testis cancer - Unknown function"	"Cluster 30: Epididymal principal cells - Sperm storage microenvironment"				"HPA028445: , HPA030534: "																															
DDB1		ENSG00000167986	"Damage specific DNA binding protein 1"	Q16531	11	61299451-61342596	"Disease related genes, Essential proteins, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, DNA damage, DNA repair, Host-virus interaction, Ubl conjugation pathway"	DNA-binding	"Disease variant, Intellectual disability"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adrenal cortex cells: 305.7;Cytotrophoblasts: 391.0;Rod photoreceptor cells: 385.8;Syncytiotrophoblasts: 543.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032821, HPA045174, HPA068456"	Approved		Enhanced	"Nucleoplasm,Mid piece,Principal piece,End piece"			NA	NA		860000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 69: Parathyroid gland - Mixed function"	"Cluster 27: Non-specific - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 63: Cytotrophoblasts - Basic cellular functions"	307	Nucleoplasm	"Mid piece, Principal piece, End piece"	"CAB032821: , HPA045174: , HPA068456: "	"unprognostic (3.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.12e-2)"	"unprognostic (1.09e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.02e-2)"	"unprognostic (7.87e-3)"	"potential prognostic favorable (2.28e-8)"	"unprognostic (1.14e-2)"	"unprognostic (3.78e-2)"	"unprognostic (9.34e-3)"	"unprognostic (1.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.85e-2)"	"unprognostic (3.25e-1)"	"unprognostic (4.33e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.83e-1)"	"unprognostic (5.39e-2)"	"unprognostic (4.55e-2)"
DDB2	"DDBB, FLJ34321, UV-DDB2, XPE"	ENSG00000134574	"Damage specific DNA binding protein 2"	Q92466	11	47214465-47239217	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	DNA-binding	"Cancer-related genes, Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adrenal cortex cells: 120.5"	"Cell type enhanced"	"Detected in all"		"central nervous system macrophage: 79.6;leukocyte: 58.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Skin - Keratinocyte (other)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025912, HPA058406"	Enhanced		Supported	"Nucleoplasm,Cell Junctions"			NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 58: Skin - Keratinization"	"Cluster 30: White matter - Myelination"	"Cluster 40: Non-specific - Unknown function"	"Cluster 26: Keratinocytes - Keratinization"	82	"Nucleoplasm, Cell Junctions"		"CAB025912: , HPA058406: "	"unprognostic (9.99e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.60e-1)"	"unprognostic (7.66e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.54e-2)"	"potential prognostic unfavorable (3.82e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.11e-1)"	"validated prognostic favorable (2.50e-10)"	"validated prognostic favorable (1.22e-4)"	"unprognostic (3.41e-3)"	"unprognostic (5.18e-2)"	"unprognostic (7.95e-2)"	"unprognostic (9.16e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.45e-2)"	"unprognostic (9.09e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.73e-2)"	"unprognostic (4.63e-2)"	"unprognostic (3.24e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.38e-2)"	"unprognostic (4.43e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-1)"
DDX3Y	DBY	ENSG00000067048	"DEAD-box helicase 3 Y-linked"	O15523	Y	12904108-12920478	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		"DNA-binding, Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 90.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 307.2;Hematopoietic stem cells: 270.3;Late spermatids: 1005.1;Megakaryocyte-Erythroid progenitors: 211.8;Neutrophils: 257.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in many"		"Adrenocortical cancer: 140.2"		"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059583"	Enhanced	Supported	Supported	"Plasma membrane,Cytosol"			NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 44: Bone marrow - Nuclear processes"	"Cluster 31: Non-specific - Transcription"	"Cluster 47: Leukemia - Hemostasis"	"Cluster 48: Neutrophils - Phagocytosis & degranulation"	20	Cytosol	"Plasma membrane"	"HPA001648: , HPA005631: , HPA059583: "	"unprognostic (7.46e-2)"				"unprognostic (2.77e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.31e-2)"	"potential prognostic favorable (1.01e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.99e-2)"	"unprognostic (4.69e-1)"			"unprognostic (8.77e-2)"	"unprognostic (2.94e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.20e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.53e-1)"	"unprognostic (1.70e-2)"	
ENOSF1	"FUCD, HSRTSBETA, rTS, TYMSAS"	ENSG00000132199	"Enolase superfamily member 1"	Q7L5Y1	18	670318-712662	"Enzymes, Predicted intracellular proteins"		"Isomerase, Lyase"	"Dyskeratosis congenita"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"oligodendrocyte: 304.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Lung - Alveolar cells type 2, Minor Salivary Gland - Minor salivary glandular cells"					"Low region specificity"	"Detected in all"			HPA047829	Enhanced						NA	NA		3700	"Cluster 3: Non-specific - Nuclear processes"	"Cluster 72: Kidney - Transmembrane transport"	"Cluster 11: White matter - Signal transduction"	"Cluster 13: Non-specific - Mixed function"	"Cluster 7: Non-specific - Transcription"				"HPA047829: "	"unprognostic (1.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.53e-3)"	"potential prognostic favorable (5.27e-4)"	"unprognostic (9.79e-2)"	"unprognostic (7.34e-2)"	"unprognostic (4.53e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"validated prognostic favorable (3.54e-5)"	"validated prognostic favorable (1.27e-4)"	"potential prognostic favorable (1.03e-4)"	"unprognostic (2.23e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.02e-2)"	"potential prognostic favorable (2.74e-4)"	"potential prognostic favorable (9.81e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.94e-2)"	"unprognostic (4.82e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.20e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.04e-1)"
ERCC2	"EM9, MAG, MGC102762, MGC126218, MGC126219, XPD"	ENSG00000104884	"ERCC excision repair 2, TFIIH core complex helicase subunit"	P18074	19	45349837-45370918	"Cancer-related genes, Disease related genes, Enzymes, Essential proteins, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Chromosome partition, DNA damage, DNA repair, Host-virus interaction, Transcription, Transcription regulation"	"DNA-binding, Helicase, Hydrolase, Isomerase"	"Cancer-related genes, Cataract, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Ichthyosis, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early primary spermatocytes: 48.9;Oocytes: 115.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Adipose visceral - Adipose progenitor cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005375, HPA038057, HPA069266"	Approved		Supported	Nucleoplasm,Cytosol			NA	NA			"Cluster 13: Non-specific - Mitochondria"	"Cluster 67: Testis - Mixed function"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 41: Oocytes - Oogenesis"	38	Nucleoplasm	Cytosol	"CAB005375: , HPA038057: , HPA069266: "	"unprognostic (1.11e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.97e-2)"	"unprognostic (9.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.75e-3)"	"unprognostic (1.98e-2)"	"potential prognostic favorable (4.09e-5)"	"unprognostic (4.11e-2)"	"potential prognostic favorable (9.44e-4)"	"unprognostic (2.92e-3)"	"unprognostic (2.31e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.89e-2)"	"unprognostic (8.02e-3)"	"unprognostic (3.23e-3)"	"unprognostic (3.05e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.66e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.04e-1)"	"unprognostic (8.41e-2)"	"unprognostic (3.25e-3)"	"unprognostic (4.52e-2)"
ERCC5	"ERCM2, XPGC"	ENSG00000134899	"ERCC excision repair 5, endonuclease"	P28715	13	102845831-102875995	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Endonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Cockayne syndrome, Deafness, Disease variant, Dwarfism, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 25.7;Bergmann glia: 39.3;Brain excitatory neurons: 42.7;Brain inhibitory neurons: 44.2;Choroid plexus epithelial cells: 35.6;Ependymal cells: 15.8;Microglia: 49.0;Oligodendrocyte progenitor cells: 34.1;Oligodendrocytes: 45.0;Other brain neurons: 35.9"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045845, HPA050374"	Supported		Supported	Nucleoplasm			NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 26: Kidney & Intestine - Metabolism"	"Cluster 6: Non-specific - Immune response"	"Cluster 19: Non-specific - Unknown function"	"Cluster 22: Non-specific - Basic cellular functions"	15	Nucleoplasm		"HPA045845: , HPA050374: "	"unprognostic (1.49e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.91e-2)"	"unprognostic (6.49e-2)"	"unprognostic (8.89e-2)"	"unprognostic (9.17e-2)"	"potential prognostic favorable (8.18e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-1)"	"validated prognostic favorable (4.22e-7)"	"validated prognostic favorable (3.12e-4)"	"unprognostic (9.13e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.08e-2)"	"unprognostic (9.11e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.39e-2)"	"unprognostic (2.75e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.63e-2)"	"unprognostic (8.43e-2)"
GTF2H5	"bA120J8.2, C6orf175, FLJ30544, TFB5, TFIIH, TTD, TTD-A, TTDA"	ENSG00000272047	"General transcription factor IIH subunit 5"	Q6ZYL4	6	158168350-158199344	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 355.7;Esophageal apical cells: 475.2;Esophageal suprabasal cells: 392.1;Late primary spermatocytes: 494.9;Parietal cells: 397.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Early spermatids, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"										NA	NA			"Cluster 13: Non-specific - Mitochondria"	"Cluster 48: Ciliated tissues - Cilium organization"	"Cluster 31: Non-specific - Transcription"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 97: Non-specific - Cellular respiration"	32				"unprognostic (8.17e-2)"	"potential prognostic unfavorable (9.36e-4)"	"unprognostic (2.51e-1)"	"unprognostic (4.66e-3)"	"unprognostic (2.36e-1)"	"unprognostic (2.25e-3)"	"unprognostic (9.78e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-3)"	"unprognostic (4.17e-3)"	"unprognostic (4.65e-2)"	"unprognostic (3.41e-3)"	"unprognostic (8.31e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.19e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.08e-1)"		"unprognostic (1.91e-2)"	"unprognostic (4.26e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.66e-1)"
HAND1	"bHLHa27, eHand, Hxt, Thing1"	ENSG00000113196	"Heart and neural crest derivatives expressed 1"	O96004	5	154474972-154478227	"Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 23.1;intestine: 63.4"	"Cell type enriched"	"Detected in some"	4	"Smooth muscle cells: 12.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Testicular Germ Cell Tumor (TCGA): 5.2"	"Region enriched"	"Detected in single"	4	"thalamus: 3.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"Neuroblastoma: 88.8;testis cancer: 195.7"	"Adrenal gland - Adrenal medulla cells, Heart muscle - Cardiomyocytes"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA040925, HPA075313"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"			NA	NA				"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 38: Sub-cortical - Mixed function"	"Cluster 59: Leukemia - T-cell receptor"	"Cluster 108: Fibroblasts - ECM organization"	5	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA040925: , HPA075313: "	"unprognostic (1.53e-1)"					"unprognostic (1.18e-1)"																				"unprognostic (1.41e-1)"			"unprognostic (5.41e-2)"		
HAND2	"bHLHa26, dHand, Hed, Thing2"	ENSG00000164107	"Heart and neural crest derivatives expressed 2"	P61296	4	173524969-173530229	"Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 101.2"	"Cell type enhanced"	"Detected in some"		"Adrenal medulla cells: 180.8;Decidual stromal cells: 211.2;Endometrial stromal cells: 270.0;Epicardial cells: 70.5;Hepatic stellate cells: 77.5;Ovarian stromal cells: 93.4;Schwann cells: 158.3;Smooth muscle cells: 53.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Pancreatic Adenocarcinoma (TCGA): 9.1;Stomach Adenocarcinoma (TCGA): 8.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	16	"Neuroblastoma: 313.4"	"Adrenal gland - Adrenal medulla cells, Breast - Fibroblasts, Heart muscle - Cardiomyocytes, Liver - Hepatic stellate cells"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA019591, CAB025576"	Approved		Approved	Nucleoplasm,Vesicles			NA	NA				"Cluster 12: Smooth muscle tissue - ECM organization"	"Cluster 35: Non-specific - DNA binding"	"Cluster 17: Neuroblastoma - Neuronal signaling"	"Cluster 108: Fibroblasts - ECM organization"	9	Nucleoplasm	Vesicles	"CAB025576: , HPA019591: "	"unprognostic (4.66e-3)"		"unprognostic (1.20e-1)"		"unprognostic (3.17e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.86e-2)"							"unprognostic (2.68e-3)"					"unprognostic (1.54e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.70e-1)"			"unprognostic (1.95e-2)"		"unprognostic (2.19e-2)"	"unprognostic (1.89e-1)"		"unprognostic (5.84e-2)"
IL13	"ALRH, BHR1, IL-13, MGC116786, MGC116788, MGC116789, P600"	ENSG00000169194	"Interleukin 13"	P35225	5	132656263-132661110	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	45	"testis: 23.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 90.7;Late primary spermatocytes: 138.5;Late spermatids: 375.5;Mast cells: 87.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	45	"lymphoma: 4.8"	"Testis - Early spermatids, Testis - Late spermatids"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	Interleukin	NA	NA	40000			"Cluster 23: Testis - Spermatogenesis"		"Cluster 59: Leukemia - T-cell receptor"	"Cluster 23: Elongating spermatids - Sperm cell metabolism & fertilization"	10																																		
IL4	"BCGF-1, BCGF1, BSF1, IL-4, MGC79402"	ENSG00000113520	"Interleukin 4"	P05112	5	132673986-132682678	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"B-cell activation"	"Cytokine, Growth factor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Epicardial cells: 2.3;Kupffer cells: 1.0;Retinal amacrine cells: 2.6;Retinal horizontal cells: 2.0;T-cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	862	"basophil: 476.8"	"Lineage enriched"	"Detected in single"	862	"granulocytes: 476.8"	"Cancer enhanced"	"Detected in single"		"lymphoma: 1.8"		"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA072995, CAB078477"	Approved				"Secreted to blood"	Interleukin	NA	NA	13600		"Cluster 46: Basophils - Proteolysis"		"Cluster 10: Cerebellum - Nucleic acid binding"	"Cluster 50: Lymphoma - Unknown function"	"Cluster 9: T-cells - Adaptive immunity: Regulation"	3			"CAB078477: , HPA072995: "																															
LIG4		ENSG00000174405	"DNA ligase 4"	P49917	13	108207439-108218368	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA recombination, DNA repair"	Ligase	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001334, HPA057325"	Approved		Supported	Nucleoplasm,Vesicles			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 32: Retina & Lymphoid tissues - Signaling"	"Cluster 23: Choroid plexus - Mixed function"	"Cluster 19: Non-specific - Unknown function"	"Cluster 48: Neutrophils - Phagocytosis & degranulation"	41	Nucleoplasm	Vesicles	"HPA001334: , HPA057325: "	"unprognostic (9.10e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.59e-2)"	"unprognostic (8.79e-2)"	"unprognostic (2.11e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.17e-1)"	"unprognostic (5.53e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.15e-2)"	"potential prognostic favorable (5.29e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.20e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.63e-1)"	"unprognostic (5.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.24e-1)"	"unprognostic (2.54e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.14e-1)"
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.2"	"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Thyroid gland - Thyroid glandular cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles			NA	NA			"Cluster 20: Non-specific - DNA binding"	"Cluster 4: Adrenal gland - Steroid metabolism"	"Cluster 25: Non-specific - Transcription"	"Cluster 28: Non-specific - Nuclear processes"	"Cluster 87: B-cells - Adaptive immunity: Humoral response"	4	Vesicles		"HPA016491: , HPA019547: "	"unprognostic (4.34e-2)"	"unprognostic (9.87e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.98e-1)"	"potential prognostic unfavorable (3.09e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.19e-2)"	"potential prognostic favorable (3.48e-9)"	"unprognostic (4.08e-3)"	"unprognostic (9.34e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.67e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.53e-1)"	"unprognostic (9.41e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.83e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.07e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.27e-2)"
MMAB	"cblB, CFAP23"	ENSG00000139428	"Metabolism of cobalamin associated B"	Q96EY8	12	109553715-109573580	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 105.3"	"Cell type enhanced"	"Detected in many"		"Breast lactating cells: 202.3;Esophageal apical cells: 162.7;Hepatocytes: 220.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Liver - Hepatocytes, Prostate - Prostate glandular cells, Skin - Sebaceous gland cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039017	Supported		Approved	Mitochondria			NA	NA		43000	"Cluster 30: Non-specific - DNA binding"	"Cluster 70: Non-specific - Protein processing"	"Cluster 30: White matter - Myelination"	"Cluster 35: RS4;11 - Unknown function"	"Cluster 25: Hepatocytes - Plasma protein synthesis & secretion"	19	Mitochondria		"HPA039017: "	"unprognostic (2.27e-2)"	"unprognostic (6.90e-3)"	"unprognostic (4.06e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.42e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.17e-2)"	"unprognostic (8.60e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.57e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.25e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.36e-2)"
MRE11	"ATLD, MRE11A"	ENSG00000020922	"MRE11 homolog, double strand break repair nuclease"	P49959	11	94415570-94493885	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction, Meiosis"	"Endonuclease, Exonuclease, Hydrolase, Nuclease"	"Cancer-related genes, Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Skeletal muscle - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002691, CAB004081"	Supported		Enhanced	Nucleoplasm			NA	NA		4000	"Cluster 5: Non-specific - Cell proliferation"	"Cluster 54: Non-specific - Ribosome"	"Cluster 46: Brainstem - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 7: Non-specific - Transcription"	83	Nucleoplasm		"CAB004081: , HPA002691: "	"unprognostic (1.13e-1)"	"unprognostic (1.78e-3)"		"unprognostic (8.41e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.48e-2)"	"unprognostic (2.47e-2)"	"potential prognostic unfavorable (3.17e-4)"		"potential prognostic unfavorable (5.64e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-2)"	"unprognostic (4.71e-3)"	"unprognostic (9.70e-3)"	"unprognostic (2.49e-3)"	"potential prognostic favorable (4.59e-5)"	"unprognostic (7.60e-3)"	"unprognostic (6.94e-3)"	"unprognostic (3.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.43e-1)"
MTR	cblG	ENSG00000116984	"5-methyltetrahydrofolate-homocysteine methyltransferase"	Q99707	1	236795260-236921278	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"	"Amino-acid biosynthesis, Methionine biosynthesis"	"Methyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal convoluted tubule cells: 454.8;Renal collecting duct intercalated cells: 835.5;Renal collecting duct principal cells: 503.8;Renal connecting tubule cells: 486.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054915	Approved		Approved	"Microtubules,Cytokinetic bridge,Primary cilium,Basal body,Cytosol"			Yes	NA			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 72: Kidney - Transmembrane transport"	"Cluster 30: White matter - Myelination"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 50: Renal epithelial cells - Ion transport and pH regulation"	13	"Microtubules, Primary cilium"	"Cytokinetic bridge, Basal body, Cytosol"	"HPA054915: "	"unprognostic (2.30e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.15e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.29e-1)"	"potential prognostic favorable (7.87e-6)"	"unprognostic (3.29e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.20e-1)"	"unprognostic (9.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.90e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.80e-3)"	"unprognostic (4.82e-1)"	"unprognostic (2.08e-3)"	"unprognostic (8.46e-2)"
MUS81	"FLJ44872, SLX3"	ENSG00000172732	"MUS81 structure-specific endonuclease subunit"	Q96NY9	11	65857126-65867653	"Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.7;Late spermatids: 263.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059530	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center"			NA	NA			"Cluster 45: Eosinophils - Unknown function"	"Cluster 64: Non-specific - Transcription"	"Cluster 6: Non-specific - Immune response"	"Cluster 24: Non-specific - Unknown function"	"Cluster 33: Early spermatids - Spermiogenesis: Cap phase"	25	"Nucleoli fibrillar center"	Nucleoplasm	"HPA059530: "	"unprognostic (1.71e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.09e-2)"	"unprognostic (1.70e-1)"	"validated prognostic favorable (6.46e-4)"	"validated prognostic favorable (3.33e-4)"	"unprognostic (1.52e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.90e-1)"	"potential prognostic unfavorable (6.26e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.90e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.22e-2)"	"potential prognostic favorable (2.68e-4)"	"unprognostic (1.44e-1)"	"unprognostic (8.98e-2)"	"unprognostic (3.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.92e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.86e-1)"
NEIL2	"FLJ31644, MGC2832, MGC4505, NEH2"	ENSG00000154328	"Nei like DNA glycosylase 2"	Q969S2	8	11769639-11787345	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Glycosidase, Hydrolase, Lyase, Multifunctional enzyme"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 7.0;Brain excitatory neurons: 10.8;Brain inhibitory neurons: 10.7;Choroid plexus epithelial cells: 7.9;Ependymal cells: 7.4;Microglia: 7.8;Oligodendrocyte progenitor cells: 9.0;Oligodendrocytes: 6.6;Other brain neurons: 17.7;Papillary tip epithelial cells: 5.7;Proximal tubule cells: 6.7;Renal collecting duct principal cells: 7.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - B-cells (Spleen), Testis - Spermatogonia"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA073029, HPA073916"			Supported	Nucleoplasm,Vesicles			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 36: Brain & Liver - Signaling"	"Cluster 41: Monoamines - Neurotransmitter signalling"	"Cluster 40: Non-specific - Unknown function"	"Cluster 98: Neurons - Neurotransmission & signaling"	9	Nucleoplasm	Vesicles	"HPA073029: , HPA073916: "	"unprognostic (3.90e-3)"	"unprognostic (1.07e-1)"	"potential prognostic favorable (4.90e-4)"	"unprognostic (5.17e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.18e-3)"	"unprognostic (6.28e-3)"	"unprognostic (3.12e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.78e-2)"	"unprognostic (6.73e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.07e-1)"	"unprognostic (7.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (7.67e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.94e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.84e-1)"	"potential prognostic favorable (4.63e-4)"
NICN1	MGC12936	ENSG00000145029	"Nicolin 1, tubulin polyglutamylase complex subunit"	Q9BSH3	3	49422333-49429326	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Astrocytes: 2.4;Bergmann glia: 3.1;Brain excitatory neurons: 2.8;Brain inhibitory neurons: 2.9;Choroid plexus epithelial cells: 1.8;Ependymal cells: 1.9;Microglia: 2.8;Oligodendrocyte progenitor cells: 2.5;Oligodendrocytes: 1.9;Other brain neurons: 2.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 20.4"	"Skeletal muscle - Fibroblasts, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058014			Supported	Nucleoplasm			NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 65: Brain - Transcription"	"Cluster 51: Neurons - Mixed function"	"Cluster 8: Non-specific - Basic cellular processes"	"Cluster 98: Neurons - Neurotransmission & signaling"	11	Nucleoplasm		"HPA058014: "	"unprognostic (1.35e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.85e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.77e-1)"	"unprognostic (4.84e-2)"	"unprognostic (1.50e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.84e-1)"	"validated prognostic favorable (3.51e-4)"	"validated prognostic favorable (7.55e-6)"	"potential prognostic favorable (2.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (5.77e-2)"	"unprognostic (4.45e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.61e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.27e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.29e-2)"	"unprognostic (5.25e-1)"
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 546.5;Endometrial stromal cells: 339.2;Fibro-adipogenic progenitors: 371.6;Hofbauer cells: 616.3;Kupffer cells: 469.4;Macrophages: 453.0;Medullary thymic epithelial cells: 410.4;pDCs: 321.7;Pericytes: 357.2;Proximal tubule cells: 611.9;Vascular endothelial cells: 593.1"	"Cell type enhanced"	"Detected in all"		"hippocampal CA4: 1340.3;hippocampal dentate gyrus: 669.1"	"Cancer enhanced"	"Detected in all"		"Kidney Renal Clear Cell Carcinoma (TCGA): 170.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 39.4"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 39.4"	"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Endothelial cells, Adipose visceral - Endothelial cells, Adrenal gland - Fibroblasts, Breast - Endothelial cells, Prostate - Endothelial cells, Skeletal muscle - Fibroblasts"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved		Uncertain	Mitochondria	"Secreted in other tissues"	Receptor	NA	NA		270000000	"Cluster 8: Plasmacytoid DCs - Unknown function"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 29: Forebrain - Mixed function"	"Cluster 72: Neuronal - Signal transduction"	"Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis"	32	Mitochondria		"CAB004511: , HPA030278: "	"unprognostic (1.03e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.50e-1)"	"potential prognostic unfavorable (2.16e-6)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.99e-2)"	"validated prognostic favorable (4.67e-7)"	"validated prognostic favorable (4.70e-4)"	"unprognostic (1.42e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.60e-1)"	"unprognostic (1.66e-1)"	"potential prognostic unfavorable (1.36e-4)"	"unprognostic (2.31e-2)"	"unprognostic (3.57e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"potential prognostic unfavorable (1.01e-4)"	"unprognostic (8.75e-2)"	"unprognostic (9.60e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.83e-2)"	"potential prognostic unfavorable (3.33e-5)"	"unprognostic (9.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (3.49e-1)"
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528520	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"	Hydrolase	"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 158.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells, Testis - Spermatocytes"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes			NA	NA			"Cluster 24: Non-specific - Transcription"	"Cluster 38: Non-specific - Basic cellular processes"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 39: Non-specific - Transcription"	"Cluster 60: Cardiomyocytes - Cardiac muscle contraction & structure"	60	Peroxisomes		"HPA020235: "	"unprognostic (3.74e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"unprognostic (5.28e-3)"	"potential prognostic favorable (2.12e-7)"	"unprognostic (1.85e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.97e-2)"	"unprognostic (4.93e-1)"	"unprognostic (6.34e-2)"	"unprognostic (6.82e-2)"	"unprognostic (8.68e-3)"	"unprognostic (7.36e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-1)"	"potential prognostic unfavorable (7.98e-4)"	"unprognostic (3.56e-2)"
PEX16		ENSG00000121680	"Peroxisomal biogenesis factor 16"	Q9Y5Y5	11	45909663-45918812	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enterocytes: 93.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Minor Salivary Gland - Minor salivary glandular cells, Skin - Sebaceous gland cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043286	Approved						NA	NA			"Cluster 6: T-cells - T-cell receptor"	"Cluster 68: Non-specific - Basic cellular processes"	"Cluster 27: Non-specific - Mixed function"	"Cluster 24: Non-specific - Unknown function"	"Cluster 45: Colonocytes & Enterocytes - Gastrointestinal absorption & barrier"	28			"HPA043286: "	"unprognostic (5.74e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.31e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.01e-2)"	"unprognostic (7.08e-2)"	"potential prognostic favorable (3.60e-4)"	"unprognostic (1.06e-3)"	"unprognostic (2.58e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.20e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.32e-1)"	"unprognostic (6.54e-3)"	"unprognostic (3.23e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.78e-1)"	"unprognostic (6.34e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.46e-1)"
PEX26	FLJ20695	ENSG00000215193	"Peroxisomal biogenesis factor 26"	Q7Z412	22	18077923-18105396	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 12.3;Bergmann glia: 15.0;Brain excitatory neurons: 21.2;Brain inhibitory neurons: 21.1;Choroid plexus epithelial cells: 31.1;Distal convoluted tubule cells: 27.6;Ependymal cells: 12.5;Loop of henle epithelial cells: 28.7;Microglia: 23.3;Oligodendrocyte progenitor cells: 15.1;Oligodendrocytes: 18.4;Other brain neurons: 17.8;Papillary tip epithelial cells: 19.3;Podocytes: 21.9;Proximal tubule cells: 34.3;Renal collecting duct intercalated cells: 30.6;Renal collecting duct principal cells: 23.7;Renal connecting tubule cells: 29.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070429	Approved						NA	NA			"Cluster 33: Non-specific - ATP binding"	"Cluster 77: Intestine - Digestion"	"Cluster 32: Cerebral cortex - Mixed function"	"Cluster 66: Non-specific - Mitochondria"	"Cluster 102: Non-specific - Mixed function"	35			"CAB070429: "	"unprognostic (1.58e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.35e-3)"	"potential prognostic favorable (1.11e-5)"	"unprognostic (2.62e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.73e-3)"	"unprognostic (1.20e-1)"	"unprognostic (5.86e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.61e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.05e-1)"	"unprognostic (8.64e-3)"	"unprognostic (4.17e-2)"	"unprognostic (3.56e-2)"	"unprognostic (4.42e-2)"
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576185-43620523	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipose progenitor cells, Testis - Early spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm			NA	Yes			"Cluster 3: Non-specific - Nuclear processes"	"Cluster 32: Retina & Lymphoid tissues - Signaling"	"Cluster 6: Non-specific - Immune response"	"Cluster 46: Lymphoma - Humoral immune response"	"Cluster 65: Non-specific - Cell growth & division"	31	Nucleoplasm		"HPA006721: , HPA026762: "	"unprognostic (3.89e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.76e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.10e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.01e-1)"	"validated prognostic favorable (1.86e-4)"	"validated prognostic favorable (2.00e-5)"	"unprognostic (4.10e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.83e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.71e-1)"
POLR3D	"BN51T, C53, RPC4, TSBN51"	ENSG00000168495	"RNA polymerase III subunit D"	P05423	8	22245133-22254601	"Essential proteins, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	"Antiviral defense, Immunity, Innate immunity, Transcription"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late primary spermatocytes: 74.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Adrenal cortex cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061331, HPA067875, HPA068461, HPA069089"	Supported		Enhanced	Nucleoplasm			NA	NA			"Cluster 14: Non-specific - Unknown function"	"Cluster 63: Non-specific - Basic cellular processes"	"Cluster 42: Choroid plexus - Mitochondria"	"Cluster 40: Non-specific - Unknown function"	"Cluster 17: Non-specific - RNA processing"	83	Nucleoplasm		"HPA061331: , HPA067875: , HPA068461: , HPA069089: "	"unprognostic (1.11e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.12e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.07e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.60e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.85e-3)"	"unprognostic (7.62e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.14e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.26e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.80e-2)"	"unprognostic (9.32e-2)"
PROK1	"EGVEGF, PK1, PRK1"	ENSG00000143125	"Prokineticin 1"	P58294	1	110451149-110457358	"Predicted secreted proteins"	Angiogenesis	"Growth factor, Mitogen"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 190.8;placenta: 47.2;testis: 56.2"	"Cell type enhanced"	"Detected in some"		"Granulosa cells: 160.6;Leydig cells: 193.6;Ovarian stromal cells: 82.0;Peritubular myoid cells: 620.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"Prostate Adenocarcinoma (TCGA): 4.7;Testicular Germ Cell Tumor (TCGA): 7.7"	"Region enhanced"	"Detected in many"		"medulla oblongata: 10.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.3;Rhabdoid: 1.2"	"Colon - Colon enteroendocrine cells"	"Region enriched"	"Detected in single"	11	"pons and medulla: 1.4"	"Low region specificity"	"Detected in many"								"Secreted to blood"	"Growth factor"	NA	NA				"Cluster 75: Ovary - Mixed function"	"Cluster 43: Hindbrain - Mixed function"	"Cluster 44: Connective tissue cells - ECM organization"	"Cluster 94: Gonadal somatic cells - Mixed function"						"unprognostic (1.75e-1)"					"unprognostic (1.67e-2)"	"unprognostic (4.72e-2)"						"unprognostic (3.40e-3)"	"unprognostic (7.33e-2)"					"unprognostic (1.03e-1)"	"unprognostic (5.49e-2)"			"potential prognostic favorable (8.92e-4)"					"unprognostic (1.86e-1)"		
RAB27A	"GS2, HsT18676, RAB27, RAM"	ENSG00000069974	"RAB27A, member RAS oncogene family"	P51159	15	55202966-55319113	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	Exocytosis	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"stomach 1: 114.2"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 417.3;Foveolar cells: 312.8;Goblet cells: 376.3;Neutrophil progenitors: 1540.7;Neutrophils: 1394.0"	"Cell type enhanced"	"Detected in all"		"leukocyte: 257.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 262.4"	"Low lineage specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"skin cancer: 102.5"	"Kidney - Endothelial cells, Prostate - Prostate glandular cells, Skeletal muscle - Endothelial cells, Spleen - Neutrophils_2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001333, CAB034046"	Enhanced		Approved	"Mid piece,Principal piece"			NA	NA			"Cluster 42: Non-specific - Vesicular transport"	"Cluster 17: Intestine - Digestion"	"Cluster 44: Non-specific - Mixed function"	"Cluster 9: Skin cancer - Melanin biosynthesis"	"Cluster 37: Neutrophil progenitors - Granulopoiesis"	30	"Mid piece, Principal piece"		"CAB034046: , HPA001333: "	"unprognostic (3.26e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.74e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.26e-1)"	"potential prognostic unfavorable (2.45e-5)"	"unprognostic (1.90e-3)"	"unprognostic (1.43e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.93e-2)"	"unprognostic (7.69e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (8.97e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.51e-1)"	"potential prognostic unfavorable (8.35e-4)"	"unprognostic (4.90e-2)"	"unprognostic (2.06e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.00e-3)"
RAD23B	"HHR23B, HR23B, P58"	ENSG00000119318	"RAD23 homolog B, nucleotide excision repair protein"	P54727	9	107283137-107332192	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2069.5;Neutrophils: 668.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Liver - Hepatocytes, Testis - Early spermatids, Testis - Late spermatids"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029718, HPA029720, CAB033868"	Enhanced		Supported	Nucleoplasm,Cytosol			No	No		4800000	"Cluster 24: Non-specific - Transcription"	"Cluster 63: Non-specific - Basic cellular processes"	"Cluster 16: Non-specific - Transcription"	"Cluster 43: Non-specific - Basic cellular processes"	"Cluster 48: Neutrophils - Phagocytosis & degranulation"	72	Nucleoplasm	Cytosol	"CAB033868: , HPA029718: , HPA029720: "	"unprognostic (1.22e-1)"	"unprognostic (1.41e-3)"	"unprognostic (1.87e-1)"	"unprognostic (7.12e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.28e-2)"	"potential prognostic favorable (1.32e-6)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.69e-3)"	"potential prognostic unfavorable (1.58e-4)"	"unprognostic (1.64e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.67e-2)"	"unprognostic (8.11e-3)"	"unprognostic (7.83e-3)"	"unprognostic (4.10e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.88e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.44e-2)"
RAD52		ENSG00000002016	"RAD52 homolog, DNA repair protein"	P43351	12	911736-990053	"Cancer-related genes, Predicted intracellular proteins"	"DNA damage, DNA recombination, DNA repair"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 113.9;Epicardial cells: 127.4;Myonuclei: 144.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028957			Approved	"Nuclear speckles,Plasma membrane"			NA	NA			"Cluster 5: Non-specific - Cell proliferation"	"Cluster 63: Non-specific - Basic cellular processes"	"Cluster 11: White matter - Signal transduction"	"Cluster 38: Non-specific - Transcription"	"Cluster 36: Skeletal myocytes - Muscle excitation & contraction"	24	"Nuclear speckles"	"Plasma membrane"	"HPA028957: "	"unprognostic (1.69e-1)"	"unprognostic (6.64e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.28e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.70e-3)"	"unprognostic (7.64e-2)"	"potential prognostic unfavorable (1.65e-5)"	"unprognostic (2.98e-3)"	"unprognostic (6.54e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.04e-1)"	"unprognostic (6.36e-2)"	"unprognostic (8.19e-2)"	"unprognostic (4.29e-3)"	"unprognostic (8.84e-3)"	"unprognostic (4.05e-1)"	"potential prognostic favorable (7.14e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.70e-2)"	"unprognostic (4.71e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.22e-1)"
RBMS2	SCR3	ENSG00000076067	"RNA binding motif single stranded interacting protein 2"	Q15434	12	56521820-56596193	"Plasma proteins, Predicted intracellular proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 231.4;Vascular endothelial cells: 234.8"	"Cell type enhanced"	"Detected in all"		"endothelial cell: 368.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 4.7"	"Low lineage specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Heart muscle - Endothelial cells, Kidney - Endothelial cells, Lung - Endothelial cells, Pituitary gland - Endothelial cells, Skeletal muscle - Endothelial cells, Spleen - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039225, HPA058784"	Approved		Approved	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 14: Adipose tissue - Angiogenesis"	"Cluster 47: Endothelial cells - Vasculature"	"Cluster 53: Squamous epithelial cells - Keratinization"	"Cluster 12: Endothelial cells - Angiogenesis & vascular homeostasis"	98	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"HPA039225: , HPA058784: "	"unprognostic (1.49e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.47e-3)"	"unprognostic (9.52e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.23e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.70e-2)"	"unprognostic (8.41e-3)"	"validated prognostic favorable (5.32e-7)"	"validated prognostic favorable (1.15e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.57e-3)"	"unprognostic (3.38e-2)"	"unprognostic (3.87e-2)"	"unprognostic (9.30e-2)"	"unprognostic (3.58e-3)"	"potential prognostic unfavorable (9.86e-4)"	"unprognostic (1.82e-2)"	"unprognostic (4.14e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.39e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.99e-1)"	"unprognostic (6.82e-2)"
RFXANK	"ANKRA1, BLS, F14150_1, MGC138628, RFX-B"	ENSG00000064490	"Regulatory factor X associated ankyrin containing protein"	O14593	19	19192229-19201869	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Esophageal apical cells: 112.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049157, HPA053330"	Approved		Enhanced	Nucleoplasm			NA	NA			"Cluster 29: Non-specific - Unknown function"	"Cluster 68: Non-specific - Basic cellular processes"	"Cluster 19: Astrocytes - Mixed function"	"Cluster 23: Non-specific - Transcription"	"Cluster 97: Non-specific - Cellular respiration"	76	Nucleoplasm		"HPA049157: , HPA053330: "	"unprognostic (3.51e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.97e-2)"	"unprognostic (5.74e-2)"	"unprognostic (5.94e-2)"	"unprognostic (3.42e-3)"	"unprognostic (1.19e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.61e-3)"	"unprognostic (3.18e-1)"	"unprognostic (2.62e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.78e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.56e-2)"	"unprognostic (9.50e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.09e-1)"
RFXAP		ENSG00000133111	"Regulatory factor X associated protein"	O00287	13	36819222-36829104	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"		DNA-binding	"Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Testis - Spermatocytes, Testis - Spermatogonia"	"Low region specificity"	"Detected in all"							HPA032035			Supported	"Nuclear speckles"			NA	NA			"Cluster 22: Eosinophils - Transcription"	"Cluster 61: Non-specific - Transcription"	"Cluster 2: Neurons - Nucleosome"	"Cluster 19: Non-specific - Unknown function"	"Cluster 7: Non-specific - Transcription"	8	"Nuclear speckles"		"HPA032035: "	"unprognostic (6.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.92e-1)"	"potential prognostic unfavorable (9.50e-4)"	"unprognostic (4.96e-2)"	"potential prognostic favorable (3.48e-4)"	"unprognostic (6.36e-3)"	"unprognostic (1.23e-3)"		"unprognostic (4.88e-2)"	"potential prognostic favorable (8.39e-5)"	"unprognostic (8.71e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.44e-2)"	"potential prognostic unfavorable (1.48e-5)"	"unprognostic (2.30e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.09e-1)"	"potential prognostic favorable (1.69e-4)"	"unprognostic (1.63e-3)"	"unprognostic (7.00e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.88e-2)"
SELL	"CD62L, hLHRc, LAM-1, LAM1, Leu-8, LNHR, LSEL, Lyam-1, LYAM1, PLNHR"	ENSG00000188404	"Selectin L"	P14151	1	169690665-169711702	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 142.1;lymphoid tissue: 216.7"	"Cell type enriched"	"Detected in many"	4	"Neutrophils: 1390.5"	"Cell type enriched"	"Detected in some"	5	"leukocyte: 58.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Leukemia: 34.0;lymphoma: 29.2;Myeloma: 15.1"	"Adipose visceral - Neutrophils, Heart muscle - Neutrophils, Liver - Neutrophils, Lung - Neutrophils_2, Skeletal muscle - Neutrophils, Spleen - Neutrophils_2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB002144, HPA051972"	Enhanced		Uncertain	Cytosol			NA	NA		1100000000	"Cluster 35: Neutrophils - Protein binding"	"Cluster 18: Lymphoid tissue - Immune response"	"Cluster 28: Oligodendrocytes - Mixed function"	"Cluster 55: Lymphoma - Immune response"	"Cluster 48: Neutrophils - Phagocytosis & degranulation"	1	Cytosol		"CAB002144: , HPA051972: "	"unprognostic (7.76e-2)"	"potential prognostic favorable (7.41e-4)"	"unprognostic (1.73e-2)"	"potential prognostic favorable (9.69e-4)"	"unprognostic (3.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.89e-3)"	"unprognostic (1.75e-3)"	"unprognostic (1.57e-3)"	"unprognostic (4.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"potential prognostic unfavorable (5.33e-4)"	"potential prognostic favorable (5.49e-4)"	"unprognostic (1.47e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.86e-2)"	"unprognostic (6.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (3.70e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.78e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.77e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"
UBA1	"A1S9T, CFAP124, GXP1, POC20, UBE1, UBE1X"	ENSG00000130985	"Ubiquitin like modifier activating enzyme 1"	P22314	X	47190861-47215128	"Cancer-related genes, Disease related genes, Enzymes, Essential proteins, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Ligase	"Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Esophageal apical cells: 225.2"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000289, HPA001506, CAB019435, CAB073410"	Approved		Supported	Nucleoplasm,Cytosol			NA	NA		16000000	"Cluster 37: Monocytes & Neutrophils - Innate immune response"	"Cluster 68: Non-specific - Basic cellular processes"	"Cluster 21: Non-specific - Metabolism"	"Cluster 36: Non-specific - mRNA processing"	"Cluster 17: Non-specific - RNA processing"	95	Nucleoplasm	Cytosol	"CAB019435: , CAB073410: , HPA000289: , HPA001506: "	"unprognostic (1.40e-1)"	"unprognostic (4.36e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.13e-1)"	"potential prognostic unfavorable (6.78e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.48e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.32e-1)"	"potential prognostic unfavorable (6.10e-4)"	"unprognostic (3.88e-1)"	"unprognostic (4.68e-2)"	"unprognostic (4.49e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.24e-2)"	"unprognostic (2.54e-1)"
UBE2T	"FANCT, HSPC150"	ENSG00000077152	"Ubiquitin conjugating enzyme E2 T"	Q9NPD8	1	202331544-202341984	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase	"Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 44.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 88.1;Differentiating spermatogonia: 90.1;Early primary spermatocytes: 137.2;Enteric transient amplifying cells: 69.7;Erythrocyte progenitors: 91.4;Esophageal basal cells: 68.2;Extravillous trophoblasts: 114.3;Gastric progenitor cells: 210.2;Late primary spermatocytes: 123.2;Megakaryocyte progenitors: 74.7;Migrating cytotrophoblasts: 115.0;Oocytes: 133.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Adrenal gland - Mitotic cells (Adrenal gland), Lung - Mitotic cells (Lung), Minor Salivary Gland - Mitotic cells (Minor salivary gland), Skin - Mitotic cells (Skin), Spleen - Mitotic cells (Spleen), Stomach - Mitotic cells (Stomach), Testis - Early spermatids"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA002831			Approved	Nucleoplasm,Nucleoli			NA	Yes			"Cluster 16: Non-specific - Cell proliferation"	"Cluster 59: Lymphoid tissue & Bone marrow - Cell proliferation"	"Cluster 14: Neurons - Synaptic function"	"Cluster 45: Non-specific - Nuclear processes"	"Cluster 27: Non-specific - Cell proliferation"	13	Nucleoli	Nucleoplasm	"HPA002831: "	"unprognostic (1.32e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (3.85e-2)"	"unprognostic (9.77e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.30e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.37e-3)"	"potential prognostic unfavorable (4.08e-5)"	"unprognostic (1.38e-3)"	"potential prognostic unfavorable (9.05e-5)"	"validated prognostic unfavorable (4.37e-7)"	"validated prognostic unfavorable (4.68e-8)"	"potential prognostic unfavorable (4.74e-4)"	"unprognostic (6.41e-3)"	"unprognostic (8.28e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.37e-3)"	"unprognostic (8.08e-2)"	"potential prognostic unfavorable (5.47e-4)"	"unprognostic (1.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.70e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.52e-2)"	"unprognostic (8.34e-2)"
UBE2W	"FLJ11011, UBC-16"	ENSG00000104343	"Ubiquitin conjugating enzyme E2 W"	Q96B02	8	73780097-73878910	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 62.7;Bergmann glia: 93.2;Brain excitatory neurons: 129.1;Brain inhibitory neurons: 105.1;Choroid plexus epithelial cells: 150.9;Early spermatids: 58.8;Ependymal cells: 82.4;Late spermatids: 49.2;Microglia: 332.0;Oligodendrocyte progenitor cells: 94.7;Oligodendrocytes: 90.1;Other brain neurons: 104.5"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"				"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045161, HPA073181"	Uncertain		Approved	Nucleoli			NA	NA			"Cluster 38: Monocytes & Neutrophils - Degranulation"	"Cluster 76: Non-specific - Metabolism"	"Cluster 34: Non-specific - Mixed function"	"Cluster 40: Non-specific - Unknown function"	"Cluster 22: Non-specific - Basic cellular functions"	42	Nucleoli		"HPA045161: , HPA073181: "	"unprognostic (4.74e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.95e-3)"	"potential prognostic favorable (2.52e-6)"	"unprognostic (1.01e-1)"	"unprognostic (8.36e-2)"	"unprognostic (3.35e-3)"	"unprognostic (6.86e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.81e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.12e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-2)"	"unprognostic (5.38e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.02e-2)"
UVRAG	VPS38	ENSG00000198382	"UV radiation resistance associated"	Q9P2Y5	11	75815210-76144232	"Disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"B-cells: 672.8;cDC: 823.2;Choroid plexus epithelial cells: 870.8;Microglia: 612.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Breast - Endothelial cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016932	Uncertain						NA	NA			"Cluster 23: B-cells - Immunoglobulins"	"Cluster 44: Bone marrow - Nuclear processes"	"Cluster 50: Non-specific - Nucleic acid binding"	"Cluster 55: Lymphoma - Immune response"	"Cluster 82: Dendritic cells - Antigen presentation"	65			"HPA016932: "	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.22e-3)"	"potential prognostic unfavorable (3.55e-5)"	"potential prognostic favorable (7.49e-6)"	"unprognostic (3.55e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.79e-3)"	"unprognostic (2.51e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (4.49e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.51e-2)"	"unprognostic (4.94e-2)"